<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/2021.09.07.459276</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;2021.09.07.459276</article-id><article-id pub-id-type="other" hwp:sub-type="slug">2021.09.07.459276</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">2021.09.07.459276</article-id><article-id pub-id-type="other" hwp:sub-type="tag">2021.09.07.459276</article-id><article-version>1.2</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Microbiology" hwp:journal="biorxiv"><subject>Microbiology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1"><italic toggle="yes">Yersinia</italic> remodels epigenetic histone modifications in human macrophages</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1 xref-corresp-1-2"><label>*</label>Corresponding authors: E-mail: <email hwp:id="email-1">ibekere@uke.de</email> (IB), <email hwp:id="email-2">m.aepfelbacher@uke.de</email> (MAe)</corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" corresp="yes" hwp:id="contrib-1"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5156-2909</contrib-id><name name-style="western" hwp:sortable="Bekere Indra"><surname>Bekere</surname><given-names>Indra</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0001-5156-2909"/></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Huang Jiabin"><surname>Huang</surname><given-names>Jiabin</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Schnapp Marie"><surname>Schnapp</surname><given-names>Marie</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Rudolph Maren"><surname>Rudolph</surname><given-names>Maren</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Berneking Laura"><surname>Berneking</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-5" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Ruckdeschel Klaus"><surname>Ruckdeschel</surname><given-names>Klaus</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-6" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Grundhoff Adam"><surname>Grundhoff</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Günther Thomas"><surname>Günther</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Fischer Nicole"><surname>Fischer</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-7" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-10"><name name-style="western" hwp:sortable="Aepfelbacher Martin"><surname>Aepfelbacher</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-8" hwp:rel-id="aff-1">1</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-2" hwp:rel-id="corresp-1">*</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4 xref-aff-1-5 xref-aff-1-6 xref-aff-1-7 xref-aff-1-8"><label>1</label><institution hwp:id="institution-1">Institute of Medical Microbiology, Virology and Hygiene, Unive</institution><institution hwp:id="institution-2">rsity Medical Center Hamburg-Eppendorf (UKE)</institution>, Hamburg, <country>Germany</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2"><label>2</label><institution hwp:id="institution-3">Heinrich-Pette-Institute (HPI), Leibniz Institute for Experimental Virology, Research Group Virus Genomics</institution>, Hamburg, <country>Germany</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2021-09-07T20:03:11-07:00">
    <day>7</day><month>9</month><year>2021</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-10-23T00:03:15-07:00">
    <day>23</day><month>10</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2021-09-07T20:07:53-07:00">
    <day>7</day><month>9</month><year>2021</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-10-23T00:09:50-07:00">
    <day>23</day><month>10</month><year>2021</year>
  </pub-date><elocation-id>2021.09.07.459276</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2021-09-07"><day>07</day><month>9</month><year>2021</year></date>
<date date-type="rev-recd" hwp:start="2021-10-22"><day>22</day><month>10</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-10-22"><day>22</day><month>10</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license hwp:id="license-1"><p hwp:id="p-1">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="459276.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/2021.09.07.459276v2.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="459276.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/2021.09.07.459276v2/2021.09.07.459276v2.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/2021.09.07.459276v2/2021.09.07.459276v2.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">Various pathogens systematically reprogram gene expression in macrophages, but the underlying mechanisms are largely unknown. We investigated whether the enteropathogen <italic toggle="yes">Yersinia enterocolitica</italic> alters chromatin states to reprogram gene expression in primary human macrophages. Genome-wide chromatin immunoprecipitation (ChIP) seq analyses showed that pathogen-associated molecular patterns (PAMPs) induced up- or down-regulation of histone modifications (HMod) at approximately 14500 loci in promoters and enhancers. Effectors of <italic toggle="yes">Y. enterocolitica</italic> reorganized about half of these dynamic HMod, with the effector YopP being responsible for about half of these modulatory activities. The reorganized HMod were associated with genes involved in immune response and metabolism. Remarkably, the altered HMod also associated with 61 % of all 534 known Rho GTPase pathway genes, revealing a new level in Rho GTPase regulation and a new aspect of bacterial pathogenicity. Changes in HMod were associated to varying degrees with corresponding gene expression, e. g. depending on chromatin localization and cooperation of the HMod. In summary, infection with <italic toggle="yes">Y. enterocolitica</italic> remodels HMod in human macrophages to modulate key gene expression programs of the innate immune response.</p><sec hwp:id="sec-1"><title hwp:id="title-2">Author Summary</title><p hwp:id="p-3">Human pathogenic bacteria can affect epigenetic histone modifications to modulate gene expression in host cells. However, a systems biology analysis of this bacterial virulence mechanism in immune cells has not been performed. Here we analyzed genome-wide epigenetic histone modifications and associated gene expression changes in primary human macrophages infected with enteropathogenic <italic toggle="yes">Yersinia enterocolitica</italic>. We demonstrate that <italic toggle="yes">Yersinia</italic> virulence factors extensively modulate histone modifications and associated gene expression triggered by the pathogen-associated molecular patterns (PAMPs) of the bacteria. The epigenetically modulated genes are involved in several key pathways of the macrophage immune response, including the Rho GTPase pathway, revealing a novel level of Rho GTPase regulation by a bacterial pathogen. Overall, our findings provide an in-depth view of epigenetic and gene expression changes during host-pathogen interaction and might have further implications for understanding of the innate immune memory in macrophages.</p></sec></abstract><counts><page-count count="86"/></counts><custom-meta-wrap><custom-meta hwp:id="custom-meta-1"><meta-name>special-property</meta-name><meta-value>contains-inline-supplementary-material</meta-value></custom-meta></custom-meta-wrap><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-2">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-3">Competing Interest Statement</title><p hwp:id="p-4">The authors have declared no competing interest.</p></notes></notes></front><body><sec id="s1" hwp:id="sec-2"><title hwp:id="title-4">Introduction</title><p hwp:id="p-5">Macrophages play an essential role in the response to bacterial infection. They sense pathogen-associated molecular patterns (PAMPs) like lipopolysaccharide (LPS), nucleic acids or flagellin through Toll-like, RIG-I-like or NOD-like pattern recognition receptors (PRRs), respectively (<xref ref-type="bibr" rid="c134" hwp:id="xref-ref-134-1" hwp:rel-id="ref-134">Zhang &amp; Mosser, 2008</xref>; <xref ref-type="bibr" rid="c120" hwp:id="xref-ref-120-1" hwp:rel-id="ref-120">Takeuchi &amp; Akira, 2010</xref>). RIG-I-like and NOD-like PRRs are part of inflammasomes that process and release the major pro-inflammatory cytokines interleukin (IL)-1β and IL-18 (<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">Broz &amp; Dixit, 2016</xref>; <xref ref-type="bibr" rid="c75" hwp:id="xref-ref-75-1" hwp:rel-id="ref-75">Lupfer et al., 2015</xref>). While PRRs recognize a wide variety of PAMPs, their downstream signaling often converges on mitogen activated protein kinase- (MAPK), nuclear factor κB- (NF-κB) and type I interferon (IFN) signal pathways (<xref ref-type="bibr" rid="c79" hwp:id="xref-ref-79-1" hwp:rel-id="ref-79">Mogensen, 2009</xref>; <xref ref-type="bibr" rid="c120" hwp:id="xref-ref-120-2" hwp:rel-id="ref-120">Takeuchi &amp; Akira, 2010</xref>). These pathways include activation of transcription factors that control expression of genes for cytokines, chemokines, and inflammasome components, as well as genes for metabolism, cytoskeleton regulation, and transcriptional regulation (<xref ref-type="bibr" rid="c120" hwp:id="xref-ref-120-3" hwp:rel-id="ref-120">Takeuchi &amp; Akira, 2010</xref>; <xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">Christgen et al., 2020</xref>; <xref ref-type="bibr" rid="c102" hwp:id="xref-ref-102-1" hwp:rel-id="ref-102">Ryan &amp; O’Neill, 2020</xref>; <xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">Doyle et al., 2004</xref>; <xref ref-type="bibr" rid="c98" hwp:id="xref-ref-98-1" hwp:rel-id="ref-98">Roach et al., 2007</xref>). Thousands of functionally diverse genes are up- or downregulated by PAMPs in macrophages. Many of these genes belong to elaborate transcriptional programs that drive macrophage functions during infection. Such programs contribute crucially to the immunological phenomena of priming, tolerance (immunosuppression) and trained immunity (<xref ref-type="bibr" rid="c88" hwp:id="xref-ref-88-1" hwp:rel-id="ref-88">Park et al., 2017</xref>; <xref ref-type="bibr" rid="c104" hwp:id="xref-ref-104-1" hwp:rel-id="ref-104">Saeed et al., 2014</xref>). The inflammatory gene expression programs in macrophages form an intricate network that is characterized by crosstalk and feedback loops (<xref ref-type="bibr" rid="c88" hwp:id="xref-ref-88-2" hwp:rel-id="ref-88">Park et al., 2017</xref>; <xref ref-type="bibr" rid="c61" hwp:id="xref-ref-61-1" hwp:rel-id="ref-61">Kang et al., 2019</xref>). Because of their central role in immune defense, numerous pathogenic bacteria have developed mechanisms to suppress or modulate macrophage gene expression (<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">Diacovich &amp; Gorvel, 2010</xref>). Pathogenic <italic toggle="yes">Yersinia</italic> species, which comprise the enteropathogens <italic toggle="yes">Y. pseudotuberculosis</italic> and <italic toggle="yes">Y. enterocolitica</italic> as well as the plague agent <italic toggle="yes">Yersinia pestis</italic>, can proliferate extracellularly in lymphoid tissues of animal hosts (<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">Balada-Llasat &amp; Mecsas, 2006</xref>; <xref ref-type="bibr" rid="c125" hwp:id="xref-ref-125-1" hwp:rel-id="ref-125">Viboud &amp; Bliska, 2005</xref>). Yersiniae can on one hand exploit intracellular niches early during infection, e.g., within macrophages and dendritic cells, in order to disseminate to lymphoid tissues and organs such as spleen and liver (<xref ref-type="bibr" rid="c117" hwp:id="xref-ref-117-1" hwp:rel-id="ref-117">St. John et al., 2014</xref>; <xref ref-type="bibr" rid="c114" hwp:id="xref-ref-114-1" hwp:rel-id="ref-114">Spinner et al., 2014</xref>; <xref ref-type="bibr" rid="c93" hwp:id="xref-ref-93-1" hwp:rel-id="ref-93">Pujol et al., 2009</xref>; <xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">Drechsler-Hake et al., 2016</xref>; <xref ref-type="bibr" rid="c92" hwp:id="xref-ref-92-1" hwp:rel-id="ref-92">Pujol &amp; Bliska, 2003</xref>). On the other hand these bacteria have been shown to suppress phagocytosis, migration and immune signaling in resident cells of the innate immune system (<xref ref-type="bibr" rid="c125" hwp:id="xref-ref-125-2" hwp:rel-id="ref-125">Viboud &amp; Bliska, 2005</xref>; <xref ref-type="bibr" rid="c77" hwp:id="xref-ref-77-1" hwp:rel-id="ref-77">Marketon et al., 2005</xref>). The major virulence mechanism of pathogenic yersiniae is a type III secretion system (T3SS) by which they inject effector proteins, named <italic toggle="yes">Yersinia</italic> outer proteins (Yops), into immune cells (<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">Cornelis &amp; Wolf-Watz, 1997</xref>; <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">Galán &amp; Wolf-Watz 2006</xref>; <xref ref-type="bibr" rid="c125" hwp:id="xref-ref-125-3" hwp:rel-id="ref-125">Viboud &amp; Bliska, 2005</xref>). The seven known Yops exert different activities to suppress immune cell functions. E.g., YopE, YopT and YopO block cytoskeletal reorganization by modifying the activity of Rho GTP binding proteins (<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">Aktories et al., 2000</xref>; <xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">Aepfelbacher &amp; Wolters, 2017</xref>). Further, YopP/J, and YopM inhibit the inflammatory responses triggered by the PAMPs (e.g., LPS, heptose containing metabolites, T3SS pore or the adhesins YadA and invasin) or the effector-triggered immunity (ETI) elicited by the bacteria (<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">Brodsky et al., 2010</xref>; <xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">Chung et al., 2016</xref>; <xref ref-type="bibr" rid="c81" hwp:id="xref-ref-81-1" hwp:rel-id="ref-81">Mukherjee et al., 2006</xref>; <xref ref-type="bibr" rid="c110" hwp:id="xref-ref-110-1" hwp:rel-id="ref-110">Schubert et al., 2020</xref>; <xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">Auerbuch et al., 2009</xref>; <xref ref-type="bibr" rid="c109" hwp:id="xref-ref-109-1" hwp:rel-id="ref-109">Schmid et al., 2004</xref>; <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">Grassl et al., 2003</xref>; <xref ref-type="bibr" rid="c111" hwp:id="xref-ref-111-1" hwp:rel-id="ref-111">Schulte et al., 2000</xref>; <xref ref-type="bibr" rid="c72" hwp:id="xref-ref-72-1" hwp:rel-id="ref-72">Lopes Fischer et al., 2020</xref>). Induction of ETI is a consequence of bacterial virulence activities in host cells that disrupt cellular processes and are sensed by the host (<xref ref-type="bibr" rid="c72" hwp:id="xref-ref-72-2" hwp:rel-id="ref-72">Lopes Fischer et al., 2020</xref>). <italic toggle="yes">Yersinia</italic> triggers ETI e.g., by the T3SS translocation pore-produced membrane damage or by deactivation of Rho GTPases through YopE and YopT (<xref ref-type="bibr" rid="c110" hwp:id="xref-ref-110-2" hwp:rel-id="ref-110">Schubert et al., 2020</xref>). YopP/J acetylates and inhibits components of NF-κB and MAPK pathways and thereby profoundly suppresses pro-inflammatory gene expression downstream of TLRs (<xref ref-type="bibr" rid="c81" hwp:id="xref-ref-81-2" hwp:rel-id="ref-81">Mukherjee et al., 2006</xref>). YopM acts by both, increasing production of the anti-inflammatory cytokine IL-10 and counteracting activation of the pyrin inflammasome, which is triggered by the Yop-induced deactivation of Rho GTPases (<xref ref-type="bibr" rid="c78" hwp:id="xref-ref-78-1" hwp:rel-id="ref-78">McPhee et al., 2012</xref>; <xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">Berneking et al., 2016</xref>; <xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">Chung et al., 2016</xref>). Thus, on one hand pathogenic yersiniae contain immunostimulatory PAMPs and their T3SS effectors elicit ETI that strongly alter gene expression in macrophages. On the other hand, the bacteria employ an arsenal of activities to systematically modulate and antagonize the PAMP- and ETI triggered immune responses (<xref ref-type="bibr" rid="c91" hwp:id="xref-ref-91-1" hwp:rel-id="ref-91">Philip et al., 2016</xref>; <xref ref-type="bibr" rid="c110" hwp:id="xref-ref-110-3" hwp:rel-id="ref-110">Schubert et al., 2020</xref>; <xref ref-type="bibr" rid="c72" hwp:id="xref-ref-72-3" hwp:rel-id="ref-72">Lopes Fischer et al., 2020</xref>).</p><p hwp:id="p-6">Epigenetic mechanisms play a master role in the regulation of macrophage gene expression. Among others they i) determine the phenotypes of macrophages in different tissues and disease states, ii) control trained innate immunity, iii) regulate priming and immune tolerance and iv) integrate stimulus triggered responses (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-1" hwp:rel-id="ref-59">Ivashkiv, 2013</xref>; <xref ref-type="bibr" rid="c88" hwp:id="xref-ref-88-3" hwp:rel-id="ref-88">Park et al., 2017</xref>; <xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">Glass &amp; Natoli, 2015</xref>; <xref ref-type="bibr" rid="c104" hwp:id="xref-ref-104-2" hwp:rel-id="ref-104">Saeed et al., 2014</xref>). Gene expression in response to external stimuli is controlled by the concerted activity and binding of macrophage lineage-determining transcription factors and stimulus-regulated transcription factors to accessible cis-regulatory elements (promoters and enhancers) in the cellular chromatin (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-2" hwp:rel-id="ref-59">Ivashkiv, 2013</xref>; <xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-2" hwp:rel-id="ref-41">Glass &amp; Natoli, 2015</xref>). DNA accessibility is determined by the pre-existing epigenomic landscape, which is the sum of DNA methylation, nucleosome occupancy, pre-bound factors and histone modifications (<xref ref-type="bibr" rid="c63" hwp:id="xref-ref-63-1" hwp:rel-id="ref-63">Klemm et al., 2019</xref>). The types of histone modifications located at gene promoters and enhancers influence DNA accessibility and transcriptional activity. For instance, a trimethylated lysine at position 4 in histone 3 (H3K4me3) is characteristic for active promoters, an acetylated lysine at position 27 in histone 3 (H3K27ac) indicates active promoters and enhancers while H3K9me3 signifies repressed, transcriptionally inactive heterochromatin (<xref ref-type="bibr" rid="c95" hwp:id="xref-ref-95-1" hwp:rel-id="ref-95">Rada-Iglesias et al., 2011</xref>; <xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">Barski et al., 2007</xref>; <xref ref-type="bibr" rid="c127" hwp:id="xref-ref-127-1" hwp:rel-id="ref-127">Wang et al., 2008</xref>). Most posttranslational histone modifications are transient and their turnover is regulated by enzymes that mediate their deposition or deletion (<xref ref-type="bibr" rid="c131" hwp:id="xref-ref-131-1" hwp:rel-id="ref-131">Yun et al., 2011</xref>; <xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">Allis &amp; Jenuwein, 2016</xref>). Bacterial PAMP-induced signaling has been shown to intensely modulate histone modifications and this has been implicated in priming, immune tolerance and trained immunity in macrophages (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-3" hwp:rel-id="ref-59">Ivashkiv, 2013</xref>; <xref ref-type="bibr" rid="c88" hwp:id="xref-ref-88-4" hwp:rel-id="ref-88">Park et al., 2017</xref>; <xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">Dong &amp; Hamon, 2020</xref>; <xref ref-type="bibr" rid="c104" hwp:id="xref-ref-104-3" hwp:rel-id="ref-104">Saeed et al., 2014</xref>). Consequently, numerous pathogens can interfere with histone modifications in host cells using unique and sophisticated strategies (<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">Connor et al., 2019</xref>; <xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">Bierne et al., 2012</xref>; <xref ref-type="bibr" rid="c99" hwp:id="xref-ref-99-1" hwp:rel-id="ref-99">Rolando et al., 2013</xref>).</p><p hwp:id="p-7">The current understanding of how <italic toggle="yes">Yersinia</italic> modulates gene expression in macrophages is that it uses its effectors YopP and YopM to interfere with PAMP-induced MAP-kinase and NF-kB signaling to the nucleus (<xref ref-type="bibr" rid="c110" hwp:id="xref-ref-110-4" hwp:rel-id="ref-110">Schubert et al., 2020</xref>). Previous microarray or RNA-seq studies of <italic toggle="yes">Yersinia</italic> effects on gene expression were so far conducted in <italic toggle="yes">Y. pestis</italic> infected rat lymph nodes (<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">Comer et al., 2010</xref>), African green monkeys (<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">Chakraborty et al., 2019</xref>; <xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">Hammamieh et al., 2016</xref>) and neutrophils (<xref ref-type="bibr" rid="c118" hwp:id="xref-ref-118-1" hwp:rel-id="ref-118">Subrahmanyam et al., 2001</xref>), in <italic toggle="yes">Y. pseudotuberculosis</italic> infected mouse cecum (<xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">Heine et al., 2018</xref>) and Peyer’s patches (<xref ref-type="bibr" rid="c84" hwp:id="xref-ref-84-1" hwp:rel-id="ref-84">Nuss et al., 2017</xref>) as well as in <italic toggle="yes">Y. enterocolitica</italic> infected epithelial and NK cells (<xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">Bohn et al., 2004</xref>; <xref ref-type="bibr" rid="c64" hwp:id="xref-ref-64-1" hwp:rel-id="ref-64">Koch et al., 2013</xref>). In macrophages systematic gene expression analysis was performed during <italic toggle="yes">Y. enterocolitica</italic> or <italic toggle="yes">Y. pseudotuberculosis</italic> infection of cultured mouse macrophages for up to 4 h and utilizing microarrays (<xref ref-type="bibr" rid="c106" hwp:id="xref-ref-106-1" hwp:rel-id="ref-106">Sauvonnet et al., 2002</xref>; <xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">Hoffmann et al., 2004</xref>; <xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">Auerbuch et al., 2009</xref>; <xref ref-type="bibr" rid="c133" hwp:id="xref-ref-133-1" hwp:rel-id="ref-133">Zhang et al., 2005</xref>). Here we employed primary human macrophages and genome wide chromatin immunoprecipitation (ChIP)-seq and RNA-seq technologies to globally analyze histone modifications and associated gene expression patterns for up to 6 h of <italic toggle="yes">Y. enterocolitica</italic> infection. We uncover a profound and coordinated reorganization of histone modifications as basis for systematic <italic toggle="yes">Yersinia</italic> effects on gene expression in macrophages. In addition to extensive modulation of histone modifications at inflammatory, immune response and metabolism genes, we found that the bacteria caused alterations of histone modifications at 61 % of all 534 known Rho GTPase pathway genes in macrophages. These results describe the previously unrecognized strategy of pathogenic <italic toggle="yes">Yersinia</italic> to modulate specific gene expression programs in innate immune cells through the systematic reorganization of histone modifications.</p></sec><sec id="s2" hwp:id="sec-3"><title hwp:id="title-5">Results</title><sec id="s2a" hwp:id="sec-4"><title hwp:id="title-6">Global reorganization of histone modifications in macrophages upon <italic toggle="yes">Yersinia enterocolitica</italic> infection</title><p hwp:id="p-8">We first investigated on a global scale whether <italic toggle="yes">Y. enterocolitica</italic> alters histone modification patterns in human macrophages (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-4" hwp:rel-id="ref-59">Ivashkiv, 2013</xref>). For this, <italic toggle="yes">in vitro</italic> differentiated primary human macrophages (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-1" hwp:rel-id="F7">S1A Fig</xref>) were mock infected or infected with <italic toggle="yes">Y. enterocolitica</italic> wild type strain WA314 or its avirulent derivative WAC and subjected to chromatin immunoprecipitation (ChIP)-seq (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig 1A</xref>). WAC lacks a T3SS and therefore was used to separate the effects of the <italic toggle="yes">Yersinia</italic> PAMPs from the T3SS associated effects (for strains employed in this study see S1 Table). We investigated cells after infection with a multiplicity of infection (MOI) 100 for 6 h, conditions at which 100 % of cells were positive for translocated Yops (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-2" hwp:rel-id="F7">S1A Fig</xref>) and a maximal effect on gene expression (<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-2" hwp:rel-id="ref-12">Berneking et al., 2016</xref>) and histone modifications (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-3" hwp:rel-id="F7">S1B Fig</xref>) but no signs of cell death as measured by membrane permeability (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-4" hwp:rel-id="F7">S1C Fig</xref>) and caspase-3 cleavage (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-5" hwp:rel-id="F7">S1D Fig</xref>; <xref ref-type="bibr" rid="c100" hwp:id="xref-ref-100-1" hwp:rel-id="ref-100">Ruckdeschel et al., 1997</xref>; <xref ref-type="bibr" rid="c105" hwp:id="xref-ref-105-1" hwp:rel-id="ref-105">Sarhan et al., 2018</xref>) are detectable in the human macrophages.</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7 xref-fig-1-8 xref-fig-1-9 xref-fig-1-10 xref-fig-1-11 xref-fig-1-12 xref-fig-1-13 xref-fig-1-14 xref-fig-1-15 xref-fig-1-16 xref-fig-1-17"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig 1.</label><caption hwp:id="caption-1"><title hwp:id="title-7">Changes of epigenetic histone modifications in <italic toggle="yes">Y. enterocolitica</italic> infected primary human macrophages.</title><p hwp:id="p-9"><bold>A,</bold> Experimental design. CD14<sup>+</sup> monocytes were isolated and differentiated into macrophages by cultivation with 20 % human serum for 6 days. Macrophages from <underline>&gt;</underline> two independent donors were mock infected or infected with avirulent <italic toggle="yes">Y. enterocolitica</italic> strain WAC, wild type strain WA314 or the single Yop-mutant strains WA314ΔYopM and WA314ΔYopP with multiplicity-of-infection (MOI) of 100 for 6 h. Samples were subjected to ChIP-seq for histone modifications H3K27ac, H3K4me3 and RNA-seq. H3K4me1 and H3K27me3 ChIP-seq was performed only for mock, WAC and WA314 infected macrophages. For all replicates used in the analysis see Table S17.</p><p hwp:id="p-10"><bold>B,</bold> Bar plot showing proportions of dynamic and constant regions of ChIP-seq data obtained from mock-, WAC- and WA314 infected macrophages as described in <bold>(A)</bold>. Dynamic regions were defined as MACS (H3K4me3, H3K27ac) or SICER (H3K4me1, H3K27me3) peaks overlapping significantly (≥ 2-fold change, adjusted P-value ≤ 0.05) up- or down-regulated differentially enriched regions from diffReps in the three pairwise comparisons WAC vs mock, WA314 vs mock and WAC vs WA314.</p><p hwp:id="p-11"><bold>C,</bold> Bar plot showing distribution of dynamic regions from <bold>(B)</bold> at gene promoters and enhancers.</p><p hwp:id="p-12"><bold>D,</bold> Heatmap showing Spearman correlation (cor.) of H3K27ac tag density at all H3K27ac peaks from mock-, WAC- and WA314-infected samples and publicly available H3K27ac ChIP-seq data of naive* and LPS* treated macrophages. Low to high correlation is indicated by blue-white-red colour scale.</p><p hwp:id="p-13"><bold>E,</bold> Number of differentially enriched regions (diffReps ≥ 2-fold change, adjusted P-value ≤ 0.05) for the indicated histone marks. Total (unique) refers to all unique regions in each row or column after merging overlapping regions.</p><p hwp:id="p-14"><bold>F, G,</bold> Venn diagrams showing overlaps of differentially enriched regions from diffReps depicting suppression of WAC induced upregulation of H3K4me3 marks by WA314 <bold>(F)</bold> and suppression of WAC induced up-regulation of H3K27ac marks by WA314 or prevention of WAC induced down-regulation of H3K27ac marks by WA314 <bold>(G)</bold>.</p><p hwp:id="p-15"><bold>H,</bold> Bar plot showing the number of genes associated with promoters, enhancers or both for the indicated histone marks associated with dynamic regions in <bold>(E)</bold> or when taking all regions together (total).</p></caption><graphic xlink:href="459276v2_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-16">ChIP-seq analyzes were performed for four histone-3 (H3) marks whose impact on macrophage gene expression has been well established: H3K4me3, indicating active promoters; H3K4me1, which is highly enriched at distal regulatory elements (enhancers); H3K27ac, indicating active promoters and enhancers; and H3K27me3 indicating inactive promoters and enhancers (<xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">Heintzman et al., 2009</xref>; <xref ref-type="bibr" rid="c95" hwp:id="xref-ref-95-2" hwp:rel-id="ref-95">Rada-Iglesias et al., 2011</xref>; <xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">Barski et al., 2007</xref>; <xref ref-type="bibr" rid="c127" hwp:id="xref-ref-127-2" hwp:rel-id="ref-127">Wang et al., 2008</xref>). Successful ChIP was confirmed using ChIP-qPCR with positive and negative control primers for different histone marks (<xref ref-type="fig" rid="figs2" hwp:id="xref-fig-8-1" hwp:rel-id="F8">S2A Fig</xref>). Dynamic regions were defined as those exhibiting at least a 2-fold change in any pairwise comparison between mock-, WA314- or WAC infected macrophages. Overall, H3K27ac peaks were the most dynamic (43 %) followed by H3K4me3 peaks (7 %), H3K4me1 regions (3 %) and H3K27me3 regions (0.1 %) (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig 1B</xref>). Around half of the dynamic H3K4me3 peaks and H3K4me1 regions and one fourth of the dynamic H3K27ac peaks were at promoters (+/− 2 kb from transcription start site; <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Fig 1C</xref>). The remaining half of the dynamic H3K4me3 peaks and H3K4me1 regions and three fourth of the dynamic H3K27ac peaks were at enhancers (H3K4me1-enriched regions outside promoters; <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Fig 1C</xref>).</p><p hwp:id="p-17">A Spearman correlation heatmap of the H3K27ac peaks and two corresponding datasets published elsewhere from naive and <italic toggle="yes">E. coli</italic> LPS-stimulated primary human macrophages (<xref ref-type="bibr" rid="c88" hwp:id="xref-ref-88-5" hwp:rel-id="ref-88">Park et al., 2017</xref>; <xref ref-type="bibr" rid="c83" hwp:id="xref-ref-83-1" hwp:rel-id="ref-83">Novakovic et al., 2016</xref>) revealed i) a strong correlation between WAC infected and LPS-treated macrophages (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Fig 1D</xref>), indicating that the PAMP-induced histone modifications are to a large part caused by LPS, although yersiniae possess a number of additional PAMPs (<xref ref-type="bibr" rid="c96" hwp:id="xref-ref-96-1" hwp:rel-id="ref-96">Reinés et al., 2012</xref>; <xref ref-type="bibr" rid="c136" hwp:id="xref-ref-136-1" hwp:rel-id="ref-136">Zhou et al., 2018</xref>; <xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-2" hwp:rel-id="ref-18">Brodsky et al., 2010</xref>); ii) a close similarity between the mock-infected macrophages in our study and the naïve macrophages employed in other studies, and iii) a higher similarity of WA314 infected macrophages to naïve and mock-infected macrophages than to WAC- and LPS infected macrophages (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Fig 1D</xref>). This likely reflects suppression of PAMP/LPS-induced H3K27ac modifications by the T3SS effectors of WA314 (<xref ref-type="bibr" rid="c110" hwp:id="xref-ref-110-5" hwp:rel-id="ref-110">Schubert et al., 2020</xref>).</p><p hwp:id="p-18">We evaluated whether histone marks were significantly (≥ 2-fold change, adjusted P-value ≤ 0.05) up- or down-regulated in the three pairwise comparisons WAC vs mock, WA314 vs mock and WAC vs WA314 (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Fig 1E</xref>; S18 Table). An eminent result was that, consistently, around 14-times more H3K27ac regions than H3K4me3 regions were dynamic (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-8" hwp:rel-id="F1">Fig 1E</xref>; S18 Table). Further, 2156 unique H3K4me1 regions were dynamic whereas H3K27me3 regions were essentially unaltered under these conditions (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-9" hwp:rel-id="F1">Fig 1E</xref>; S18 Table), further suggesting that H3K27me3 marks are not affected by <italic toggle="yes">Yersinia</italic> infection in macrophages. WAC up- and down-regulated histone modifications at 14559 unique loci vs mock, reflecting the effect of the PAMPs (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-10" hwp:rel-id="F1">Fig 1E</xref>). As determined by comparison with the WAC effects, WA314 inhibited the up regulation of 571 H3K4me3 regions (53 %; <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-11" hwp:rel-id="F1">Fig 1F</xref>) and 2881 H3K27ac regions (42 %; <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-12" hwp:rel-id="F1">Fig 1G</xref>) and inhibited the down regulation of 2627 H3K27ac regions (40 %; <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-13" hwp:rel-id="F1">Fig 1G</xref>).</p><p hwp:id="p-19">Further analysis revealed that histone modification patterns were modified at promoters of 6228 genes and at enhancers of 7730 genes, whereby 2964 genes were modified both at the promoter and nearby enhancer regions (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-14" hwp:rel-id="F1">Fig 1H</xref>). We conclude that <italic toggle="yes">Y. enterocolitica</italic> triggers extensive reprogramming of chromatin states in human macrophages by regulating H3K27ac-, H3K4me1- and H3K4me3 marks at promoters and enhancers of about 11000 genes (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-15" hwp:rel-id="F1">Fig 1H</xref>).</p></sec><sec id="s2b" hwp:id="sec-5"><title hwp:id="title-8"><italic toggle="yes">Y. enterocolitica</italic> virulence factors suppress PAMP-induced histone modifications at promoters and enhancers</title><p hwp:id="p-20">We investigated the bacteria induced reprogramming of histone modifications at promoters and enhancers in more detail. By genome wide analysis of dynamic H3K27ac and H3K4me3 regions at promoters of mock-, WAC- and WA314 infected macrophages we identified 10 clusters which could be assigned to 6 classes and 2 modules (Methods; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig 2A</xref>, S2 Table). Promoter module 1 (P1) contains dynamic H3K4me3- and H3K27ac regions that change concordantly (classes P1a, b; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Figs 2A, B</xref>). Promoter module 2 (P2) contains dynamic H3K27ac regions at largely constant H3K4me3 regions (classes P2a-d; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Figs 2A, B</xref>). The patterns of histone modifications in the classes were clearly distinct and assigned to 4 different profiles. In profile “Suppression”, WAC increases deposition of histone marks and this is suppressed by WA314 (P1a and P2a; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Figs 2A-C</xref>). In profile “Prevention”, WAC downregulates histone marks and this is prevented by WA314 (P1b and P2d; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Figs 2A-C</xref>). In profile “Down”, WA314 selectively downregulates H3K27ac marks when compared to mock and WAC (P2b; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-6" hwp:rel-id="F2">Figs 2A-C</xref>). In profile “Up” WA314 selectively upregulates H3K27ac marks when compared to mock and WAC (P2c; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-7" hwp:rel-id="F2">Figs 2A-C</xref>). These profiles are also illustrated by tag densities of H3K4me3 and H3K27ac ChIP-seq at promoters of selected genes (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-8" hwp:rel-id="F2">Figs 2C</xref>). WA314 strongly counteracted the PAMP-induced up- and downregulation of histone modifications at promoters in Suppression and Prevention profiles, which was also confirmed by ChIP-qPCR analysis of H3K4me3 and H3K27ac for IL6, IL1B and PTGS2 (Suppression) and ASB2 and CEBPE (Prevention) genes (<xref ref-type="fig" rid="figs2" hwp:id="xref-fig-8-2" hwp:rel-id="F8">S2B Fig</xref>). However, WA314 counter-regulation often was not complete therefore the levels of histone modifications in WA314 infected cells were frequently in between the levels in mock- and WAC infected macrophages (e.g. in Suppression profile classes P1a and P2a; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-9" hwp:rel-id="F2">Figs 2A, B</xref>).</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5 xref-fig-2-6 xref-fig-2-7 xref-fig-2-8 xref-fig-2-9 xref-fig-2-10 xref-fig-2-11 xref-fig-2-12 xref-fig-2-13 xref-fig-2-14 xref-fig-2-15 xref-fig-2-16 xref-fig-2-17 xref-fig-2-18 xref-fig-2-19 xref-fig-2-20"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig 2.</label><caption hwp:id="caption-2"><title hwp:id="title-9">Dynamic chromatin modifications at promoters and enhancers in <italic toggle="yes">Y. enterocolitica</italic> infected macrophages.</title><p hwp:id="p-21"><bold>A,</bold> Heatmap showing clustering of all H3K4me3 (module P1) and H3K27ac (module P2) differentially enriched regions at promoters in mock-, WAC- and WA314 infected human macrophages. P1 contains dynamic H3K4me3 regions and P2 contains dynamic H3K27ac regions at largely constant H3K4me3 regions. H3K4me3 and H3K27ac tag densities are shown in both modules. The identified clusters (colour coded bars on the left side) were grouped in classes P1a-P2d.</p><p hwp:id="p-22"><bold>B,</bold> Boxplots of H3K4me3 and H3K27ac tag counts for the classes in <bold>(A)</bold>. Profiles describing relation of histone mark levels between mock, WAC and WA314 are indicated on top. Data are representative of at least two independent experiments.</p><p hwp:id="p-23"><bold>C</bold> Peak tracks of H3K4me3 (red) and H3K27ac (blue) ChIP-seq tag densities at promoter regions of the genes OASL from Suppression profile classes P1a and ACOT7 from Prevention profile class P1b (left) and ZNF513 from Down profile class P2b and SLC30A3 from Up profile class P2c (right).</p><p hwp:id="p-24"><bold>D,</bold> Heatmap showing clustering of H3K27ac differentially enriched regions at enhancers of mock-, WAC- and WA314 infected macrophages. H3K4me1 tag counts are shown for the associated regions. Clustering analysis yielded 6 clusters (color coded, left side) which were assembled into classes E1-4.</p><p hwp:id="p-25"><bold>E,</bold> Boxplot of H3K27ac tag counts of classes E1-E4 in <bold>(D)</bold>. Profiles describing relation of histone mark levels between mock, WAC and WA314 are indicated on top. Data are representative of two independent experiments.</p><p hwp:id="p-26"><bold>F,</bold> Heatmap showing H3K4me1 and H3K27ac tag counts at latent enhancers induced by WAC vs mock. For <bold>(A)</bold>, <bold>(D)</bold> and <bold>(F)</bold> rows are genomic regions from −10 to +10 kb around the centre of the analyzed regions. “n” indicates number of regions.</p></caption><graphic xlink:href="459276v2_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-27">We further sought to investigate in detail the <italic toggle="yes">Yersinia</italic> induced reprogramming of histone modifications at distal regulatory elements/enhancers. A genome wide heatmap of dynamic H3K27ac regions at enhancer regions, characterized by the presence of H3K4me1 marks, was prepared in mock-, WAC- and WA314 infected macrophages (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-10" hwp:rel-id="F2">Fig 2D</xref>, S3 Table). Six clusters comprising altogether 16408 dynamic enhancers were identified and assembled into four classes (E1-E4; <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-11" hwp:rel-id="F2">Fig 2D</xref>). Analogous to the promoter classes, the enhancer classes E1, E2, E3 and E4 correspond to Suppression, Down, Up and Prevention profiles, respectively (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-12" hwp:rel-id="F2">Fig 2E</xref>). In unstimulated macrophages (mock) enhancers were either poised (no or low level of H3K27ac marks; E1 and E3) or constitutive (presence of H3K27ac marks; E2 and E4) (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-13" hwp:rel-id="F2">Figs 2D, E</xref>; Ostuni et al., 2010). WAC infection activated poised enhancers by increasing H3K27ac marks (E1) or repressed constitutive enhancers by decreasing H3K27ac marks (E4) (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-14" hwp:rel-id="F2">Figs 2D, E</xref>). WA314 inhibited the WAC induced up-regulation of poised enhancers in Suppression profile E1 and down-regulation of constitutive enhancers in Prevention profile E4 (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-15" hwp:rel-id="F2">Figs 2D, E</xref>). WA314 also down-regulated constitutive enhancers in Down profile E2 and up-regulated poised enhancers in Up profile E3 (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-16" hwp:rel-id="F2">Figs 2D, E</xref>).</p><p hwp:id="p-28">We also investigated the effect of <italic toggle="yes">Yersinia</italic> on latent enhancers, defined by the initial absence of H3K4me1- and H3K27ac marks (Ostuni et al., 2010). We identified 149 latent enhancers in mock infected macrophages that gained H3K4me1- and H3K27ac marks upon WAC infection, which converts these latent enhancers into a constitutive state (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-17" hwp:rel-id="F2">Fig 2F</xref>, S4 Table). WA314 also increased H3K4me1 levels but did not produce an increase of H3K27ac levels in most of these latent enhancers (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-18" hwp:rel-id="F2">Fig 2F</xref>). Thus, WA314 infection does not inhibit the unveiling of latent enhancers and their conversion into a poised state by the bacterial PAMPs, but suppresses their transition to a constitutive state.</p><p hwp:id="p-29">In summary, four profiles describe how <italic toggle="yes">Y. enterocolitica</italic> alters H3K4me3 and H3K27ac marks at macrophage promoters and enhancers. In the profiles Suppression and Prevention, the bacteria’s virulence plasmid-encoded factors block the PAMP-induced deposition or removal of H3K4me3- and H3K27ac marks, respectively. In profiles Down and Up the T3SS-associated effectors down- or up-regulate, respectively, H3K27ac marks.</p></sec><sec id="s2c" hwp:id="sec-6"><title hwp:id="title-10"><italic toggle="yes">Yersinia</italic> reorganization of histone marks and gene expression targets central immune pathways in macrophages</title><p hwp:id="p-30">We asked to what extent the histone modifications reprogrammed by the bacteria associate with expression of the corresponding genes. Therefore, infected macrophages were analyzed by RNA-seq in parallel to ChIP-seq (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-16" hwp:rel-id="F1">Fig 1A</xref>). 6148 differentially expressed genes (DEGs) were altogether found in three pairwise comparisons (WAC vs mock, WA314 vs mock and WAC vs WA314; <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Fig 3A</xref>; <xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-1" hwp:rel-id="F11">S5</xref> and S6 Tables). Four classes (R1-R4) were identified in the DEGs which corresponded to Suppression- (R1), Down- (R2), Up- (R3) or Prevention (R4) profiles (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Fig 3A</xref> and S6 Table). WAC up-regulated 3020 genes (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Fig 3B</xref>) and down-regulated 2152 genes (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Fig 3C</xref>) vs mock reflecting the transcriptional response of macrophages to the PAMPs of <italic toggle="yes">Y. enterocolitica.</italic> In the Suppression profile, 42 % of the genes upregulated by WAC were not or only partly upregulated by WA314 (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Fig 3B</xref>). In the Prevention profile, 39 % of the genes downregulated by WAC were not or much less downregulated by WA314 (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-6" hwp:rel-id="F3">Fig 3C</xref>). RT-qPCR analysis confirmed WA314 counteraction of PAMP-induced changes in mRNA levels for PPARGC1B (Prevention) and ABI1, IL1B and TNF (Suppression) genes (<xref ref-type="fig" rid="figs2" hwp:id="xref-fig-8-3" hwp:rel-id="F8">S2C Fig</xref>). WA314 often did not completely reverse the PAMP-induced up- or downregulation of genes, as shown by the fact that gene expression levels in the WA314 infected cells were frequently in between mock- and WAC infected macrophages (e.g. in classes R1 and R4, <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-7" hwp:rel-id="F3">Fig 3A</xref>). Thus, coinciding with histone modifications, gene expression is modulated extensively by <italic toggle="yes">Y. enterocolitica</italic> in human macrophages and can also be divided into Suppression-, Down-, Up-, and Prevention profiles.</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5 xref-fig-3-6 xref-fig-3-7 xref-fig-3-8 xref-fig-3-9 xref-fig-3-10 xref-fig-3-11 xref-fig-3-12 xref-fig-3-13 xref-fig-3-14 xref-fig-3-15 xref-fig-3-16 xref-fig-3-17 xref-fig-3-18 xref-fig-3-19 xref-fig-3-20 xref-fig-3-21 xref-fig-3-22 xref-fig-3-23 xref-fig-3-24 xref-fig-3-25 xref-fig-3-26 xref-fig-3-27 xref-fig-3-28 xref-fig-3-29 xref-fig-3-30 xref-fig-3-31 xref-fig-3-32 xref-fig-3-33"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Fig 3.</label><caption hwp:id="caption-3"><title hwp:id="title-11">Association between histone modifications and gene expression in <italic toggle="yes">Y. enterocolitica</italic> infected macrophages.</title><p hwp:id="p-31"><bold>A,</bold> Heatmap from clustering of all DEGs from mock, WAC and WA314 comparisons. Clustering identified 4 major classes R1-R4 (color coded, right side). Profiles describing relation of expression levels between mock, WAC and WA314 are indicated on the left. In the heatmap, gene rlog counts are row-scaled (row Z-score).</p><p hwp:id="p-32"><bold>B, C,</bold> Venn diagrams of DEG overlaps between WAC vs mock up and WAC vs WA314 up <bold>(B)</bold> and WAC vs mock down and WAC vs WA314 down <bold>(C)</bold>. Overlaps show the number of genes whose up-regulation by WAC is suppressed by WA314 <bold>(B)</bold> and whose down-regulation by WAC is prevented by WA314 <bold>(C)</bold>.</p><p hwp:id="p-33"><bold>D,</bold> Barplot showing percentage of genes from ChIP-seq profiles with promoter or enhancer modifications overlapping with corresponding RNA-seq profiles from DEG analysis.</p><p hwp:id="p-34"><bold>E,</bold> Heatmap presentation showing relative overlap of genes in promoter classes P1a-P2d and enhancer classes E1-4. Light to dark color scale indicates low to high overlap.</p><p hwp:id="p-35"><bold>F,</bold> Barplot showing percentage of genes with coordinated promoter and enhancer changes from ChIP-seq profiles in <bold>(E)</bold> overlapping with corresponding RNA-seq profiles.</p><p hwp:id="p-36"><bold>G,</bold> Bar plot showing fraction and number (numbers in bars) of genes from RNA-seq profiles overlapping with genes from corresponding ChIP-seq profiles at promoters or enhancers. <bold>H,</bold> Bar plot showing enriched GO and KEGG (hsa prefix) terms for genes overlapping in RNA-seq and ChIP-seq as in <bold>(G)</bold>. Bars represent log10 transformed P-values correlating with significance of enrichment. Pos: positive, reg: regulation, pol: polymerase, prom: promoter.</p><p hwp:id="p-37"><bold>I-K,</bold> Heatmaps of row-scaled (row Z-score) RNA-seq rlog gene counts for genes with RNA-seq and ChIP-seq promoter or enhancer overlaps from pathways in <bold>(H)</bold>.</p><p hwp:id="p-38"><bold>J,</bold> Representative enriched transcription factor motifs in promoter and enhancer regions of genes with RNA-seq and ChIP-seq (promoter or enhancer) overlaps as in <bold>(G)</bold>.</p></caption><graphic xlink:href="459276v2_fig3" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-39">We evaluated all individual histone modifications which associated with gene expression changes in the different profiles and found that Suppression-, Down-, Up- and Prevention profiles showed on average 30 %, 2 %, 4 % and 16 % corresponding gene expression changes, respectively (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-8" hwp:rel-id="F3">Fig 3D</xref>). Overlap between histone modifications and gene expression was stronger for H3K4me3 and H3K27ac changes at promoters (8-81 % overlap; <xref ref-type="fig" rid="figs3" hwp:id="xref-fig-9-1" hwp:rel-id="F9">S3A-C Figs</xref>) than for H3K27ac changes at enhancers (5-29 % overlap; <xref ref-type="fig" rid="figs3" hwp:id="xref-fig-9-2" hwp:rel-id="F9">S3D Fig</xref>), indicating that enhancer modifications associate with direct gene expression to a lesser extent than promoter modifications.</p><p hwp:id="p-40">To find out whether histone modifications at promoters and enhancers cooperate to regulate gene expression, we analyzed pairwise overlaps of genes associated with promoter- and enhancer classes (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-9" hwp:rel-id="F3">Fig 3E</xref>). The strongest overlaps occurred in classes belonging to the same profiles: P1a/P2a/E1 (Suppression), P2b/E2 (Down), P2c/E3 (Up) and P1b/P2d/E4 (Prevention) (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-10" hwp:rel-id="F3">Fig 3E</xref>). We found that 57 % of the genes overlapping in the Suppression profile classes and 26 % of the genes overlapping in the Prevention profile classes showed corresponding changes in gene expression (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-11" hwp:rel-id="F3">Fig 3F</xref>). In comparison, only 4 % and 3 % of genes associated with histone modifications in the Down and Up profile classes, respectively, showed expression changes (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-12" hwp:rel-id="F3">Fig 3F</xref>). We conclude that reprogramming of histone modifications upon <italic toggle="yes">Y. enterocolitica</italic> infection in macrophages can cause significant changes in gene expression. The size of the effect displays a very wide range from 2 to over 80 % and strongly depends on the localization (promoter or enhancers), cooperation (e.g. at promoters or between related promoters and enhancers) and profile of the histone modifications.</p><p hwp:id="p-41">To address the question which biological pathways are regulated by the epigenetic reprogramming upon <italic toggle="yes">Yersinia</italic> infection, we subjected all DEGs in the different expression classes/profiles that are associated with histone modifications (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-13" hwp:rel-id="F3">Fig 3G</xref>) to Gene Ontology (GO) and KEGG analysis (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-14" hwp:rel-id="F3">Fig 3H</xref>). In profiles Suppression, Down, Up and Prevention, 51 %, 19 %, 19 % and 36 % of DEGs, respectively, were associated with at least one corresponding histone modification change (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-15" hwp:rel-id="F3">Fig 3G</xref>). Thus, the proportion of gene expression changes that is associated with histone modifications is clearly higher than the proportion of histone modifications that is associated with corresponding gene expression changes (compare <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-16" hwp:rel-id="F3">Fig 3D</xref> and <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-17" hwp:rel-id="F3">Fig 3G</xref>). Suppression profile genes were most highly enriched in inflammatory response, type I interferon signaling and apoptotic process (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-18" hwp:rel-id="F3">Fig 3H</xref>) and mainly encode pro-inflammatory cytokines, chemokines, feedback regulators (like TNFAIPs) and type I IFN signaling mediators (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-19" hwp:rel-id="F3">Fig 3I</xref>, <xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-1" hwp:rel-id="F10">S4A Fig</xref>). Down profile was enriched in regulation of transcription (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-20" hwp:rel-id="F3">Fig 3H</xref>) containing CEBPE and FOS (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-21" hwp:rel-id="F3">Fig 3J</xref>). CEBPE regulates myeloid lineage differentiation (<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">Bedi et al., 2009</xref>), inflammasome activation and interferon signaling (<xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">Göös et al., 2019</xref>). FOS encoding c-Fos protein is a part of AP1 complex, which regulates macrophage differentiation and long range enhancer interactions (<xref ref-type="bibr" rid="c90" hwp:id="xref-ref-90-1" hwp:rel-id="ref-90">Phanstiel et al., 2017</xref>), suppresses pro-inflammatory cytokine and IL-10 expression and increases lysosome mediated bacterial killing (<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">Hop et al., 2018</xref>). Up profile genes were enriched in Wnt signaling (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-22" hwp:rel-id="F3">Figs 3H, J</xref>), which directs macrophage differentiation, regulates expression of key anti-inflammatory mediators and modulates phagocytosis (<xref ref-type="bibr" rid="c76" hwp:id="xref-ref-76-1" hwp:rel-id="ref-76">Malsin et al., 2019</xref>). Prevention profile genes were enriched in pathways involving regulation of GTPases, including mostly Rho GTPase pathway genes (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-23" hwp:rel-id="F3">Figs 3H, K</xref>) and in metabolic pathways (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-24" hwp:rel-id="F3">Fig 3H</xref>), including 22 genes for the metabolism of cholesterol, fatty acids, acyl-CoA or glucose (S7 Table). Suppression profile genes associated with latent enhancers (<xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-19" hwp:rel-id="F2">Fig 2F</xref>) were enriched among others in negative regulation of transcription and inflammatory signaling (<xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-2" hwp:rel-id="F10">S4B Fig</xref>).</p><p hwp:id="p-42">Pathogenic <italic toggle="yes">Yersinia</italic> exploit a variety of host signaling pathways for pathogenesis such as MAP kinase (<xref ref-type="bibr" rid="c81" hwp:id="xref-ref-81-3" hwp:rel-id="ref-81">Mukherjee et al., 2006</xref>), PI3K/ Akt (<xref ref-type="bibr" rid="c107" hwp:id="xref-ref-107-1" hwp:rel-id="ref-107">Sauvonnet et al., 2002b</xref>), cell death (<xref ref-type="bibr" rid="c105" hwp:id="xref-ref-105-2" hwp:rel-id="ref-105">Sarhan et al., 2018</xref>) and trafficking pathways, e.g., involving Rab GTPases (<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">Connor et al., 2018</xref>). Notably, gene expressions and histone modifications belonging to these pathways are also modulated by <italic toggle="yes">Yersinia</italic> T3SS effectors (Table S16). For instance, <italic toggle="yes">Yersinia</italic> was shown to inhibit activation of the MAPK pathway (<xref ref-type="bibr" rid="c81" hwp:id="xref-ref-81-4" hwp:rel-id="ref-81">Mukherjee et al., 2006</xref>) and several MAPK kinases and phosphatases were found to be suppressed by plasmid-encoded virulence factors in the Suppression profile (<xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-3" hwp:rel-id="F10">S4C Fig</xref>). Furthermore, both Suppression and Prevention profiles contained genes from Rab GTPase signaling (<xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-4" hwp:rel-id="F10">S4D Fig</xref>), which is exploited by pathogenic <italic toggle="yes">Yersinia</italic> to promote intracellular survival (<xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">Connor et al., 2018</xref>).</p><p hwp:id="p-43">Analysis of transcription factor (TF) motif enrichment revealed binding sites of inflammatory regulators from the RHD- (NFkB-p65-Rel), IRF- (ISRE, IRF2) and bZIP- (Fra2, Fosl2, Jun-AP1) families in Suppression profile genes (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-25" hwp:rel-id="F3">Fig 3J</xref>, <xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-5" hwp:rel-id="F10">S4E Fig</xref>). No transcription factor motifs were enriched in Down profile. Up profile was enriched for RHD (NFkB-p65-Rel) binding sites (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-26" hwp:rel-id="F3">Fig 3J</xref>, <xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-6" hwp:rel-id="F10">S4E Fig</xref>) indicating that <italic toggle="yes">Yersinia</italic> effector activities can lead to increased gene expression also through regulation of NF-κB signaling. Prevention profile genes were enriched for distinct motifs from ETS (SpiB, PU.1) family (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-27" hwp:rel-id="F3">Fig 3J</xref>, <xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-7" hwp:rel-id="F10">S4E Fig</xref>). ETS TFs are known to interact extensively with other TFs (<xref ref-type="bibr" rid="c124" hwp:id="xref-ref-124-1" hwp:rel-id="ref-124">Verger &amp; Duterque-Coquillaud, 2002</xref>) and play a role in cytokine gene expression (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">Gao et al., 2016</xref>; <xref ref-type="bibr" rid="c67" hwp:id="xref-ref-67-1" hwp:rel-id="ref-67">Lennard Richard et al., 2014</xref>; <xref ref-type="bibr" rid="c85" hwp:id="xref-ref-85-1" hwp:rel-id="ref-85">O’Reilly et al., 2003</xref>; <xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">Gallant &amp; Gilkeson, 2006</xref>) and macrophage differentiation (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-3" hwp:rel-id="ref-41">Glass &amp; Natoli, 2015</xref>).</p><p hwp:id="p-44">Taken together, the histone modifications that are reprogrammed upon <italic toggle="yes">Y. enterocolitica</italic> infection associate with central transcriptional programs in macrophages. Most significantly, PAMP-induced up-regulation of immune signaling and inflammatory response genes is suppressed and the down-regulation of metabolic and Rho GTPase pathway genes is prevented by the bacteria.</p></sec><sec id="s2d" hwp:id="sec-7"><title hwp:id="title-12"><italic toggle="yes">Y. enterocolitica</italic> reprogramms histone marks of Rho GTPase pathway genes</title><p hwp:id="p-45">Interestingly, the Rho GTPase pathway genes were most significantly enriched in Prevention profile genes connected to histone modifications (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-28" hwp:rel-id="F3">Figs 3H, K</xref>). It was also found enriched in the Suppression profile and in the latent enhancer associated genes (S8 Table). Altogether, the dynamic histone modifications identified here were associated with 324 unique Rho GTPase pathway genes (61 % of all known Rho GTPase genes; <xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Fig 4A</xref>, S9 Table).</p><fig id="fig4" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4 xref-fig-4-5 xref-fig-4-6 xref-fig-4-7 xref-fig-4-8 xref-fig-4-9 xref-fig-4-10 xref-fig-4-11 xref-fig-4-12 xref-fig-4-13 xref-fig-4-14 xref-fig-4-15"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Fig 4.</label><caption hwp:id="caption-4"><title hwp:id="title-13">Epigenetic and transcriptional regulation of Rho GTPase pathway genes in <italic toggle="yes">Y. enterocolitica</italic> infected macrophages.</title><p hwp:id="p-46"><bold>A,</bold> Number of Rho GTPase pathway genes associated with changed regions in promoter (P1- b, P2a-d) or enhancer (E1-4) classes. “Unique” refers to total unique genes or regions (overlapping regions were merged together) when counting together all promoter and enhancer classes.</p><p hwp:id="p-47"><bold>B,</bold> Heatmap of all DEGs from Rho GTPase pathway belonging to classes R1-R4 (color coded, right side) in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-29" hwp:rel-id="F3">Fig 3A</xref>. Association with profiles is shown on the left side. “n” refers to the number of genes. Gene rlog counts were row-scaled (row Z-score).</p><p hwp:id="p-48"><bold>C,</bold> Bar plot showing number of DEGs belonging to Rho GTPase pathway from RNA-seq profiles in <bold>(B)</bold> overlapping with genes with corresponding promoter (P1a-b, P2a-d classes) and/ or enhancer (E1-4 classes) changes from the same profiles.</p><p hwp:id="p-49"><bold>D,</bold> Bar plot showing Rho GTPase specificity of active GAPs (<xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-1" hwp:rel-id="ref-82">Müller et al., 2020</xref>) for genes with RNA-seq and ChIP-seq overlaps in <bold>(C).</bold>.Fraction and number (in bars) for all active GAPs and for GAPs in the Suppression and Prevention profiles are shown.</p><p hwp:id="p-50"><bold>E, F,</bold> Heatmaps of RNA-seq rlog counts for GAP <bold>(E)</bold> and Rho GTPase genes <bold>(F)</bold> with RNA-seq and ChIP-seq overlaps in <bold>(C)</bold>. Associated profiles are indicated on the left and specificity of GAPs for Rho GTPases are indicated on the right. Gene rlog counts were row-scaled (row Z-score).</p><p hwp:id="p-51"><bold>G,</bold>Table showing DEGs (from <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-30" hwp:rel-id="F3">Fig 3A</xref>, S6 Table) known to regulate ubiquitination and/ or proteosomal degradation of Rho GTPases.</p><p hwp:id="p-52"><bold>H,</bold> Schematic representation of Rho GTPase cycle showing reprogrammed Rho GTPase pathway genes divided into GAPs, GEFs, Rho GTPases and effectors, and assigned to profiles.</p></caption><graphic xlink:href="459276v2_fig4" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-53">A great variety of bacterial virulence factors target or imitate Rho proteins or their regulators to manipulate immune cell functions (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">Heasman &amp; Ridley, 2008</xref>; <xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">Aktories, 2011</xref>). Subversion of Rho GTPase activities is also a central virulence strategy of <italic toggle="yes">Yersinia</italic> and there is mediated by the T3SS effectors YopE, YopT and YopO/YpkA (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1">Aepfelbacher &amp; Wolters, 2017</xref>). However, only scarce information is available on the epigenetic regulation of Rho GTPase pathway genes in general and relevant systems-level studies are lacking (<xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">Chen et al., 2020</xref>). Considering the strong association of dynamic histone modifications with Rho GTPase pathway genes in <italic toggle="yes">Yersinia</italic> infected macrophages, we examined this connection in more detail here.</p><p hwp:id="p-54">The Rho GTPase family is composed of 20 proteins, which can be divided into 8 subfamilies (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">Boureux et al., 2006</xref>). Rho GTPases are best known for regulating the actin cytoskeleton but also for control of vesicle transport, microtubule dynamics, cell cycle and gene expression (<xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-1" hwp:rel-id="ref-60">Jaffe &amp; Hall, 2005</xref>; <xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">Hodge &amp; Ridley, 2016</xref>). Through these basic activities, they play central roles in immune cell functions such as phagocytosis, chemotaxis and adhesion (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-2" hwp:rel-id="ref-49">Heasman &amp; Ridley, 2008</xref>). The classical Rho GTPases cycle between inactive GDP-bound and active GTP-bound states (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Fig 4H</xref>). Guanine nucleotide exchange factors (GEFs) promote the dissociation of GDP leading to GTP loading and activation (<xref ref-type="bibr" rid="c66" hwp:id="xref-ref-66-1" hwp:rel-id="ref-66">Laurin &amp; Côté, 2014</xref>). Active GTP-bound Rho proteins stimulate effector proteins which carry out basic molecular activities (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">Bagci et al., 2020</xref>; <xref ref-type="bibr" rid="c80" hwp:id="xref-ref-80-1" hwp:rel-id="ref-80">Mott &amp; Owen, 2015</xref>). GTPase activating proteins (GAPs) bind to GTP-loaded Rho proteins and thereby stimulate their intrinsic GTPase activity and lead to their deactivation (<xref ref-type="bibr" rid="c121" hwp:id="xref-ref-121-1" hwp:rel-id="ref-121">Tcherkezian &amp; Lamarche-Vane, 2007</xref>). Most GEFs, GAPs and effectors are not specific for individual Rho GTPases but associate with members of one or more subfamilies (<xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-2" hwp:rel-id="ref-82">Müller et al., 2020</xref>; <xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">Bagci et al., 2020</xref>). Currently 77 RhoGEFs (<xref ref-type="bibr" rid="c66" hwp:id="xref-ref-66-2" hwp:rel-id="ref-66">Laurin &amp; Côté, 2014</xref>), 66 Rho GAPs (<xref ref-type="bibr" rid="c121" hwp:id="xref-ref-121-2" hwp:rel-id="ref-121">Tcherkezian &amp; Lamarche-Vane, 2007</xref>) and up to 370 Rho GTPase effectors are known, whereby the number of effectors may still be growing (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">Bustelo et al., 2007</xref>; <xref ref-type="bibr" rid="c89" hwp:id="xref-ref-89-1" hwp:rel-id="ref-89">Paul et al., 2017</xref>; <xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-3" hwp:rel-id="ref-8">Bagci et al., 2020</xref>).</p><p hwp:id="p-55">Notably, 68 %, 62 %, 58 % and 74 % of all known genes for GAPs, GEFs, effectors and Rho proteins, respectively, exhibited altered histone modification patterns in <italic toggle="yes">Y. enterocolitica</italic> infected macrophages (<xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-2" hwp:rel-id="F11">S5A Fig</xref> “RNA &amp; ChIP” and “ChIP only” fractions). Histone modifications were concomitantly altered at enhancers and promoters of 127 Rho GTPase pathway genes (<xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-3" hwp:rel-id="F11">S5B Fig</xref>). More than 2 enhancer regions in the E1 and E4 enhancer classes were on average associated with an individual Rho GTPase pathway gene (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Fig 4A</xref>) and the number of enhancers per Rho GTPase gene ranged from 1 to 14 (<xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-4" hwp:rel-id="F11">S5C Fig</xref>, S9 Table). FNBP1, RAPGEF1 and ELMO1 were the genes for which 13, 13 and 14 putative enhancers, respectively, were found (S9 Table).</p><p hwp:id="p-56">To draw the most informed conclusion about the biological significance of Rho GTPase pathway gene regulation by <italic toggle="yes">Yersinia</italic>, we created a heatmap of all Rho GTPase pathway DEGs in mock-, WAC-, and WA314-infected macrophages independent of their association with histone modifications (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-2" hwp:rel-id="ref-20">Bustelo et al., 2007</xref>; <xref ref-type="bibr" rid="c89" hwp:id="xref-ref-89-2" hwp:rel-id="ref-89">Paul et al., 2017</xref>; <xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-4" hwp:rel-id="ref-8">Bagci et al., 2020</xref>; <xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-3" hwp:rel-id="ref-82">Müller et al., 2020</xref>; Wennerberg et al., 2004; <xref ref-type="bibr" rid="c112" hwp:id="xref-ref-112-1" hwp:rel-id="ref-112">Senoo et al., 2019</xref>). This revealed altogether 204 DEGs in Suppression-, Down-, Up- and Prevention profiles (classes R1-R4, <xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Fig 4B</xref>, S10 Table). Of these, 29 encode GTPase activating proteins (GAPs), 31 guanine nucleotide exchange factors (GEFs), 134 effectors and 11 Rho GTPases (S10 Table). 115 (56 %) of these DEGs were in fact associated with dynamic histone modifications (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-5" hwp:rel-id="F4">Fig 4C</xref>).</p><p hwp:id="p-57">Recently all known proteins with putative GAP or GEF activities were biochemically characterized regarding their actual effect on the three main Rho family proteins RhoA, Rac1 and Cdc42 (<xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-4" hwp:rel-id="ref-82">Müller et al., 2020</xref>). Analysis of our data in view of this report revealed that in the Prevention profile 60 % of the active GAPs (6/10) act specifically on Rac as compared to 36 % (18/50) of all known GAPs (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-6" hwp:rel-id="F4">Figs 4D, E</xref>, S11 Table; <xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-5" hwp:rel-id="ref-82">Müller et al., 2020</xref>). In the Suppression profile, Rho-, Rac- or Cdc42 specific GAP genes are not enriched and the percentages of GAP activities acting on Rho (25 %) or Rac (25 %) are identical to those of total GAPs (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-7" hwp:rel-id="F4">Figs 4D, E</xref>; <xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-6" hwp:rel-id="ref-82">Müller et al., 2020</xref>). We conclude that aided by epigenetic remodelling <italic toggle="yes">Y. enterocolitica</italic> tends to keep Rac-inhibiting GAPs at the level of uninfected cells.</p><p hwp:id="p-58">Of the 8 Rho GTPase genes in the Suppression and Prevention profiles, three encode classical Rho proteins (Rac1, RhoC, RhoG) and five encode atypical Rho proteins (RhoH, RhoU, RND1, RhoBTB1, RhoBTB2) (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-8" hwp:rel-id="F4">Fig 4F</xref>). Most atypical Rho proteins are considered constitutively active and consequently are not regulated by GEFs and GAPs but instead are controlled at the level of transcription and targeted destruction, i.e. proteasomal degradation (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">Aspenström et al., 2007</xref>; <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">Haga &amp; Ridley, 2016</xref>). The cellular levels of RhoC and RhoG were also shown to be transcriptionally regulated (<xref ref-type="bibr" rid="c126" hwp:id="xref-ref-126-1" hwp:rel-id="ref-126">Vincent et al., 1992</xref>; <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">Fritz et al., 1999</xref>). Classical and atypical Rho proteins often have overlapping cellular functions and share the same effector proteins. Atypical Rho proteins have so far been implicated in multiple activities including tumour suppression (e.g. RhoBTB2), cell transformation and -morphogenesis as well as development (e.g. RhoU and Rnd) (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-2" hwp:rel-id="ref-6">Aspenström et al., 2007</xref>; <xref ref-type="bibr" rid="c116" hwp:id="xref-ref-116-1" hwp:rel-id="ref-116">Stiegler &amp; Boggon, 2020</xref>; <xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-2" hwp:rel-id="ref-54">Hodge &amp; Ridley, 2016</xref>; <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">Chardin, 2006</xref>). Many atypical Rho proteins have been found to regulate the activity of classical Rho Proteins, e.g. RhoH spatially controls Rac1 activity (<xref ref-type="bibr" rid="c119" hwp:id="xref-ref-119-1" hwp:rel-id="ref-119">Tajadura-Ortega et al., 2018</xref>) and Rnd proteins bind and steer Rho GAP proteins to specific cell sites (<xref ref-type="bibr" rid="c116" hwp:id="xref-ref-116-2" hwp:rel-id="ref-116">Stiegler &amp; Boggon, 2020</xref>). Notably, the Rho protein genes in the Suppression profile include Rac1, the Rac1 activator RhoG and the atypical Rho proteins RhoH and RhoU (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-9" hwp:rel-id="F4">Fig 4F</xref>). These Rho proteins can alternatively activate Rac effectors, spatiotemporally control Rac activity or take over Rac functions in cells (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-5" hwp:rel-id="ref-8">Bagci et al., 2020</xref>; <xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-3" hwp:rel-id="ref-6">Aspenström et al., 2007</xref>; <xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-3" hwp:rel-id="ref-54">Hodge &amp; Ridley, 2016</xref>; <xref ref-type="bibr" rid="c119" hwp:id="xref-ref-119-2" hwp:rel-id="ref-119">Tajadura-Ortega et al.,2018</xref>; <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-2" hwp:rel-id="ref-23">Chardin, 2006</xref>). Thus, a prominent effect of <italic toggle="yes">Yersinia</italic> in the Suppression profile is to inhibit the expression of genes, whose products can keep up Rac activity. This effect complements well the blocked downregulation of Rac GAPs in the Prevention profile (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-10" hwp:rel-id="F4">Figs 4D, E</xref>).</p><p hwp:id="p-59">Altogether epigenetically controlled gene expression might cause low Rac activity in <italic toggle="yes">Yersinia</italic> infected cells and thereby cooperate with the Rac down-regulating T3SS effectors YopE, YopO and YopT (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-3" hwp:rel-id="ref-1">Aepfelbacher &amp; Wolters, 2017</xref>). 66 Rho GTPase effectors were altogether found in the overlaps of gene expression and epigenetic profiles (<xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-5" hwp:rel-id="F11">S5A, D, F Figs</xref>; <xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-3" hwp:rel-id="ref-20">Bustelo et al., 2007</xref>; <xref ref-type="bibr" rid="c89" hwp:id="xref-ref-89-3" hwp:rel-id="ref-89">Paul et al., 2017</xref>; <xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-6" hwp:rel-id="ref-8">Bagci et al., 2020</xref>). This includes effectors for all eight Rho GTPase subfamilies (Rho, Rac, Cdc42, RhoD/Rif, Rnd, Wrch-1/Chp, RhoH and RhoBTB) (<xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-6" hwp:rel-id="F11">S5F Fig</xref>, S12 Table). Interestingly, while <italic toggle="yes">Yersinia</italic> prevents downregulation of genes for the atypical RhoBTBs (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-11" hwp:rel-id="F4">Fig 4F</xref>), it at the same time suppresses expression of genes encoding specific RhoBTB effectors (<xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-7" hwp:rel-id="F11">S5F Fig</xref>, S12 Table). Furthermore, 19 of the identified Rho GTPase effectors have been implicated in epigenetic and transcriptional regulation, suggesting mechanisms for crosstalk and feedback in the epigenetic control of Rho GTPase pathway gene expression (S12 Table). Another level of regulation is provided by the finding that some DEGs from Suppression- and Prevention profile genes belong to the machinery for ubiquitination and/or proteasomal degradation of Rho proteins (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-12" hwp:rel-id="F4">Fig 4G</xref>; <xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-4" hwp:rel-id="ref-54">Hodge &amp; Ridley, 2016</xref>).</p><p hwp:id="p-60">Altogether these data indicate that yersiniae modulate expression of a large part of Rho GTPase pathway genes in macrophages through reprogramming of cellular chromatin on multiple levels (<xref ref-type="fig" rid="figs5" hwp:id="xref-fig-11-8" hwp:rel-id="F11">S5D, E Figs</xref>, <xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-13" hwp:rel-id="F4">Figs 4E, F, H</xref>).</p></sec><sec id="s2e" hwp:id="sec-8"><title hwp:id="title-14">YopP is a major modulator of epigenetic reprogramming upon <italic toggle="yes">Y. enterocolitica</italic> infection</title><p hwp:id="p-61">The <italic toggle="yes">Y. enterocolitica</italic> T3SS effectors YopP (YopJ in <italic toggle="yes">Y. pseudotuberculosis</italic>) and YopM have been shown to modulate inflammatory gene expression in <italic toggle="yes">Yersinia</italic> infected macrophages (<xref ref-type="bibr" rid="c110" hwp:id="xref-ref-110-6" hwp:rel-id="ref-110">Schubert et al., 2020</xref>). We therefore examined whether YopP and YopM contribute to the epigenetic reprogramming by <italic toggle="yes">Y. enterocolitica.</italic> Macrophages were infected (6 h) with WA314 strains lacking YopP or YopM (strains WA314ΔYopP or WA314ΔYopM; S1 Table) and investigated using ChIP-seq and RNA-seq (H3K4me3 and H3K27ac modifications; <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-17" hwp:rel-id="F1">Fig 1A</xref>). Principal component analysis (PCA) revealed that the WA314ΔYopM- and WA314 induced H3K27ac- and H3K4me3 modifications located close to each other, while the WA314ΔYopP induced modifications were clearly separate (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Fig 5A</xref>, <xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-1" hwp:rel-id="F12">S6A Fig</xref>). This suggests that YopP but not YopM significantly contributes to the epigenetic changes produced by WA314. The effects of WA314ΔYopP and WA314ΔYopM were directly compared with the effects of WA314 on H3K27ac- and H3K4me3 modifications and gene expression. Notably, 684 H3K4me3 regions and 5094 H3K27ac regions were differentially regulated between WA314ΔYopP and WA314 (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-2" hwp:rel-id="F5">Fig 5B</xref>). In contrast, altogether only 29 histone modifications were differentially regulated between WA314ΔYopM and WA314 (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-3" hwp:rel-id="F5">Fig 5B</xref>). While 1616 DEGs were detected between WA314ΔYopP and WA314, also 804 DEGs were found between WA314ΔYopM and WA314 (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-4" hwp:rel-id="F5">Fig 5B</xref>). This suggests that YopP affects gene transcription in macrophages to a large extent through modulation of H3K27ac- and H3K4me3 histone modifications. In contrast, although YopM strongly affects gene transcription, it does not do so by regulating H3K4me3- and H3K27ac histone modifications. We next studied what proportions of the WA314-induced histone modifications in the Suppression-, Prevention-, and Up- and Down profiles were due to YopP (<xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-2" hwp:rel-id="F12">S6B Fig</xref>). For this, the percentage YopP effect was calculated from the ratio of fold change (FC) between WA314ΔYopP vs WA314 and either WA314 vs WAC (Suppression and Prevention profiles) or WA314 vs mock (Up and Down profiles). In the promoter and enhancer classes the median Yop contribution to the WA314 effects was 42 % and ranged from 8.9 % - 57.2 % (<xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-3" hwp:rel-id="F12">S6B Fig</xref>). Furthermore, the median YopP contribution to the WA314 effects on gene expression associated with histone modifications was 51.4 % (<xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-4" hwp:rel-id="F12">S6C Fig</xref>). We conclude that YopP on average contributes around one half to the effects of <italic toggle="yes">Y. enterocolitica</italic> on histone modifications and gene expression. Consequently, other T3SS associated virulence factors - except YopM – also contribute significantly.</p><fig id="fig5" position="float" orientation="portrait" fig-type="figure" hwp:id="F5" hwp:rev-id="xref-fig-5-1 xref-fig-5-2 xref-fig-5-3 xref-fig-5-4 xref-fig-5-5 xref-fig-5-6 xref-fig-5-7 xref-fig-5-8 xref-fig-5-9 xref-fig-5-10 xref-fig-5-11 xref-fig-5-12 xref-fig-5-13 xref-fig-5-14 xref-fig-5-15 xref-fig-5-16"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Fig 5.</label><caption hwp:id="caption-5"><title hwp:id="title-15">Role of YopP and YopM in the epigenetic and transcriptional reprogramming of macrophages by <italic toggle="yes">Y. enterocolitica</italic>.</title><p hwp:id="p-62"><bold>A,</bold> Principal component analysis of H3K27ac tag counts in classes P1a-P2d and E1-4 in two replicates of macrophages infected with the indicated strains.</p><p hwp:id="p-63"><bold>B,</bold> Number of statistically significant (≥ 2-fold change, adjusted P-value ≤ 0.05) DEGs and differentially enriched H3K4me3 and H3K27ac regions for WA314ΔYopM vs WA314 and WA314ΔYopP vs WA314.</p><p hwp:id="p-64"><bold>C, D,</bold> Percentage of WA314 effect on expression of Rho GTPase pathway <bold>(C)</bold> or Inflammatory response <bold>(D)</bold> genes that is caused by YopP. Genes with associated promoter or enhancer changes from the same profile and significant change for RNA-seq (DESeq2) and ChIP-seq (diffReps) between WAC vs WA314 are shown. The percentage value was calculated from the ratio of fold change (FC) between WA314ΔYopP vs WA314 and WA314 vs WAC for Suppression <bold>(C, D)</bold> and Prevention <bold>(C)</bold> profiles.</p><p hwp:id="p-65"><bold>E,</bold> Peak tracks of ChIP-seq tag densities showing H3K4me3 and H3K27ac changes associated with IL2RA gene, whose suppression of gene expression by WA314 is produced in a YopP- dependent manner <bold>(D)</bold>. H3K4me3 and H3K27ac densities at the IL2RA promoter (green shade) and H3K27ac densities at the enhancers (purple shade) are not affected by YopP (compare effects of WA314 and WA314ΔYopP).</p><p hwp:id="p-66"><bold>F,</bold> Dot plots of H3K4me3 and H3K27ac ChIP-qPCR signals at indicated genes in macrophages not infected (mock) or infected with indicated strains. WA314ΔYopP infections occurred in the absence and presence of MAPK inhibitors (inh). The ChIP-qPCR signal was expressed as relative (rel.) enrichment (enr.) vs mock. Lines represent mean of 3 biological replicates (dots with different shapes). SOCS3: Suppressor of cytokine signaling 3, IDO1: Indoleamine 2,3-Dioxygenase 1, PTGS2: Prostaglandin-Endoperoxide Synthase 2.</p><p hwp:id="p-67"><bold>G,</bold> Western blot analysis (top) and quantification (bottom) of ABI1 levels in primary human macrophages infected with WA314, WA314ΔYopP and WA314ΔYopP+inh (MAPK inhibitors) at an MOI of 100 for 6 h. GAPDH was used as a loading control and for normalization of ABI1 signal. Western blot is representative of three independent experiments shown in quantification.</p><p hwp:id="p-68"><bold>H,</bold> Immunofluorescence staining of primary human macrophages infected with WA314, WA314ΔYopP+inh (MAPK inhibitors) and WA314ΔYopP with MOI of 100 for 6 h. Cells were stained with Alexa568 phalloidin (red) to visualize actin and antibodies for ABI1 (cyan), vinculin (blue) and ZO-1 (green). Fourth column shows an overlay of actin and ABI1 (top) and actin, vinculin and ZO-1 (bottom) for WA314ΔYopP infection. Data are representative of two independent experiments.</p><p hwp:id="p-69"><bold>I,</bold> Quantification of actin (left) and ABI1 (right) signal intensity at cell junctions from immunofluorescence of primary human macrophages infected with WA314, WA314ΔYopP+inh (MAPK inhibitors) and WA314ΔYopP with MOI of 100 for 6 h. Data are representative of two independent experiments.</p><p hwp:id="p-70"><bold>J,</bold> Immunofluorescence staining of primary human macrophages infected with WA314, WA314ΔYopP+C646 (p300 inhibitor) and WA314ΔYopP with MOI of 100 for 6 h (left). Cells were stained with Alexa568 phalloidin (red) to visualize actin and antibody for ABI1 (cyan). Quantification of ABI1 signal at cell cell contacts is shown on the right. Data are representative of two independent experiments. In <bold>(I)</bold> and <bold>(J)</bold> bars show mean and error bars represent standard deviation. ****: P-adjusted &lt; 0.0001 by unpaired Wilcoxon test.</p></caption><graphic xlink:href="459276v2_fig5" position="float" orientation="portrait" hwp:id="graphic-5"/></fig><p hwp:id="p-71">We looked in more detail at the effects of YopP on Rho GTPase pathway genes (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-14" hwp:rel-id="F4">Fig 4</xref>, S13 Table). In the Suppression- and Prevention profiles of Rho GTPase pathway genes, YopP contributed in the mean 48.5 % and 78.5 %, respectively, to the WA314 effects on gene expression (S13 Table). However, at the level of individual genes the YopP effect was widely spread from 2 to 103 % in the Suppression- and from 29 to 177 % in Prevention profile (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-5" hwp:rel-id="F5">Fig 5C</xref>, S13 Table). We tested whether this widely distributed effect of YopP also applies to inflammatory genes (<xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-31" hwp:rel-id="F3">Fig 3H</xref>, <xref ref-type="fig" rid="figs4" hwp:id="xref-fig-10-8" hwp:rel-id="F10">S4A Fig</xref>, S14 Table). Notably, while the mean effect of YopP on the Suppression profile inflammatory genes was 46 % (S14 Table), the effect on individual genes was spread from −57 to 103 % (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-6" hwp:rel-id="F5">Fig 5D</xref>). Although the majority of YopP induced changes in gene expression were associated with corresponding YopP induced changes in histone modifications, some YopP regulated genes were associated with histone modifications induced by other T3SS effectors and vice versa (e.g. IL2RA highlighted in <xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-7" hwp:rel-id="F5">Figs 5D, E</xref>; S13 and S14 Tables, <xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-5" hwp:rel-id="F12">S6D Fig</xref>). Further, although YopP contribution to gene expression and histone modifications was evident for the majority of genes and regions associated with inflammatory response and Rho GTPase pathways, the YopP effects on gene expression on one hand and histone modifications on the other hand frequently did not correlate (<xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-6" hwp:rel-id="F12">S6D Fig</xref>). Thus, the YopP effect on the expression of individual Rho GTPase pathway and inflammatory genes varies considerably from representing the complete <italic toggle="yes">Yersinia</italic> wild type effect to just a minor contribution. It thereby appears that different T3SS effectors and histone modifications contribute to the widely varying YopP effects on gene expression.</p><p hwp:id="p-72">YopP/YopJ blocks PAMP-induced inflammatory gene expression by inhibiting NF-κB and MAP-kinase signaling (<xref ref-type="bibr" rid="c110" hwp:id="xref-ref-110-7" hwp:rel-id="ref-110">Schubert et al., 2020</xref>). Interestingly, MAP-kinases also phosphorylate histone-3 at serine-10, a modification that is thought to promote the deposition of activating histone marks like H3K14ac and H3K16ac (<xref ref-type="bibr" rid="c108" hwp:id="xref-ref-108-1" hwp:rel-id="ref-108">Sawicka &amp; Seiser, 2014</xref>). We therefore sought to find out whether YopP reduces the deposition of H3K4me3- and/or H3K27ac marks through inhibition of MAP-kinases. WA314 inhibited the deposition of H3K4me3 at the IDO1- and SOCS3 promoters and deposition of H3K27ac at the SOCS3 and PTGS2 promoters in the macrophages (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-8" hwp:rel-id="F5">Fig 5F</xref>). YopP contributed to the WA314 effects on these genes, as seen by significantly less inhibitory activity of WA314ΔYopP on deposition of the histone marks when compared to WA314 (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-9" hwp:rel-id="F5">Fig 5F</xref>). When combined with the MAP-kinase inhibitors SB203580 and PD98059, targeting p38 and MEK1, respectively, WA314ΔYopP was nearly as effective as WA314 in inhibiting the deposition of H3K4me3 marks at the IDO1 and SOCS3 promoters and deposition of H3K27ac marks at the PTGS2 and SOCS3 promoters (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-10" hwp:rel-id="F5">Fig 5F</xref>). Thus, MAP-kinase inhibitors can substitute for the missing YopP activity in WA314ΔYopP. This is consistent with the idea that YopP blocks deposition of the histone marks through MAP-kinase inhibition.</p><p hwp:id="p-73">Finally, we wanted to determine whether the histone modification-driven reprogramming of Rho GTPase pathway genes has functional consequences in macrophages. For this, we took advantage of suppression of ABI1 gene expression by WA314, which is entirely dependent on YopP (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-11" hwp:rel-id="F5">Fig 5C</xref> and <xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-7" hwp:rel-id="F12">S6D Fig</xref>). ABI1 encodes a component of the WAVE regulatory complex that controls actin polymerization in macrophages (<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="c115" hwp:id="xref-ref-115-1" hwp:rel-id="ref-115">Stahnke et al., 2021</xref>). ChIP-qPCR analysis confirmed that YopP suppresses H3K27ac at enhancer within ABI1 gene and H3K4me3 at ABI1 promoter (<xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-8" hwp:rel-id="F12">S6E Fig</xref>). Interestingly, during WA314ΔYopP infection treatment with MAP kinase inhibitors suppressed only H3K4me3 and not H3K27ac (<xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-9" hwp:rel-id="F12">S6E Fig</xref>), suggesting that different signaling pathways regulate promoter H3K4me3 and enhancer H3K27ac. Gene expression analysis by RT-qPCR confirmed suppression of ABI1 expression by YopP, which was dependent on inhibition of the MAPK pathway (<xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-10" hwp:rel-id="F12">S6F Fig</xref>). Corresponding to gene expression, the ABI1 protein was upregulated in WA314ΔYopP- compared to WA314 infected macrophages and this could be prevented by MAP-kinase inhibitors (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-12" hwp:rel-id="F5">Fig 5G</xref>). In the WA314ΔYopP infected macrophages ABI1 prominently accumulated at cell cell contacts, where it colocalized with actin, vinculin and the zonula occludens protein ZO1 (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-13" hwp:rel-id="F5">Figs 5H, I</xref>). Further, accumulation of ABI1 was associated with increased levels of actin at the cell cell contacts, indicating enhanced WAVE regulatory complex-induced actin polymerization (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-14" hwp:rel-id="F5">Figs 5H, I</xref>; <xref ref-type="bibr" rid="c129" hwp:id="xref-ref-129-1" hwp:rel-id="ref-129">Yamazaki et al., 2007</xref>). Notably, accumulation of ABI1 and actin was reversed by treatment of p300 histone acetyltransferase inhibitor C646 (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-15" hwp:rel-id="F5">Fig 5J</xref>; <xref ref-type="fig" rid="figs6" hwp:id="xref-fig-12-11" hwp:rel-id="F12">S6G Fig</xref>). Altogether this data shows that through inhibition of the MAPK pathway YopP targets histone modifications and gene expression of the ABI1 gene, causing a redistribution of ABI1 and actin in <italic toggle="yes">Yersinia</italic> infected macrophages.</p></sec></sec><sec id="s3" hwp:id="sec-9"><title hwp:id="title-16">Discussion</title><p hwp:id="p-74">At present only scarce information is available on epigenetic reprogramming of immune cells by pathogenic bacteria (<xref ref-type="bibr" rid="c99" hwp:id="xref-ref-99-2" hwp:rel-id="ref-99">Rolando et al., 2013</xref>; <xref ref-type="bibr" rid="c87" hwp:id="xref-ref-87-1" hwp:rel-id="ref-87">Pacis et al., 2019</xref>). This study was conducted to find out whether the enteropathogen <italic toggle="yes">Y. enterocolitica</italic> alters chromatin states to globally control gene expression in human macrophages. Our results provide a number of novel insights into systemic reorganization of epigenetic histone modifications in human macrophages upon infection of pathogenic yersiniae.</p><p hwp:id="p-75">A primary goal was to map in detail whether and how the effects of the <italic toggle="yes">Yersinia</italic> PAMPs on histone modifications are reorganized by the T3SS associated virulence factors of the bacteria. To this end, we systematically compared the effects of a <italic toggle="yes">Y. enterocolitica</italic> wild type strain and a derived avirulent strain.</p><p hwp:id="p-76">Infection with virulent and avirulent yersiniae extensively reorganized histone marks (H3K4me1, H3K4me3 and H3K27ac) at macrophage gene promoters and enhancers. H3K27ac marks were the most dynamic (&gt; 22.000 loci altered) followed by H3K4me1 marks (2156 loci altered). That H3K27ac marks are highly dynamic in human macrophages stimulated with bacterial agents has been reported previously (<xref ref-type="bibr" rid="c83" hwp:id="xref-ref-83-2" hwp:rel-id="ref-83">Novakovic et al., 2016</xref>).</p><p hwp:id="p-77">We could classify the bacteria-induced reorganization of histone modifications into four profiles, which we named Suppression, Down, Up and Prevention. In the Suppression- and Prevention profiles, the bacteria’s T3SS effectors block the PAMP-induced deposition or removal, respectively, of histone marks. In Down- and Up profiles, the T3SS-associated effectors down- or up-regulate, respectively, histone marks independently of PAMP activities.</p><p hwp:id="p-78">The fraction of histone modifications overlapping with actual gene expression in the four profiles varied widely. Overlaps ranged from 30 % in the Suppression profile to 2% in the Down profile. The biological significance of <italic toggle="yes">Yersinia</italic>-modulated histone modifications that do not immediately affect gene expression is unclear. It has been observed that chromatin changes in stimulated macrophages do not always associate with gene expression (<xref ref-type="bibr" rid="c88" hwp:id="xref-ref-88-6" hwp:rel-id="ref-88">Park et al., 2017</xref>; Qiao et al., 2013; <xref ref-type="bibr" rid="c61" hwp:id="xref-ref-61-2" hwp:rel-id="ref-61">Kang et al., 2019</xref>). These “silent” histone modifications may be involved in priming, immune memory, immune tolerance or other complex gene regulatory processes in macrophages (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-4" hwp:rel-id="ref-41">Glass &amp; Natoli, 2015</xref>; <xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-5" hwp:rel-id="ref-59">Ivashkiv, 2013</xref>).</p><p hwp:id="p-79">It was interesting to note that different histone marks at individual promoters or at related promoters and enhancers were reorganized in a coordinated manner upon infection, mostly in the Suppression- and Prevention profiles. In these instances, the histone modifications were more frequently associated with changes in gene expression. Thus, the activity of bacterial pathogenicity factors lead to systematic co-regulation of different histone modifications to effectively act on gene transcription.</p><p hwp:id="p-80">The T3SS effector YopP accounted for 40-50% of the changes in histone modifications and gene expression produced by virulent <italic toggle="yes">Y. enterocolitica</italic> in macrophages, as exemplified with inflammatory and Rho GTPase pathway genes. Inhibition of MAP-kinase signaling was a crucial mechanism underlying these YopP effects for selected target genes. YopP regulated the expression of genes, at which it changed histone modifications, to very different degrees. E.g., for individual inflammatory or Rho GTPase pathway genes the contribution of YopP to the <italic toggle="yes">Yersinia</italic> effect ranged from null to 100%. Interestingly, the histone modifications at some of the genes whose expression was strongly affected by YopP were changed by other T3SS effectors. We could exclude YopM as one of these effectors, because it did not alter close to any of the histone modifications investigated here. Thus, YopP but not YopM regulates the expression of selective genes through histone modifications and thereby seemingly cooperates to varying extents with other T3SS effectors. Of note, in addition to histone modifications, other gene regulatory mechanisms clearly also contribute to the <italic toggle="yes">Yersinia-</italic> and YopP effects on gene expression (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-1" hwp:rel-id="ref-62">Köberle et al., 2012</xref>). Thus, our data suggest that virulent yersiniae fine tune expression of individual genes in specific biological pathways through governing the cooperation between histone modifications and other gene regulatory mechanisms. For this the bacteria employ YopP as the main T3SS effector that cooperates with other effectors. Together the effectors mostly remodel PAMP-induced signal transduction but also exert PAMP independent effects on gene transcription (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-2" hwp:rel-id="ref-62">Köberle et al., 2012</xref>).</p><p hwp:id="p-81">Among the most significant findings of our study was the remodeling of histone modifications at 61 % of all 534 known Rho GTPase genes. When considered in terms of gene expression, 38 % of all known Rho GTPase pathway genes were differentially expressed whereby well over half of them were associated with dynamic histone modifications. The latter encode Rho proteins (Rho GTPases) and their effectors, activators (GEFs) and deactivators (GAPs). To control dynamic cellular processes such as cytoskeletal reorganization or vesicular transport, the right Rho proteins, regulators and effectors have to be activated or deactivated at the right time and location. Rho GTPase signaling networks are characterized by the sheer countless interactions that can take place between the different Rho GTPases, regulators and effectors and by crosstalk and feedback loops (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-4" hwp:rel-id="ref-20">Bustelo et al., 2007</xref>; <xref ref-type="bibr" rid="c89" hwp:id="xref-ref-89-4" hwp:rel-id="ref-89">Paul et al., 2017</xref>; <xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-7" hwp:rel-id="ref-8">Bagci et al., 2020</xref>; <xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-7" hwp:rel-id="ref-82">Müller et al., 2020</xref>). Our results add a further level of complexity to Rho GTPase regulation in macrophages by revealing an extensive epigenetic control of Rho GTPase pathway gene expression.</p><p hwp:id="p-82">One of our intriguing findings was that genes encoding GAPs for Rac were overrepresented in the Prevention profile. This indicates that epigenetic changes upon <italic toggle="yes">Yersinia</italic> infection create a cellular state in which downregulation of Rac inhibitors is prevented, which favours Rac inhibition. Inhibition of Rac is a known central strategy of <italic toggle="yes">Yersinia</italic> with the three T3SS effectors YopE, YopT and YopO acting as Rac inhibitors (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-4" hwp:rel-id="ref-1">Aepfelbacher &amp; Wolters, 2017</xref>). Further consistent with this bacterial strategy is the finding that expression of Rac1, the Rac1 activator RhoG and the atypical Rho proteins RhoH and RhoU, which can take over Rac functions (<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-8" hwp:rel-id="ref-8">Bagci et al., 2020</xref>; <xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-4" hwp:rel-id="ref-6">Aspenström et al., 2007</xref>; <xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-5" hwp:rel-id="ref-54">Hodge &amp; Ridley, 2016</xref>; <xref ref-type="bibr" rid="c119" hwp:id="xref-ref-119-3" hwp:rel-id="ref-119">Tajadura-Ortega et al.,2018</xref>; <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-3" hwp:rel-id="ref-23">Chardin, 2006</xref>), were suppressed by the bacteria. A reason why <italic toggle="yes">Yersinia</italic> places a focus on inhibition of Rac may be the outstanding role that it plays in anti-microbial activities of macrophages such as phagocytosis, chemotaxis and production of reactive oxygen species (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">Bokoch, 2005</xref>). Rac inhibition by YopE also prevents overshooting translocation of T3SS effectors into cells (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-5" hwp:rel-id="ref-1">Aepfelbacher &amp; Wolters, 2017</xref>). A number of genes for atypical Rho proteins (RHOH, RHOU, RND1, RHOBTB1, RHOBTB2) were found in the Suppression and Prevention profiles. The activities of atypical Rho proteins are generally controlled by gene transcription and protein degradation and not by GAPs and GEFs (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-5" hwp:rel-id="ref-6">Aspenström et al., 2007</xref>; <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-2" hwp:rel-id="ref-47">Haga &amp; Ridley, 2016</xref>), but their regulation by epigenetic mechanisms has so far not been reported. Although the specific functions of atypical Rho proteins in macrophages are widely unknown, atypical Rho proteins also can regulate the activity of classical Rho proteins in different cell types (<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-6" hwp:rel-id="ref-6">Aspenström et al., 2007</xref>; <xref ref-type="bibr" rid="c116" hwp:id="xref-ref-116-3" hwp:rel-id="ref-116">Stiegler &amp; Boggon, 2020</xref>; <xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-6" hwp:rel-id="ref-54">Hodge &amp; Ridley, 2016</xref>; <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-4" hwp:rel-id="ref-23">Chardin, 2006</xref>). For instance, RhoH spatially controls Rac1 activity (<xref ref-type="bibr" rid="c119" hwp:id="xref-ref-119-4" hwp:rel-id="ref-119">Tajadura-Ortega et al.,2018</xref>) and Rnd proteins bind and steer Rho GAP proteins to specific cell sites (<xref ref-type="bibr" rid="c116" hwp:id="xref-ref-116-4" hwp:rel-id="ref-116">Stiegler &amp; Boggon, 2020</xref>). We also found that downregulation of genes for the atypical Rho proteins RhoBTBs was prevented and expression of genes for some RhoBTB effectors was suppressed in parallel by the bacteria. Thus, through epigenetic mechanisms <italic toggle="yes">Yersinia</italic> may determine which atypical Rho protein/effector pairs are functional in macrophages. Considering the universal role that Rho GTPases play in cellular function, the multifaceted epigenetic regulation of their expression will undoubtedly affect their activities and thereby have functional consequences in macrophages.</p><p hwp:id="p-83">Providing support for this notion, we here show that MAP kinase (MAPK) pathway regulates histone modifications, gene expression and protein levels of ABI1 gene with associated redistribution of actin cytoskeleton and ABI1 protein, a component of the WAVE actin regulatory complex, at macrophage-macrophage contacts. Furthermore, treatment of macrophages with p300 histone acetyltransferase inhibitor reversed this ABI1 and actin accumulation, providing a direct link between histone modifications and actin reorganization. Increased ABI1 enhances actin accumulation and recruitment of adhesion proteins at these contacts, likely promoting the stabilization of these structures (<xref ref-type="bibr" rid="c103" hwp:id="xref-ref-103-1" hwp:rel-id="ref-103">Ryu et al., 2009</xref>; <xref ref-type="bibr" rid="c137" hwp:id="xref-ref-137-1" hwp:rel-id="ref-137">Zipfel et al., 2006</xref>).</p><p hwp:id="p-84">Taken together, in this study we decipher key principles of epigenetic reorganization of human macrophages upon infection of the bacterial enteropathogen <italic toggle="yes">Y. enterocolitica</italic>. 1) Remodeling of histone modifications and associated changes in gene expression can be classified in different profiles, with virulent bacteria mainly suppressing or preventing the effects of bacterial PAMPs, but also exerting independent stimulatory or inhibitory activities through their T3SS effectors. Suppressed histone modifications with corresponding gene suppression mostly belong to immune and inflammatory signaling, whereas prevented modifications/genes belong to Rho GTPase pathway and metabolic pathways (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Fig 6</xref>). 2) Changes in the different histone modifications at promoters and enhancers are often coordinated, so that they can act cooperatively on gene expression. 3) The T3SS effector YopP contributes up to 50 % to <italic toggle="yes">Yersinia</italic>-induced remodeling of histone modifications and gene expression, through its inhibitory effect on MAP kinase signaling. At the level of individual gene expression, the contribution of YopP varies from null to 100%, even in genes belonging to the same biological pathways. 4) Histone modifications, transcription factor expression, and other unidentified mechanisms are reprogrammed by YopP and other T3SS effectors and cooperatively cause the effects of <italic toggle="yes">Yersinia</italic> on individual gene expression. 5) While there was an up to 30% overlap between histone modifications and associated gene expression in the profiles, the majority of histone modifications did not alter gene expression. In these cases, such epigenetic modifications could prepare cells for subsequent stimuli or provide a basis for innate immune memory or tolerance. Further studies are warranted to test these intriguing possibilities.</p><fig id="fig6" position="float" orientation="portrait" fig-type="figure" hwp:id="F6" hwp:rev-id="xref-fig-6-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIG6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">fig6</object-id><label>Fig 6.</label><caption hwp:id="caption-6"><title hwp:id="title-17">Summary schematic showing the main effects of <italic toggle="yes">Y. enterocolitica</italic> on macrophage chromatin in gene expression.</title><p hwp:id="p-85">Plasmid-encoded virulence factors suppress upregulation (Suppression profile) and prevent downregulation (Prevention profile) of PAMP induced H3K27ac and H3K4me3 changes at gene promoters and/ or enhancers and consequently the expression of associated genes. Suppression profile is associated with genes from Inflammatory response and Type I IFN signaling, whereas Prevention profile is associated with genes from Metabolic pathways and Rho GTPase signaling. Representative genes belonging to each pathway are shown. Enhancer activity is indicated with arched arrows. Increased promoter activity is indicated with more mRNAs.</p></caption><graphic xlink:href="459276v2_fig6" position="float" orientation="portrait" hwp:id="graphic-6"/></fig></sec><sec id="s4" hwp:id="sec-10"><title hwp:id="title-18">Materials and Methods</title><sec id="s4a" hwp:id="sec-11"><title hwp:id="title-19">Bacterial strains</title><p hwp:id="p-86"><italic toggle="yes">Yersinia enterocolitica</italic> strains used in this study are derivatives of the serotype O:8 strain WA314 harboring the virulence plasmid pYVO8 (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">Heesemann &amp; Laufs, 1983</xref>). WA314ΔYopM was constructed by replacing the YopM gene in WA314 with a kanamycin resistance cassette (<xref ref-type="bibr" rid="c123" hwp:id="xref-ref-123-1" hwp:rel-id="ref-123">Trülzsch et al., 2004</xref>). WA314ΔYopP was generated by insertional inactivation of <italic toggle="yes">yopP</italic> gene (<xref ref-type="bibr" rid="c101" hwp:id="xref-ref-101-1" hwp:rel-id="ref-101">Ruckdeschel et al., 2001</xref>). WA314-YopE-ALFA strain was constructed using CRISPR-Cas12a-assisted recombineering approach as described in preprint from <xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">Carsten et al., 2021</xref>. S1 Table provides an overview of the bacterial strains used in this study and oligonucleotide sequences for the generation of WA314-YopE-ALFA strain.</p></sec><sec id="s4b" hwp:id="sec-12"><title hwp:id="title-20">Cell culture</title><p hwp:id="p-87">Human peripheral blood monocytes were isolated from buffy coats as described in <xref ref-type="bibr" rid="c65" hwp:id="xref-ref-65-1" hwp:rel-id="ref-65">Kopp et al., 2006</xref>. Cells were cultured in RPMI1640 containing 20 % autologous serum at 37 °C and 5 % CO<sub>2</sub> atmosphere. The medium was changed every three days until cells were differentiated into macrophages after 7 days. Macrophages were used for infection 1 week after the isolation except for RNA-seq experiments for two mock, WA314 and WA314ΔYopM samples from <xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-3" hwp:rel-id="ref-12">Berneking et al., 2016</xref> and WA314ΔYopP RNA-seq samples where cells were used after 2 weeks of differentiation (RNA-seq samples from batch 2 in S17 Table).</p></sec><sec id="s4c" hwp:id="sec-13"><title hwp:id="title-21">Infection of cells</title><p hwp:id="p-88">On the day before infection of primary human macrophages the cell medium was changed to RPMI1640 without antibiotics and serum and precultures of <italic toggle="yes">Y. enterocolitica</italic> strains (S1 Table) were grown overnight in LB medium with appropriate antibiotics at 27 °C and 200 x rpm. On the day of infection precultures were diluted 1:20 in fresh LB medium without antibiotics and incubated for 90 min at 37 °C and 200 x rpm to induce activation of the <italic toggle="yes">Yersinia</italic> T3SS machinery and Yop expression. Afterwards bacteria were pelleted by centrifugation for 10 min at 6000 x g, 4 °C and resuspended in 1 ml ice-cold PBS containing 1 mM MgCl<sub>2</sub> and CaCl<sub>2</sub>. The optical density OD<sub>600</sub> was adjusted to 3.6 and afterwards macrophages were infected at multiplicity-of-infection (MOI) of 100. Cell culture dishes were centrifuged for 2 min at RT and 200 x g to sediment bacteria on the cells and synchronize infection. Cells were incubated at 37 °C for 6 h.</p></sec><sec id="s4d" hwp:id="sec-14"><title hwp:id="title-22">CFU assay</title><p hwp:id="p-89">For analysis of bacterial growth (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-6" hwp:rel-id="F7">S1E Fig</xref>) <italic toggle="yes">Yersinia</italic> cultures were prepared and cells infected as described above in “Infection of cells”. Bacterial sample at 0 h was prepared from bacteria used as an input. Afterwards macrophages and bacteria present in the wells were harvested by scraping without washing and centrifuged at 5000 x g at 4 °C. Pellet was resuspended in 0.5 % Digitonin in PBS to lyze macrophages and not bacteria and incubated for 10 min on ice. Afterwards lysate was used to prepare 10-fold serial dilutions, which were plated in duplicate on LB agar plates containing appropriate antibiotics. Plates were incubated at 26 °C for 24 h before counting the colonies. Two independent experiments with different biological replicates were used for the analysis. The results showed that the number of wild type <italic toggle="yes">Yersinia</italic> at 6 h increased about 3 fold when compared to 0 h (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-7" hwp:rel-id="F7">S1E Fig</xref>) indicating a low level of replication under selected infection conditions.</p></sec><sec id="s4e" hwp:id="sec-15"><title hwp:id="title-23">SYTOX Green assay</title><p hwp:id="p-90">For analysis of cell death during infection SYTOX Green assay (Thermo Fisher Scientific) was performed which measures membrane permeability (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">Grootjans et al., 2016</xref>). 6×10<sup>4</sup> macrophages per well in a 96-well plate were seeded in RPMI1640 on the day before analysis. The following day macrophages were treated with PBS (mock), WA314 (MOI 100) or positive control (1 % TRITON-X-100) in duplicates. Plates were centrifuged for 2 min at RT, 200 x g and incubated at 37 °C for 6 h. SYTOX Green reagent was added to cells 30 min before the end of 6 h incubation. SYTOX fluorescence due to membrane permeabilization was measured with plate reader (Tecan infinite M200) at 485/520 nm. Two biological replicates were used for the analysis.</p></sec><sec id="s4f" hwp:id="sec-16"><title hwp:id="title-24">Flow cytometry</title><p hwp:id="p-91">Antibody staining for flow cytometry was done in FACS buffer (PBS, 0.1 % BSA) at room temperature in the dark for 30 min, followed by washing in FACS buffer and fixation with 2 % paraformaldehyde in FACS buffer. Cells were stained with the following antibodies: anti-CD14 (Biolegend, 301806), anti-CD16 (Biolegend, 302018), anti-CD38 (Biolegend, 301806), anti-CD86 (BD biosciences), anti-HLA-DR (Biolegend, 307642), anti-CD163 (Biolegend, 333608) and anti-CD206 (Biolegend, 321109). In addition, cells were stained with live/dead dye (Invitrogen, P30253) to identify live cells.</p><p hwp:id="p-92">Flow cytometry data was acquired on a Celesta flow cytometer (BD biosciences) and flow cytometry data was analyzed using Flowing software (Turku Bioscience). Analysis showed that 63.9 % of macrophage culture were CD14<sup>+</sup> macrophages (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-8" hwp:rel-id="F7">S1F Fig</xref>). CD14<sup>+</sup> macrophages were positive for macrophage markers CD38 (99 %), CD86 (98.5 %), HLA-DR (74.9 %), CD206 (91.6 %), CD163 (61.6 %) and CD16 (88 %) (<xref ref-type="fig" rid="figs1" hwp:id="xref-fig-7-9" hwp:rel-id="F7">S1F Fig</xref>).</p></sec><sec id="s4g" hwp:id="sec-17"><title hwp:id="title-25">Treatment with inhibitors</title><p hwp:id="p-93">For the MAPK pathway inhibition combination of 5 μM SB203580 (Cayman Chemical) and 5 μM PD98059 (Merck Millipore), which target p38 and MEK1, respectively, was used. Inhibitors were added to macrophages 30-60 min before the infection. Staurosporine (LC Laboratories; 5 μM) or C646 (Merck; 10 μM) were added at the start of infection.</p></sec><sec id="s4h" hwp:id="sec-18"><title hwp:id="title-26">RNA-seq</title><p hwp:id="p-94">Total RNA of 1-2 x 10<sup>6</sup> human macrophages (2-4 biological replicates/ macrophage donors per condition, see Table S17) was isolated using RNeasy extraction kit (Qiagen) including DNAse treatment according to manufacturer’s instructions. RNA integrity of the isolated RNA was analyzed with the RNA 6000 Nano Chip (Agilent Technologies) on an Agilent 2100 Bioanalyzer (Agilent Technologies). mRNA was extracted using the NEBNext Poly(A) mRNA Magnetic Isolation module (New England Biolabs) and RNA-seq libraries were generated using the NEBNext Ultra RNA Library Prep Kit for Illumina (New England Biolabs) as per manufacturer’s recommendations. Concentrations of all samples were measured with a Qubit 2.0 Fluorometer (Thermo Fisher Scientific) and fragment lengths distribution of the final libraries was analyzed with the DNA High Sensitivity Chip (Agilent Technologies) on an Agilent 2100 Bioanalyzer (Agilent Technologies). All samples were normalized to 2 nM and pooled equimolar. The library pool was sequenced on the NextSeq500 (Illumina) with 1 x 75 bp and total 19.9 to 23.8 million reads per sample.</p></sec><sec id="s4i" hwp:id="sec-19"><title hwp:id="title-27">RNA-seq analysis</title><p hwp:id="p-95">Sequencing reads containing bases with low quality scores (quality Phred score cutoff 20) or adapters were trimmed using TrimGalore program (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/" ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/" hwp:id="ext-link-1">http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/</ext-link>).</p><p hwp:id="p-96">Reads were aligned to the human reference assembly hg19 using STAR (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">Dobin et al., 2012</xref>). FeatureCounts (<xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-1" hwp:rel-id="ref-71">Liao et al., 2014</xref>) was employed to obtain the number of reads mapping to each gene.</p><p hwp:id="p-97">RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.ebi.ac.uk/arrayexpress" ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress" hwp:id="ext-link-2">www.ebi.ac.uk/arrayexpress</ext-link>) under accession number E-MTAB-10473. RNA-seq data from additional replicates of mock, WA314 6h and WA314ΔYopM 6h were obtained from European Nucleotide Archive (ENA) at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.ebi.ac.uk/ena/data/view/PRJEB10086" ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/ena/data/view/PRJEB10086" hwp:id="ext-link-3">http://www.ebi.ac.uk/ena/data/view/PRJEB10086</ext-link>.</p></sec><sec id="s4j" hwp:id="sec-20"><title hwp:id="title-28">RNA-seq differential expression analysis</title><p hwp:id="p-98">Statistical analysis of differential expression was carried out with DESeq2 (<xref ref-type="bibr" rid="c73" hwp:id="xref-ref-73-1" hwp:rel-id="ref-73">Love et al., 2014</xref>) using raw counts as an input and the experimental design <italic toggle="yes">∼batch + condition</italic>. Significantly enriched genes were defined with fold change ≥ 2 and adjusted P-value ≤ 0.05. Normalized rlog counts for each gene were obtained after batch effect removal with limma package (<xref ref-type="bibr" rid="c97" hwp:id="xref-ref-97-1" hwp:rel-id="ref-97">Ritchie et al., 2015</xref>) and used for downstream clustering analysis and visualization. PCA analysis and sample distance heatmaps confirmed high reproducibility between all biological replicates (see Table S17) used in the analysis.</p><p hwp:id="p-99">Clustering analysis of all DEGs from comparisons between mock, WAC, WA314 was done with rlog counts in R with pheatmap package. Clustering was performed with clustering distance based on Euclidean distance and Complete clustering method to yield 6 clusters which were further assembled into profiles Suppression, Prevention, Up and Down. Clustering distance, clustering method and number of clusters were selected so that all meaningful clusters were identified by the analysis. For heatmaps rlog counts from DESeq2 analysis were scaled by row (row Z-score) and low to high expression levels are indicated by blue-white-red color gradient. 2 representative biological replicates are shown for each sample in the figures for visualization purposes, count data from all replicates are available in the Table S6.</p></sec><sec id="s4k" hwp:id="sec-21"><title hwp:id="title-29">Chromatin immunoprecipitation (ChIP)</title><p hwp:id="p-100">For the ChIP with formaldehyde crosslinking, macrophages (3-10 x 10<sup>6</sup> cells per condition, 2-4 biological replicates/ macrophage donors per condition, see Table S17) were washed once with warm PBS and incubated for 30 min at 37 °C with accutase (eBioscience) to detach the cells. ChIP protocol steps were performed as described in (<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">Günther et al., 2016</xref>), except that BSA-blocked ChIP grade protein A/G magnetic beads (Thermo Fisher Scientific) were added to the chromatin and antibody mixture and incubated for 2 h at 4 °C rotating to bind chromatin-antibody complexes. Samples were incubated for ∼3 min with a magnetic stand to ensure attachment of beads to the magnet and mixed by pipetting during the wash steps. Eluted DNA was either subjected to ChIP-seq library preparation or used for ChIP-qPCR experiments. Input chromatin DNA was prepared from 1/4 of chromatin amount used for ChIP. Antibodies used for ChIP were anti-H3K4me3 (Merck Millipore, 04–745, 4 μl per ChIP), anti-H3K27me3 (Merck Millipore, 07-449, 4 μl per ChIP), anti-H3K27ac (abcam, ab4729, 4 μg per ChIP) and anti-H3K4me1 (Cell Signaling, 5326S, 5 μl per ChIP).</p></sec><sec id="s4l" hwp:id="sec-22"><title hwp:id="title-30">ChIP library preparation and sequencing</title><p hwp:id="p-101">ChIP-seq libraries were constructed with 1-10 ng of ChIP DNA or input control as a starting material. Libraries were generated using the NEXTflex™ ChIP-Seq Kit (Bioo Scientific) as per manufacturer’s recommendations. Concentrations of all samples were measured with a Qubit Fluorometer (Thermo Fisher Scientific) and fragment length distribution of the final libraries was analyzed with the DNA High Sensitivity Chip on an Agilent 2100 Bioanalyzer (Agilent Technologies). All samples were normalized to 2 nM and pooled equimolar. The library pool was sequenced on the NextSeq500 (Illumina) with 1 x 75 bp and total 18.6 to 41 million reads per sample.</p></sec><sec id="s4m" hwp:id="sec-23"><title hwp:id="title-31">ChIP-seq analysis</title><p hwp:id="p-102">Sequencing reads containing bases with low quality scores (quality Phred score cutoff 20) or adapters were trimmed using TrimGalore program (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/" ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/" hwp:id="ext-link-4">http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/</ext-link>). BWA (<xref ref-type="bibr" rid="c69" hwp:id="xref-ref-69-1" hwp:rel-id="ref-69">Li &amp; Durbin, 2009</xref>) was used to align reads from FASTQ files to hg19 human reference genome. Samtools (<xref ref-type="bibr" rid="c70" hwp:id="xref-ref-70-1" hwp:rel-id="ref-70">Li et et al., 2009</xref>) was used for manipulations (e.g. sorting, indexing, conversions) of the sequencing files. Picard (<ext-link l:rel="related" l:ref-type="uri" l:ref="https://broadinstitute.github.io/picard/" ext-link-type="uri" xlink:href="https://broadinstitute.github.io/picard/" hwp:id="ext-link-5">https://broadinstitute.github.io/picard/</ext-link>) was used for duplicate read removal. BEDTools (<xref ref-type="bibr" rid="c94" hwp:id="xref-ref-94-1" hwp:rel-id="ref-94">Quinlan &amp; Hall, 2010</xref>) was used for generation of BED files. The following command was used for the alignment to hg19:
<disp-quote hwp:id="disp-quote-1"><p hwp:id="p-103"><italic toggle="yes">bwa mem -M &lt;REFERENCE genome&gt; &lt;ChIP-seqfile.fastq&gt; | samtools view -bT &lt;REFERENCE genome&gt; | samtools view -b -q 30 -F 4 -F 256 &gt; &lt;aligned-ChIP-seq-file.bam&gt;</italic></p></disp-quote></p><p hwp:id="p-104">ChIP-seq data have been deposited in the ArrayExpress database at EMBL-EBI (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.ebi.ac.uk/arrayexpress" ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress" hwp:id="ext-link-6">www.ebi.ac.uk/arrayexpress</ext-link>) under accession number E-MTAB-10475.</p></sec><sec id="s4n" hwp:id="sec-24"><title hwp:id="title-32">ChIP-seq peak calling</title><p hwp:id="p-105">MACS2 peak calling (<xref ref-type="bibr" rid="c135" hwp:id="xref-ref-135-1" hwp:rel-id="ref-135">Zhang et al., 2008</xref>) against the input control was used for H3K4me3 and H3K27ac with <italic toggle="yes">-q 0.01</italic> parameter. SICER peak calling (<xref ref-type="bibr" rid="c132" hwp:id="xref-ref-132-1" hwp:rel-id="ref-132">Zang et al., 2009</xref>) against the input control was used for H3K4me1 and H3K27me3 with default settings. SICER peaks for ChIP enrichment over background with fold change ≥ 2 were selected. MACS2 and SICER peaks were filtered to exclude blacklisted regions (<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">Amemiya et al., 2019</xref>). To generate a file with all peaks for each modification, peaks found in replicates for different conditions were pooled together and merged using BEDTools (<xref ref-type="bibr" rid="c94" hwp:id="xref-ref-94-2" hwp:rel-id="ref-94">Quinlan &amp; Hall, 2010</xref>).</p></sec><sec id="s4o" hwp:id="sec-25"><title hwp:id="title-33">ChIP-seq differential region analysis</title><p hwp:id="p-106">DiffReps (<xref ref-type="bibr" rid="c113" hwp:id="xref-ref-113-1" hwp:rel-id="ref-113">Shen et al., 2013</xref>) was used for identification of differentially enriched regions/ dynamic regions between all collected biological replicates (see Table S17) from mock, WAC, WA314, WA314ΔYopP and WA314ΔYopM. Csaw (<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-1" hwp:rel-id="ref-74">Lun &amp; Smyth, 2015</xref>) normalization coefficients for efficiency bias were calculate with <italic toggle="yes">width 150, spacing 100, minq 50, ext 210</italic> and used as input normalization coefficients in diffReps. Other diffReps parameters were set to default except for H3K4me1 and H3K27me3 where <italic toggle="yes">–nsd broad</italic> parameter was used. Accuracy of differentially enriched regions was examined in IGV (<xref ref-type="bibr" rid="c122" hwp:id="xref-ref-122-1" hwp:rel-id="ref-122">Thorvaldsdóttir et al., 2012</xref>). Statistically significant sites with log2 FC ≥1 and adjusted P-value ≤0.05 were selected for further analysis. Regions were further filtered to exclude regions that do not overlap MACS2 or SICER peaks, overlap blacklist regions (<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-2" hwp:rel-id="ref-5">Amemiya et al., 2019</xref>) and regions with low read counts (less than 20 for any replicate in the upregulated condition; less than 20 in the upregulated condition for H3K4me3). Additionally, H3K27me3 regions with length less than 1700 bp were excluded as smaller regions appeared to be false positives. For further clustering analysis of H3K4me3 and H3K27ac dynamic regions at promoters and enhancers all differential sites for each mark for different conditions were pooled together and merged.</p></sec><sec id="s4p" hwp:id="sec-26"><title hwp:id="title-34">ChIP-seq quantification of tag counts</title><p hwp:id="p-107">For quantification of tag counts at peaks and differential sites raw counts at target regions were quantified using EaSeq (<xref ref-type="bibr" rid="c68" hwp:id="xref-ref-68-1" hwp:rel-id="ref-68">Lerdrup et al., 2016</xref>) and normalized with csaw (<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-2" hwp:rel-id="ref-74">Lun &amp; Smyth, 2015</xref>) efficiency bias coefficients with the formula: <italic toggle="yes">(1+raw counts)/(csaw effective library size/10<sup>6</sup>)/bp per kb</italic>.</p></sec><sec id="s4q" hwp:id="sec-27"><title hwp:id="title-35">ChIP-seq classification and annotation of regions</title><p hwp:id="p-108">Promoter coordinates of ±2 kb from TSS and associated gene annotations were extracted from RefSeq hg19 gene annotations in UCSC Genome Browser (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">Haeussler et al., 2018</xref>) using EaSeq (<xref ref-type="bibr" rid="c68" hwp:id="xref-ref-68-2" hwp:rel-id="ref-68">Lerdrup et al., 2016</xref>). Regions overlapping promoter coordinates were defined as regions at promoters and annotated with associated genes; one region could overlap multiple promoters and associate with multiple genes. Regions that did not overlap promoters but overlapped with H3K4me1 regions were assigned to enhancers. Enhancer regions were annotated to the closest gene in EaSeq. The remaining regions were classified as “undefined”.</p><p hwp:id="p-109">For the identification of “dynamic” and “constant” peak regions, pooled peaks (based on MACS2 or SICER) were intersected with pooled differential site regions (based on diffReps) for each histone modification. Peaks intersecting differential regions were defined as “dynamic”, whereas the rest of the peaks were termed “constant”.</p><p hwp:id="p-110">Latent enhancers were defined as sites outside promoters with H3K4me1 signal increase based on diffReps without pre-existing H3K4me1 and H3K27ac signal (no SICER and MACS2 peaks)</p></sec><sec id="s4r" hwp:id="sec-28"><title hwp:id="title-36">ChIP-seq clustering of promoters and enhancer regions</title><p hwp:id="p-111">Clustering of normalized tag counts at pooled differential sites was performed with R function heatmap.2. All H3K4me3 and H3K27ac regions from pooled differential sites that intersected promoter regions were used for promoter (P1a-P2d classes) heatmaps. For the H3K27ac enhancer heatmap (E1-E4 classes) all H3K27ac regions from pooled differential sites outside promoters and overlapping H3K4me1 peaks were used. H3K4me3 promoter heatmap was generated with clustering distance based on Pearson correlation and Complete clustering method. For H3K27ac promoter heatmap regions which did not overlap regions in H3K4me3 promoter heatmap were used for clustering. H3K27ac promoter and enhancer heatmaps were generated with clustering distance based on Spearman correlation and Average clustering method. Clustering distance, clustering method and number of clusters were selected so that all meaningful clusters were identified by the analysis. Clusters were further assembled into classes based on the pattern of histone modifications across conditions.</p></sec><sec id="s4s" hwp:id="sec-29"><title hwp:id="title-37">ChIP-seq comparison to public data</title><p hwp:id="p-112">For comparison of H3K27ac data from this study and publicly available data (<xref ref-type="bibr" rid="c88" hwp:id="xref-ref-88-7" hwp:rel-id="ref-88">Park et al., 2017</xref>; <xref ref-type="bibr" rid="c83" hwp:id="xref-ref-83-3" hwp:rel-id="ref-83">Novakovic et al., 2016</xref>) raw tag counts at all H3K27ac peaks from this study were normalized with csaw (<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-3" hwp:rel-id="ref-74">Lun &amp; Smyth, 2015</xref>) efficiency bias coefficients. Batch effect between different datasets was removed using limma package (<xref ref-type="bibr" rid="c97" hwp:id="xref-ref-97-2" hwp:rel-id="ref-97">Ritchie et al., 2015</xref>) and tag counts used to calculate Spearman correlation.</p></sec><sec id="s4t" hwp:id="sec-30"><title hwp:id="title-38">ChIP-qPCR</title><p hwp:id="p-113">ChIP-qPCR was performed with SYBR Green/ROX qPCR Master Mix kit (Thermo Fisher Scientific) following manufacturer’s instructions. Primers (S15 Table) were designed using PRIMER-Blast tool (<xref ref-type="bibr" rid="c130" hwp:id="xref-ref-130-1" hwp:rel-id="ref-130">Ye et al., 2012</xref>) with the optimal melting temperature of 60 °C and template length between 55 and 200 bp. For all primer pairs input chromatin DNA was used to generate standard curves and verify amplification efficiency between 90-100 %. The specificity of primers was confirmed using reaction without a DNA template and melting curve analysis of PCR products. qPCR was performed on a Rotorgene 6000 qPCR machine (Qiagen) and analyzed with the Rotor-Gene 6000 software (Qiagen). A gain optimization was carried out at the beginning of the run. Concentration of amplified DNA was calculated based on the standard curve. In order to compare changes in enrichment at specific regions between different conditions, normalization was done with at least 2 selected control regions which did not show change in histone modifications during infection.</p></sec><sec id="s4u" hwp:id="sec-31"><title hwp:id="title-39">RT-qPCR analysis</title><p hwp:id="p-114">Uninfected or infected primary human macrophages were subjected to RNA extraction using RNeasy Mini Kit (Qiagen) following manufacturer’s instructions. 1 μg of each RNA was reverse transcribed using iScript cDNA Synthesis Kit (Bio-Rad Hercules) and subjected to RT-qPCR reaction using the TaqMan Fast Advanced Master mix (Applied Biosystems) or SYBR Green/ROX qPCR Master Mix kit (Thermo Fisher Scientific) and gene specific primers (see Table S15 for primers).</p><p hwp:id="p-115">For determination of IL1B and TNF mRNA levels the TaqMan Gene Expression Assays for human IL1B (Hs00174097_m1) and TNF (Hs01113624_g1) were employed. As reference the TagMan Gene Expression Assay for GAPDH (Hs02758991_g1), TATA-box binding protein (TBP) (Hs00427620_m1) and beta-2-microglobulin (B2M) (Hs00187842_m1) was used (all from Thermo Fisher Scientific). PCR was performed using the LightCycler 480 Instrument (Roche Life Science) and data were analyzed according to manufacturer’s instruction (Roche LightCycler 480 software; Software release 1.5.1.62). Reference genes and external standards were employed for the relative quantification of gene expression.</p><p hwp:id="p-116">For determination of PPARGC1B and ABI1 mRNA levels RT-qPCR was performed with SYBR Green/ROX qPCR Master Mix kit (Thermo Fisher Scientific) following manufacturer’s instructions. Primers (S15 Table) were designed using PRIMER-Blast tool (<xref ref-type="bibr" rid="c130" hwp:id="xref-ref-130-2" hwp:rel-id="ref-130">Ye et al., 2012</xref>) with the optimal melting temperature of 60 °C, template length between 55 and 200 bp and including intron junctions. cDNA was used to generate standard curves and verify amplification efficiency between 90-100 %. The specificity of primers was confirmed using reaction without a cDNA template or reverse transcription reaction without the reverse transcriptase and melting curve analysis of PCR products. qPCR was performed on a Rotorgene 6000 qPCR machine (Qiagen) and analyzed with the Rotor-Gene 6000 software (Qiagen). A gain optimization was carried out at the beginning of the run. Concentration of amplified cDNA was calculated based on the standard curve and normalized using reference genes GAPDH and HPRT.</p></sec><sec id="s4v" hwp:id="sec-32"><title hwp:id="title-40">Pathway analysis</title><p hwp:id="p-117">Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) terms were determined for RNA-seq and ChIP-seq gene lists by using DAVID webtool (<xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">Huang et al., 2008</xref>; <xref ref-type="bibr" rid="c58" hwp:id="xref-ref-58-1" hwp:rel-id="ref-58">Huang et al., 2009</xref>).</p></sec><sec id="s4w" hwp:id="sec-33"><title hwp:id="title-41">Motif analysis</title><p hwp:id="p-118">Transcription factor (TF) motif enrichment for known motifs was performed using HOMER package (<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">Heinz et al., 2010</xref>). Command <italic toggle="yes">findMotifsGenome.pl</italic> was used and a list of genomic coordinates was supplied as an input; the exact size of supplied regions was used by setting parameter <italic toggle="yes">-size given</italic>.</p></sec><sec id="s4x" hwp:id="sec-34"><title hwp:id="title-42">Boxplots</title><p hwp:id="p-119">Boxplots were generated using ggplot2 in R. Boxes encompass the twenty-fifth to seventy-fifth percentile changes. Whiskers extend to the tenth and ninetieth percentiles. Outliers are depicted with black dots. The central horizontal bar indicates the median.</p></sec><sec id="s4y" hwp:id="sec-35"><title hwp:id="title-43">Association between RNA-seq and ChIP-seq</title><p hwp:id="p-120">Gene lists from RNA-seq and ChIP-seq were compared based on gene symbols to find the number of overlapping genes and determine how many genes showed associated epigenetic and gene expression changes. In some cases RNA-seq lists contained old gene symbols which did not match to symbols in ChIP-seq lists with RefSeq annotation from UCSC. All old symbols in RNA-seq lists without a match in RefSeq annotation were replaced with the new symbol using Multi-symbol checker tool (Braschi et al., 2019).</p><p hwp:id="p-121">Relative overlap between promoter and enhancer classes was obtained by dividing the number of overlapping genes from two input classes with the total number of genes from the first input class and then with total number of genes from the second input class.</p></sec><sec id="s4z" hwp:id="sec-36"><title hwp:id="title-44">Calculation of % YopP effect</title><p hwp:id="p-122">Percentage YopP effect was calculated as ratio of FC between WA314ΔYopP vs WA314 and WAC vs WA314 (Suppression and Prevention) or WA314 vs mock (Up and Down). % YopP effect was presented for individual strongly WA314-regulated genes and regions from inflammatory response and Rho GTPase pathway, which associated with gene expression and histone modification changes in Suppression and Prevention profiles. Specifically, only genes were selected, which overlapped WAC vs WA314 DEGs and differentially enriched regions. Normalized tag counts were calculated for the target regions and used to obtain FC.</p></sec><sec id="s4aa" hwp:id="sec-37"><title hwp:id="title-45">Rho GTPase pathway gene analysis</title><p hwp:id="p-123">The target gene list with 534 Rho GTPase pathway genes was compiled from publicly available data and included 370 effectors binding GTP-Rho GTPases (<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-5" hwp:rel-id="ref-20">Bustelo et al., 2007</xref>; <xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-9" hwp:rel-id="ref-8">Bagci et al., 2020</xref>; <xref ref-type="bibr" rid="c89" hwp:id="xref-ref-89-5" hwp:rel-id="ref-89">Paul et al., 2017</xref>), 66 GAPs, 77 GEFs (<xref ref-type="bibr" rid="c82" hwp:id="xref-ref-82-8" hwp:rel-id="ref-82">Müller et al., 2020</xref>) and 23 Rho GTPases (<xref ref-type="bibr" rid="c128" hwp:id="xref-ref-128-1" hwp:rel-id="ref-128">Wennerberg &amp; Der, 2004</xref>; <xref ref-type="bibr" rid="c112" hwp:id="xref-ref-112-2" hwp:rel-id="ref-112">Senoo et al., 2019</xref> list in the supplementary). The list of genes does not match the list including activities (534 vs 536) as some genes possess multiple activities.</p></sec><sec id="s4ab" hwp:id="sec-38"><title hwp:id="title-46">Immunofluorescence staining</title><p hwp:id="p-124">For analysis of YopP effect on actin and ABI1 infected cells were washed twice with PBS, fixed with 4 % PFA in PBS for 5 min and permeabilized with 0.1 % Triton X-100 (w/v) in PBS for 10 min. After fixation and permeabilization coverslips were washed twice with PBS. Unspecific binding sites were blocked with 3 % bovine serum albumin (BSA, w/v) in PBS for at least 30 min. Samples were then incubated with 1:100 (anti-ABI1 (Sigma-Aldrich), anti-ZO-1 (Zymed), anti-H3K27ac (Abcam)) or 1:200 (anti-vinculin (Sigmal-Aldrich)) dilution of the primary antibody for 1 h and incubated with a 1:200 dilution of the suitable fluorophore-coupled secondary antibody for 45 min. Secondary anti-IgG antibodies and dyes used: Alexa488 chicken anti-rabbit (Molecular Probes), Alexa568 goat anti-mouse (Molecular Probes), AlexaFluor568 phalloidin (Invitrogen, GIBCO), AlexaFluor633 phalloidin (Invitrogen, GIBCO).</p><p hwp:id="p-125">After each staining coverslips were washed three times with PBS. Both primary and secondary antibodies were applied in PBS supplemented with 3 % BSA. Fluorophore-coupled phalloidin (1:200, Invitrogen) was added to the secondary antibody staining solution as indicated. Coverslips were mounted in ProLong Diamond (Thermo Fisher Scientific). For analysis of cells positive for effector translocation primary human macrophages were infected with different MOIs (10, 25, 50 and 100) of <italic toggle="yes">Y. enterocolitica</italic> WA314<italic toggle="yes">-</italic>YopE-ALFA strain for 6 h and fixed with 4 % PFA for 10 min. The samples were permeabilized with 0.1 % Triton-X-100 for 15 min, blocked with 3 % BSA for 1h and incubated with anti-ALFA nanobody-635 (FluoTag-X2 anti-ALFA Abberior Star 635P) (1:300) for 1h at RT. After washing 3 times with PBS, the cells were counterstained with DAPI and phalloidin- 488 and mounted on glass slides in Prolong Glass Antifade Mountant (Thermo Fisher Scientific).</p></sec><sec id="s4ac" hwp:id="sec-39"><title hwp:id="title-47">Microscopy</title><p hwp:id="p-126">Fixed samples were analyzed with a confocal laser scanning microscope (Leica TCS SP8) equipped with a 63x, NA1.4 oil immersion objective and Leica LAS X SP8 software (Leica Microsystems) was used for acquisition.</p></sec><sec id="s4ad" hwp:id="sec-40"><title hwp:id="title-48">Image analysis</title><p hwp:id="p-127">For analysis of YopP effect on actin and ABI1 the z-stacks of images were combined to one image using maximum intensity projection. These images were used to measure the mean fluorescent intensity of the F-actin signal with a circle (9.02 µm diameter) around the cellular junctions between macrophages. The signal intensity at junctions refers to the maximum value of 255 for 8-bit images.</p></sec><sec id="s4ae" hwp:id="sec-41"><title hwp:id="title-49">Western blot analysis</title><p hwp:id="p-128">Primary human macrophages (1-2*10<sup>6</sup> cells per condition) were washed once with warm PBS and scrapped off the plates to harvest the cells. Cell were pelleted by centrifugation at 700 x g, 10 min and 4°C. For ABI1 western blot cells were resuspended in 60 μl Lysis buffer (50 mM HEPES-KOH, pH 7.5, 140 mM NaCl, 1 mM EDTA, 10 % glycerol, 0.5 % NP-40, 0.75 % Triton X-100, protease inhibitor (Complete, Roche Diagnostics) and lyzed by incubation at 4°C for 30 min. For caspase-3 western blot cells were resuspended in 40 μl RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 % TRITON-X-100, 0.5 % sodium deoxycholate, 0.1 % SDS, protease inhibitor (Complete, Roche Diagnostics) and lyzed by incubation at 4°C for 10 min and brief sonication. Lysates were centrifuged at 10000 x g, 10 min and 4°C and supernantant was collected for Western blot analysis.</p><p hwp:id="p-129">Proteins were separated by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membrane (Immobilion-P, Millipore) by semi-dry blotting. The membrane was incubated in blocking solution (5 % milk powder (w/v) for ABI1 or 3 % BSA (w/v) for GAPDH and caspase-3 in TBS supplemented with 0.03 % Tween 20; TBS-T) at room temperature for 30 min. Primary antibody incubations (anti-ABI1 (Sigma-Aldrich) at 1:1000, anti-GAPDH (Sigma-Aldrich) at 1:3000, anti-caspase-3 (Cell Signaling) at 1:1000) were carried out at 4°C overnight, secondary antibody incubation (horseradish peroxidase linked anti-rabbit IgG (Cell Signaling) at 1:10000) was performed at room temperature for 1 h. Washing steps with TBS-T were done between the incubations. Antibody signals were visualized with chemiluminescence technology (Supersignal West Femto, Pierce Chemical) and captured on X-ray films (Fujifilm) or digital imager (Licor).</p></sec><sec id="s4af" hwp:id="sec-42"><title hwp:id="title-50">Ethics statement</title><p hwp:id="p-130">Approval for the analysis of anonymized blood donations (WF-015/12) was obtained by the Ethical Committee of the Ärztekammer Hamburg (Germany).</p></sec></sec><sec sec-type="supplementary-material" hwp:id="sec-43"><title hwp:id="title-51">Supporting information</title><supplementary-material position="float" orientation="portrait" hwp:id="DC1"><object-id pub-id-type="other" hwp:sub-type="slug">DC1</object-id><label>Supplemental Table 1</label><media xlink:href="supplements/459276_file02.xlsx" position="float" orientation="portrait" hwp:id="media-1"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC2"><object-id pub-id-type="other" hwp:sub-type="slug">DC2</object-id><label>Supplemental Table 2</label><media xlink:href="supplements/459276_file03.xlsx" position="float" orientation="portrait" hwp:id="media-2"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC3"><object-id pub-id-type="other" hwp:sub-type="slug">DC3</object-id><label>Supplemental Table 3</label><media xlink:href="supplements/459276_file04.xlsx" position="float" orientation="portrait" hwp:id="media-3"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC4"><object-id pub-id-type="other" hwp:sub-type="slug">DC4</object-id><label>Supplemental Table 4</label><media xlink:href="supplements/459276_file05.xlsx" position="float" orientation="portrait" hwp:id="media-4"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC5"><object-id pub-id-type="other" hwp:sub-type="slug">DC5</object-id><label>Supplemental Table 5</label><media xlink:href="supplements/459276_file06.xlsx" position="float" orientation="portrait" hwp:id="media-5"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC6"><object-id pub-id-type="other" hwp:sub-type="slug">DC6</object-id><label>Supplemental Table 6</label><media xlink:href="supplements/459276_file07.xlsx" position="float" orientation="portrait" hwp:id="media-6"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC7"><object-id pub-id-type="other" hwp:sub-type="slug">DC7</object-id><label>Supplemental Table 7</label><media xlink:href="supplements/459276_file08.xlsx" position="float" orientation="portrait" hwp:id="media-7"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC8"><object-id pub-id-type="other" hwp:sub-type="slug">DC8</object-id><label>Supplemental Table 8</label><media xlink:href="supplements/459276_file09.xlsx" position="float" orientation="portrait" hwp:id="media-8"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC9"><object-id pub-id-type="other" hwp:sub-type="slug">DC9</object-id><label>Supplemental Table 9</label><media xlink:href="supplements/459276_file10.xlsx" position="float" orientation="portrait" hwp:id="media-9"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC10"><object-id pub-id-type="other" hwp:sub-type="slug">DC10</object-id><label>Supplemental Table 10</label><media xlink:href="supplements/459276_file11.xlsx" position="float" orientation="portrait" hwp:id="media-10"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC11"><object-id pub-id-type="other" hwp:sub-type="slug">DC11</object-id><label>Supplemental Table 11</label><media xlink:href="supplements/459276_file12.xlsx" position="float" orientation="portrait" hwp:id="media-11"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC12"><object-id pub-id-type="other" hwp:sub-type="slug">DC12</object-id><label>Supplemental Table 12</label><media xlink:href="supplements/459276_file13.xlsx" position="float" orientation="portrait" hwp:id="media-12"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC13"><object-id pub-id-type="other" hwp:sub-type="slug">DC13</object-id><label>Supplemental Table 13</label><media xlink:href="supplements/459276_file14.xlsx" position="float" orientation="portrait" hwp:id="media-13"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC14"><object-id pub-id-type="other" hwp:sub-type="slug">DC14</object-id><label>Supplemental Table 14</label><media xlink:href="supplements/459276_file15.xlsx" position="float" orientation="portrait" hwp:id="media-14"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC15"><object-id pub-id-type="other" hwp:sub-type="slug">DC15</object-id><label>Supplemental Table 15</label><media xlink:href="supplements/459276_file16.xlsx" position="float" orientation="portrait" hwp:id="media-15"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC16"><object-id pub-id-type="other" hwp:sub-type="slug">DC16</object-id><label>Supplemental Table 16</label><media xlink:href="supplements/459276_file17.xlsx" position="float" orientation="portrait" hwp:id="media-16"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC17"><object-id pub-id-type="other" hwp:sub-type="slug">DC17</object-id><label>Supplemental Table 17</label><media xlink:href="supplements/459276_file18.xlsx" position="float" orientation="portrait" hwp:id="media-17"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC18"><object-id pub-id-type="other" hwp:sub-type="slug">DC18</object-id><label>Supplemental Table 18</label><media xlink:href="supplements/459276_file19.xlsx" position="float" orientation="portrait" hwp:id="media-18"/></supplementary-material></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-52">Acknowledgements</title><p hwp:id="p-131">We thank the UKE Core Facility Microscopy Imaging (Umif) for help with experimental setups and data analysis. We also would like to thank Daniela Indenbirken for generating the RNA-seq libraries and Frank Bentzien (UKE Transfusion Medicine) for buffy coats. We thank Alexander Carsten and Asiri Ortega for WA314-YopE-ALFA strain and Eva Tolosa and Manuela Kolster for flow cytometry analysis.</p></ack><ref-list hwp:id="ref-list-1"><title hwp:id="title-53">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2 xref-ref-1-3 xref-ref-1-4 xref-ref-1-5"><citation publication-type="book" citation-type="book" ref:id="2021.09.07.459276v2.1" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Aepfelbacher M."><surname>Aepfelbacher</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Wolters M."><surname>Wolters</surname>, <given-names>M.</given-names></string-name> in <source hwp:id="source-1">The Actin Cytoskeleton and Bacterial Infection</source> <fpage>201</fpage>–<lpage>220</lpage> (<publisher-name>Springer International Publishing</publisher-name>, <publisher-loc>Cham</publisher-loc>, <year>2017</year>).</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Aktories K."><surname>Aktories</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schmidt G."><surname>Schmidt</surname>, <given-names>G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Just I."><surname>Just</surname>, <given-names>I.</given-names></string-name> <article-title hwp:id="article-title-2">Rho GTPases as Targets of Bacterial Protein Toxins</article-title>. <source hwp:id="source-2">Biological Chemistry</source> <volume>381</volume>, <fpage>421</fpage>–<lpage>426</lpage> (<year>2000</year>).</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Aktories K."><surname>Aktories</surname>, <given-names>K.</given-names></string-name> <article-title hwp:id="article-title-3">Bacterial protein toxins that modify host regulatory GTPases</article-title>. <source hwp:id="source-3">Nature reviews. Microbiology</source> <volume>9</volume>, <fpage>487</fpage>–<lpage>498</lpage> (<year>2011</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Allis C. D."><surname>Allis</surname>, <given-names>C. D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Jenuwein T."><surname>Jenuwein</surname>, <given-names>T.</given-names></string-name> <article-title hwp:id="article-title-4">The molecular hallmarks of epigenetic control</article-title>. <source hwp:id="source-4">Nature Reviews Genetics</source> <volume>17</volume>, <fpage>487</fpage>–<lpage>500</lpage> (<year>2016</year>).</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1 xref-ref-5-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Amemiya H. M."><surname>Amemiya</surname>, <given-names>H. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kundaje A."><surname>Kundaje</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Boyle A. P."><surname>Boyle</surname>, <given-names>A. P.</given-names></string-name> <article-title hwp:id="article-title-5">The ENCODE Blacklist: Identification of Problematic Regions of the Genome</article-title>. <source hwp:id="source-5">Scientific Reports</source> <volume>9</volume>, <fpage>9354</fpage> (<year>2019</year>).</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1 xref-ref-6-2 xref-ref-6-3 xref-ref-6-4 xref-ref-6-5 xref-ref-6-6"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Aspenström P."><surname>Aspenström</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ruusala A."><surname>Ruusala</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Pacholsky D."><surname>Pacholsky</surname>, <given-names>D.</given-names></string-name> <article-title hwp:id="article-title-6">Taking Rho GTPases to the next level: The cellular functions of atypical Rho GTPases</article-title>. <source hwp:id="source-6">Experimental Cell Research</source> <volume>313</volume>, <fpage>3673</fpage>–<lpage>3679</lpage> (<year>2007</year>).</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Auerbuch V."><surname>Auerbuch</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Golenbock D. T."><surname>Golenbock</surname>, <given-names>D. T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Isberg R. R."><surname>Isberg</surname>, <given-names>R. R.</given-names></string-name> <article-title hwp:id="article-title-7">Innate Immune Recognition of Yersinia pseudotuberculosis Type III Secretion</article-title>. <source hwp:id="source-7">PLOS Pathogens</source> <volume>5</volume>, <fpage>1</fpage>–<lpage>16</lpage> (<year>2009</year>).</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2 xref-ref-8-3 xref-ref-8-4 xref-ref-8-5 xref-ref-8-6 xref-ref-8-7 xref-ref-8-8 xref-ref-8-9"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Bagci H."><surname>Bagci</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-8">Mapping the proximity interaction network of the Rho-family GTPases reveals signalling pathways and regulatory mechanisms</article-title>. <source hwp:id="source-8">Nature cell biology</source> <volume>22</volume>, <fpage>120</fpage>—<lpage>134</lpage> (<year>2020</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Balada-Llasat J.-M."><surname>Balada-Llasat</surname>, <given-names>J.-M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Mecsas J."><surname>Mecsas</surname>, <given-names>J.</given-names></string-name> <article-title hwp:id="article-title-9">Yersinia Has a Tropism for B and T Cell Zones of Lymph Nodes That Is Independent of the Type III Secretion System</article-title>. <source hwp:id="source-9">PLOS Pathogens</source> <volume>2</volume>, <fpage>1</fpage>–<lpage>13</lpage> (<year>2006</year>).</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Barski A."><surname>Barski</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-10">High-Resolution Profiling of Histone Methylations in the Human Genome</article-title>. <source hwp:id="source-10">Cell</source> <volume>129</volume>, <fpage>823</fpage>—<lpage>837</lpage> (<year>2007</year>).</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Bedi R."><surname>Bedi</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Du J."><surname>Du</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sharma A. K."><surname>Sharma</surname>, <given-names>A. K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gomes I."><surname>Gomes</surname>, <given-names>I.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Ackerman S. J."><surname>Ackerman</surname>, <given-names>S. J.</given-names></string-name> <article-title hwp:id="article-title-11">Human C/EBP-E activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation</article-title>. <source hwp:id="source-11">Blood</source> <volume>113</volume>, <fpage>317</fpage>–<lpage>327</lpage> (<year>2009</year>).</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1 xref-ref-12-2 xref-ref-12-3"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Berneking L."><surname>Berneking</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-12">Immunosuppressive Yersinia Effector YopM Binds DEAD Box Helicase DDX3 to Control Ribosomal S6 Kinase in the Nucleus of Host Cells</article-title>. <source hwp:id="source-12">PLoS Pathogens</source> <volume>12</volume>, <fpage>1</fpage>–<lpage>35</lpage> (<year>2016</year>).</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.13" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Bierne H."><surname>Bierne</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hamon M."><surname>Hamon</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Cossart P."><surname>Cossart</surname>, <given-names>P.</given-names></string-name> <article-title hwp:id="article-title-13">Epigenetics and Bacterial Infections</article-title>. <source hwp:id="source-13">Cold Spring Harbor Perspectives in Medicine</source> <volume>2</volume> (<year>2012</year>).</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Bohn E."><surname>Bohn</surname>, <given-names>E.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-14">Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia enterocolitica†</article-title>. <source hwp:id="source-14">Cellular Microbiology</source> <volume>6</volume>, <fpage>129</fpage>–<lpage>141</lpage> (<year>2004</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Bokoch G. M."><surname>Bokoch</surname>, <given-names>G. M.</given-names></string-name> <article-title hwp:id="article-title-15">Regulation of innate immunity by Rho GTPases</article-title>. <source hwp:id="source-15">Trends in Cell Biology</source> <volume>15</volume>, <fpage>163</fpage>–<lpage>171</lpage> (<year>2005</year>).</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Boureux A."><surname>Boureux</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vignal E."><surname>Vignal</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Faure S."><surname>Faure</surname>, <given-names>S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Fort P."><surname>Fort</surname>, <given-names>P.</given-names></string-name> <article-title hwp:id="article-title-16">Evolution of the Rho Family of Ras-Like GTPases in Eukaryotes</article-title>. <source hwp:id="source-16">Molecular Biology and Evolution</source> <volume>24</volume>, <fpage>203</fpage>–<lpage>216</lpage> (<year>2006</year>).</citation></ref><ref id="c17" hwp:id="ref-17"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Braschi B."><surname>Braschi</surname>, <given-names>B.</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-17">Genenames.org: the HGNC and VGNC resources in 2019</article-title>. <source hwp:id="source-17">Nucleic Acids Research</source> <volume>47</volume>, <fpage>D786</fpage>–<lpage>D792</lpage> (<year>2018</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1 xref-ref-18-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Brodsky I. E."><surname>Brodsky</surname>, <given-names>I. E.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-18">A Yersinia Effector Protein Promotes Virulence by Preventing Inflammasome Recognition of the Type III Secretion System</article-title>. <source hwp:id="source-18">Cell Host and Microbe</source> <volume>7</volume>, <fpage>376</fpage> –<lpage>387</lpage> (<year>2010</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Broz P."><surname>Broz</surname>, <given-names>P.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Dixit V. M."><surname>Dixit</surname>, <given-names>V. M.</given-names></string-name> <article-title hwp:id="article-title-19">Inflammasomes: mechanism of assembly, regulation and signalling</article-title>. <source hwp:id="source-19">Nature reviews. Immunology</source> <volume>16</volume>, <fpage>407</fpage>–<lpage>420</lpage> (<year>2016</year>).</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1 xref-ref-20-2 xref-ref-20-3 xref-ref-20-4 xref-ref-20-5"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Bustelo X. R."><surname>Bustelo</surname>, <given-names>X. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sauzeau V."><surname>Sauzeau</surname>, <given-names>V.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Berenjeno I. M."><surname>Berenjeno</surname>, <given-names>I. M.</given-names></string-name> <article-title hwp:id="article-title-20">GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo</article-title>. <source hwp:id="source-20">BioEssays</source> <volume>29</volume>, <fpage>356</fpage>–<lpage>370</lpage> (<year>2007</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><citation publication-type="other" citation-type="journal" ref:id="2021.09.07.459276v2.21" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Carsten A."><surname>Carsten</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-21">Visualization of bacterial type 3 secretion system components down to the molecular level by MINFLUX nanoscopy</article-title>. <source hwp:id="source-21">bioRxiv</source> (<year>2021</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Chakraborty N."><surname>Chakraborty</surname>, <given-names>N.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-22">The responses of lungs and adjacent lymph nodes in responding to Yersinia pestis infection: A transcriptomic study using a non-human primate model</article-title>. <source hwp:id="source-22">PLOS ONE</source> <volume>14</volume>, <fpage>1</fpage>–<lpage>24</lpage> (<year>2019</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1 xref-ref-23-2 xref-ref-23-3 xref-ref-23-4"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Chardin P."><surname>Chardin</surname>, <given-names>P.</given-names></string-name> <article-title hwp:id="article-title-23">Function and regulation of Rnd proteins</article-title>. <source hwp:id="source-23">Nature reviews. Molecular cell biology</source> <volume>7</volume>, <fpage>54</fpage>–<lpage>62</lpage> (<year>2006</year>).</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Chen B."><surname>Chen</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-24">Epigenetic activation of the small GTPase TCL contributes to colorectal cancer cell migration and invasion</article-title>. <source hwp:id="source-24">Oncogenesis</source> <volume>9</volume>, <fpage>86</fpage> (<year>2020</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Chen X."><surname>Chen</surname>, <given-names>X.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-25">Ena/VASP Proteins Cooperate with the WAVE Complex to Regulate the Actin Cytoskeleton</article-title>. <source hwp:id="source-25">Developmental Cell</source> <volume>30</volume>, <fpage>569</fpage>–<lpage>584</lpage> (<year>2014</year>).</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Christgen S."><surname>Christgen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Place D. E."><surname>Place</surname>, <given-names>D. E.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Kanneganti T.-D."><surname>Kanneganti</surname>, <given-names>T.-D.</given-names></string-name> <article-title hwp:id="article-title-26">Toward targeting inflammasomes: insights into their regulation and activation</article-title>. <source hwp:id="source-26">Cell research</source> <volume>30</volume>, <fpage>315</fpage>–<lpage>327</lpage> (<year>2020</year>).</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Chung L. K."><surname>Chung</surname>, <given-names>L. K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-27">The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome</article-title>. <source hwp:id="source-27">Cell Host and Microbe</source> <volume>20</volume>, <fpage>296</fpage> –<lpage>306</lpage> (<year>2016</year>).</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Comer J. E."><surname>Comer</surname>, <given-names>J. E.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-28">Transcriptomic and Innate Immune Responses to Yersinia pestis in the Lymph Node during Bubonic Plague</article-title>. <source hwp:id="source-28">Infection and Immunity</source> <volume>78</volume>, <fpage>5086</fpage>–<lpage>5098</lpage> (<year>2010</year>)</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Connor M. G."><surname>Connor</surname>, <given-names>M. G.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-29">Yersinia pestis Targets the Host Endosome Recycling Pathway during the Biogenesis of the Yersinia-Containing Vacuole To Avoid Killing by Macrophages</article-title>. <source hwp:id="source-29">mBio</source> <volume>9</volume>, <fpage>e01800</fpage>–<lpage>17</lpage> (<year>2018</year>).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.30" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Connor M."><surname>Connor</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Arbibe L."><surname>Arbibe</surname>, <given-names>L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hamon M."><surname>Hamon</surname>, <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-30">Customizing Host Chromatin: a Bacterial Tale</article-title>. <source hwp:id="source-30">Microbiology Spectrum</source> <volume>7</volume> (<year>2019</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Cornelis G. R."><surname>Cornelis</surname>, <given-names>G. R.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Wolf-Watz H."><surname>Wolf-Watz</surname>, <given-names>H.</given-names></string-name> <article-title hwp:id="article-title-31">The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells</article-title>. <source hwp:id="source-31">Molecular Microbiology</source> <volume>23</volume>, <fpage>861</fpage>–<lpage>867</lpage> (<year>1997</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Diacovich L."><surname>Diacovich</surname>, <given-names>L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Gorvel J.-P."><surname>Gorvel</surname>, <given-names>J.-P.</given-names></string-name> <article-title hwp:id="article-title-32">Bacterial manipulation of innate immunity to promote infection</article-title>. <source hwp:id="source-32">Nature Reviews Microbiology</source> <volume>8</volume>, <fpage>117</fpage>–<lpage>128</lpage> (<year>2010</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Dobin A."><surname>Dobin</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-33">STAR: ultrafast universal RNA-seq aligner</article-title>. <source hwp:id="source-33">Bioinformatics</source> <volume>29</volume>, <fpage>15</fpage>–<lpage>21</lpage> (<year>2012</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Dong W."><surname>Dong</surname>, <given-names>W.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hamon M. A."><surname>Hamon</surname>, <given-names>M. A.</given-names></string-name> <article-title hwp:id="article-title-34">Revealing eukaryotic histone-modifying mechanisms through bacterial infection</article-title>. <source hwp:id="source-34">Seminars in Immunopathology</source> <volume>42</volume>, <fpage>201</fpage>–<lpage>213</lpage> (<year>2020</year>).</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Doyle S. E."><surname>Doyle</surname>, <given-names>S. E.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-35">Toll-like Receptors Induce a Phagocytic Gene Program through p38</article-title>. <source hwp:id="source-35">Journal of Experimental Medicine</source> <volume>199</volume>, <fpage>81</fpage>–<lpage>90</lpage> (<year>2004</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Drechsler-Hake D."><surname>Drechsler-Hake</surname>, <given-names>D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-36">Mononuclear phagocytes contribute to intestinal invasion and dissemination of Yersinia enterocolitica</article-title>. <source hwp:id="source-36">International Journal of Medical Microbiology</source> <volume>306</volume>, <fpage>357</fpage>–<lpage>366</lpage> (<year>2016</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Fritz G."><surname>Fritz</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Just I."><surname>Just</surname>, <given-names>I.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Kaina B."><surname>Kaina</surname>, <given-names>B.</given-names></string-name> <article-title hwp:id="article-title-37">Rho GTPases are over-expressed in human tumors</article-title>. <source hwp:id="source-37">International Journal of Cancer</source> <volume>81</volume>, <fpage>682</fpage>–<lpage>687</lpage> (<year>1999</year>).</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Gallant S."><surname>Gallant</surname>, <given-names>S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Gilkeson G."><surname>Gilkeson</surname>, <given-names>G.</given-names></string-name> <article-title hwp:id="article-title-38">ETS transcription factors and regulation of immunity</article-title>. <source hwp:id="source-38">Archivum Immunologiae et Therapiae Experimentalis</source> <volume>54</volume>, <fpage>149</fpage>–<lpage>163</lpage> (<year>2006</year>).</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Galán J. E."><surname>Galán</surname>, <given-names>J. E.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Wolf-Watz H."><surname>Wolf-Watz</surname>, <given-names>H.</given-names></string-name> <article-title hwp:id="article-title-39">Protein delivery into eukaryotic cells by type III secretion machines</article-title>. <source hwp:id="source-39">Nature</source> <volume>444</volume>, <fpage>567</fpage>—<lpage>573</lpage> (<year>2006</year>).</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Gao P."><surname>Gao</surname>, <given-names>P.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-40">Transcription factor Fli-1 positively regulates lipopolysaccharide-induced interleukin-27 production in macrophages</article-title>. <source hwp:id="source-40">Molecular immunology</source> <volume>71</volume>, <fpage>184</fpage>—<lpage>191</lpage> (<year>2016</year>).</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1 xref-ref-41-2 xref-ref-41-3 xref-ref-41-4"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Glass C. K."><surname>Glass</surname>, <given-names>C. K.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Natoli G."><surname>Natoli</surname>, <given-names>G.</given-names></string-name> <article-title hwp:id="article-title-41">Molecular control of activation and priming in macrophages</article-title>. <source hwp:id="source-41">Nature immunology</source> <volume>17</volume>, <fpage>26</fpage>–<lpage>33</lpage> (<year>2015</year>).</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Grassl G. A."><surname>Grassl</surname>, <given-names>G. A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-42">Activation of NF-κB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades</article-title>. <source hwp:id="source-42">Cellular Microbiology</source> <volume>5</volume>, <fpage>957</fpage>– <lpage>971</lpage> (<year>2003</year>).</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Grootjans S."><surname>Grootjans</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-43">A real-time fluorometric method for the simultaneous detection of cell death type and rate</article-title>. <source hwp:id="source-43">Nature Protocols</source> <volume>11</volume>, <fpage>1444</fpage>–<lpage>1454</lpage> (<year>2016</year>).</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Günther T."><surname>Günther</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Theiss J. M."><surname>Theiss</surname>, <given-names>J. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fischer N."><surname>Fischer</surname>, <given-names>N.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Grundhoff A."><surname>Grundhoff</surname>, <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-44">Investigation of Viral and Host Chromatin by ChIP-PCR or ChIP-Seq Analysis</article-title>. <source hwp:id="source-44">Current Protocols in Microbiology</source> <volume>40</volume>, <fpage>1E.10.1</fpage>–<lpage>1E.10.21</lpage> (<year>2016</year>).</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Göös H."><surname>Göös</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-45">Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy</article-title>. <source hwp:id="source-45">Journal of Allergy and Clinical Immunology</source> <volume>144</volume>, <fpage>1364</fpage>–<lpage>1376</lpage> (<year>2019</year>).</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Haeussler M."><surname>Haeussler</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-46">The UCSC Genome Browser database: 2019 update</article-title>. <source hwp:id="source-46">Nucleic Acids Research</source> <volume>47</volume>, <fpage>D853</fpage>–<lpage>D858</lpage> (<year>2018</year>).</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1 xref-ref-47-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Haga R. B."><surname>Haga</surname>, <given-names>R. B.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Ridley A. J."><surname>Ridley</surname>, <given-names>A. J.</given-names></string-name> <article-title hwp:id="article-title-47">Rho GTPases: Regulation and roles in cancer cell biology</article-title>. <source hwp:id="source-47">Small GTPases</source> <volume>7</volume>, <fpage>207</fpage>–<lpage>221</lpage> (<year>2016</year>).</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Hammamieh R."><surname>Hammamieh</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-48">Temporal Progression of Pneumonic Plague in Blood of Nonhuman Primate: A Transcriptomic Analysis</article-title>. <source hwp:id="source-48">PLOS ONE</source> <volume>11</volume>, <fpage>1</fpage>–<lpage>21</lpage> (Mar. <year>2016</year>).</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1 xref-ref-49-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Heasman S. J."><surname>Heasman</surname>, <given-names>S. J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Ridley A. J."><surname>Ridley</surname>, <given-names>A. J.</given-names></string-name> <article-title hwp:id="article-title-49">Mammalian Rho GTPases: new insights into their functions from in vivo studies</article-title>. <source hwp:id="source-49">Nature reviews. Molecular cell biology</source> <volume>9</volume>, <fpage>690</fpage>—<lpage>701</lpage> (<year>2008</year>).</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Heesemann J"><surname>Heesemann</surname>, <given-names>J</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Laufs R."><surname>Laufs</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-50">Construction of a mobilizable Yersinia enterocolitica virulence plasmid</article-title>. <source hwp:id="source-50">Journal of Bacteriology</source> <volume>155</volume>, <fpage>761</fpage>–<lpage>767</lpage> (<year>1983</year>).</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Heine W."><surname>Heine</surname>, <given-names>W.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-51">Loss of CNFY toxin-induced inflammation drives Yersinia pseudotuberculosis into persistency</article-title>. <source hwp:id="source-51">PLOS Pathogens</source> <volume>14</volume>, <fpage>1</fpage>–<lpage>32</lpage> (<year>2018</year>).</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Heintzman N. D."><surname>Heintzman</surname>, <given-names>N. D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-52">Histone modifications at human enhancers reflect global cell type-specific gene expression</article-title>. <source hwp:id="source-52">Nature</source> <volume>459</volume>, <fpage>108</fpage>–<lpage>112</lpage> (<year>2009</year>).</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Heinz S."><surname>Heinz</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-53">Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities</article-title>. <source hwp:id="source-53">Molecular Cell</source> <volume>38</volume>, <fpage>576</fpage>–<lpage>589</lpage> (<year>2010</year>).</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1 xref-ref-54-2 xref-ref-54-3 xref-ref-54-4 xref-ref-54-5 xref-ref-54-6"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Hodge R. G."><surname>Hodge</surname>, <given-names>R. G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Ridley A. J."><surname>Ridley</surname>, <given-names>A. J.</given-names></string-name> <article-title hwp:id="article-title-54">Regulating Rho GTPases and their regulators</article-title>. <source hwp:id="source-54">Nature reviews. Molecular cell biology</source> <volume>17</volume>, <fpage>496</fpage>—<lpage>510</lpage> (<year>2016</year>).</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.55" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Hoffmann R."><surname>Hoffmann</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Erp K."><surname>Van Erp</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trülzsch K."><surname>Trülzsch</surname>, <given-names>K.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Heesemann J."><surname>Heesemann</surname>, <given-names>J.</given-names></string-name> <article-title hwp:id="article-title-55">Transcriptional responses of murine macrophages to infection with Yersinia enterocolitica</article-title>. <source hwp:id="source-55">Cellular Microbiology</source> <volume>6</volume>, <fpage>377</fpage>–<lpage>390</lpage> (<year>2004</year>).</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.56" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-56"><string-name name-style="western" hwp:sortable="Hop H. T."><surname>Hop</surname>, <given-names>H. T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-56">The Key Role of c-Fos for Immune Regulation and Bacterial Dissemination in Brucella Infected Macrophage</article-title>. <source hwp:id="source-56">Frontiers in Cellular and Infection Microbiology</source> <volume>8</volume>, <fpage>287</fpage> (<year>2018</year>).</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.57" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-57"><string-name name-style="western" hwp:sortable="Huang D. W."><surname>Huang</surname>, <given-names>D. W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sherman B. T."><surname>Sherman</surname>, <given-names>B. T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Lempicki R. A."><surname>Lempicki</surname>, <given-names>R. A.</given-names></string-name> <article-title hwp:id="article-title-57">Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title>. <source hwp:id="source-57">Nucleic Acids Research</source> <volume>37</volume>, <fpage>1</fpage>–<lpage>13</lpage> (<year>2008</year>).</citation></ref><ref id="c58" hwp:id="ref-58" hwp:rev-id="xref-ref-58-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.58" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-58"><string-name name-style="western" hwp:sortable="Huang D. W."><surname>Huang</surname>, <given-names>D. W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sherman B. T."><surname>Sherman</surname>, <given-names>B. T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Lempicki R. A."><surname>Lempicki</surname>, <given-names>R. A.</given-names></string-name> <article-title hwp:id="article-title-58">Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source hwp:id="source-58">Nature Protocols</source> <volume>4</volume>, <fpage>44</fpage>–<lpage>57</lpage> (<year>2009</year>).</citation></ref><ref id="c59" hwp:id="ref-59" hwp:rev-id="xref-ref-59-1 xref-ref-59-2 xref-ref-59-3 xref-ref-59-4 xref-ref-59-5"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.59" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-59"><string-name name-style="western" hwp:sortable="Ivashkiv L. B."><surname>Ivashkiv</surname>, <given-names>L. B.</given-names></string-name> <article-title hwp:id="article-title-59">Epigenetic regulation of macrophage polarization and function</article-title>. <source hwp:id="source-59">Trends in Immunology</source> <volume>34</volume>, <fpage>216</fpage>–<lpage>223</lpage> (<year>2013</year>).</citation></ref><ref id="c60" hwp:id="ref-60" hwp:rev-id="xref-ref-60-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.60" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-60"><string-name name-style="western" hwp:sortable="Jaffe A. B."><surname>Jaffe</surname>, <given-names>A. B.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hall A."><surname>Hall</surname>, <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-60">RHO GTPASES: Biochemistry and Biology</article-title>. <source hwp:id="source-60">Annual Review of Cell and Developmental Biology</source> <volume>21</volume>, <fpage>247</fpage>–<lpage>269</lpage> (<year>2005</year>).</citation></ref><ref id="c61" hwp:id="ref-61" hwp:rev-id="xref-ref-61-1 xref-ref-61-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.61" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-61"><string-name name-style="western" hwp:sortable="Kang K."><surname>Kang</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-61">IFN-selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation</article-title>. <source hwp:id="source-61">Nature Communications</source> <volume>10</volume> (<year>2019</year>).</citation></ref><ref id="c62" hwp:id="ref-62" hwp:rev-id="xref-ref-62-1 xref-ref-62-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.62" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-62"><string-name name-style="western" hwp:sortable="Köberle M."><surname>Köberle</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-62">Yersinia enterocolitica YopT and Clostridium difficile Toxin B Induce Expression of GILZ in Epithelial Cells</article-title>. <source hwp:id="source-62">PLOS ONE</source> <volume>7</volume>, <fpage>1</fpage>–<lpage>17</lpage> (<year>2012</year>).</citation></ref><ref id="c63" hwp:id="ref-63" hwp:rev-id="xref-ref-63-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.63" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-63"><string-name name-style="western" hwp:sortable="Klemm S. L."><surname>Klemm</surname>, <given-names>S. L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shipony Z."><surname>Shipony</surname>, <given-names>Z.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Greenleaf W. J."><surname>Greenleaf</surname>,<given-names>W. J.</given-names></string-name> <article-title hwp:id="article-title-63">Chromatin accessibility and the regulatory epigenome</article-title>. <source hwp:id="source-63">Nature reviews. Genetics</source> <volume>20</volume>, <fpage>207</fpage>—<lpage>220</lpage> (<year>2019</year>).</citation></ref><ref id="c64" hwp:id="ref-64" hwp:rev-id="xref-ref-64-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.64" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-64"><string-name name-style="western" hwp:sortable="Koch I."><surname>Koch</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dach K."><surname>Dach</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heesemann J."><surname>Heesemann</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hoffmann R."><surname>Hoffmann</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-64">Yersinia enterocolitica inactivates NK cells</article-title>. <source hwp:id="source-64">International Journal of Medical Microbiology</source> <volume>303</volume>, <fpage>433</fpage>–<lpage>442</lpage> (<year>2013</year>).</citation></ref><ref id="c65" hwp:id="ref-65" hwp:rev-id="xref-ref-65-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.65" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-65"><string-name name-style="western" hwp:sortable="Kopp P."><surname>Kopp</surname>, <given-names>P.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-65">The Kinesin KIF1C and Microtubule Plus Ends Regulate Podosome Dynamics in Macrophages</article-title>. <source hwp:id="source-65">Molecular Biology of the Cell</source> <volume>17</volume>, <fpage>2811</fpage>–<lpage>2823</lpage> (<year>2006</year>).</citation></ref><ref id="c66" hwp:id="ref-66" hwp:rev-id="xref-ref-66-1 xref-ref-66-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.66" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-66"><string-name name-style="western" hwp:sortable="Laurin M."><surname>Laurin</surname>, <given-names>M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Côté J.-F."><surname>Côté</surname>, <given-names>J.-F.</given-names></string-name> <article-title hwp:id="article-title-66">Insights into the biological functions of Dock family guanine nucleotide exchange factors</article-title>. <source hwp:id="source-66">Genes and Development</source> <volume>28</volume>, <fpage>533</fpage>–<lpage>547</lpage> (<year>2014</year>).</citation></ref><ref id="c67" hwp:id="ref-67" hwp:rev-id="xref-ref-67-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.67" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-67"><string-name name-style="western" hwp:sortable="Lennard Richard M. L."><surname>Lennard Richard</surname>, <given-names>M. L.</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-67">The Fli-1 transcription factor regulates the expression of CCL5/RANTES</article-title>. <source hwp:id="source-67">Journal of immunology (Baltimore, Md. : 1950)</source> <volume>193</volume>, <fpage>2661</fpage>—<lpage>2668</lpage> (<year>2014</year>).</citation></ref><ref id="c68" hwp:id="ref-68" hwp:rev-id="xref-ref-68-1 xref-ref-68-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.68" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-68"><string-name name-style="western" hwp:sortable="Lerdrup M."><surname>Lerdrup</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Johansen J. V."><surname>Johansen</surname>, <given-names>J. V.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Agrawal-Singh S."><surname>Agrawal-Singh</surname>, <given-names>S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hansen K."><surname>Hansen</surname>, <given-names>K.</given-names></string-name> <article-title hwp:id="article-title-68">An interactive environment for agile analysis and visualization of ChIP-sequencing data</article-title>. <source hwp:id="source-68">Nature Structural &amp; Molecular Biology</source> <volume>23</volume>, <fpage>349</fpage>–<lpage>357</lpage> (<year>2016</year>).</citation></ref><ref id="c69" hwp:id="ref-69" hwp:rev-id="xref-ref-69-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.69" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-69"><string-name name-style="western" hwp:sortable="Li H."><surname>Li</surname>, <given-names>H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Durbin R."><surname>Durbin</surname>, <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-69">Fast and accurate short read alignment with Burrows–Wheeler transform</article-title>. <source hwp:id="source-69">Bioinformatics</source> <volume>25</volume>, <fpage>1754</fpage>–<lpage>1760</lpage> (<year>2009</year>).</citation></ref><ref id="c70" hwp:id="ref-70" hwp:rev-id="xref-ref-70-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.70" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-70"><string-name name-style="western" hwp:sortable="Li H."><surname>Li</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-70">The Sequence Alignment/Map format and SAMtools</article-title>. <source hwp:id="source-70">Bioinformatics</source> <volume>25</volume>, <fpage>2078</fpage>– <lpage>2079</lpage> (<year>2009</year>).</citation></ref><ref id="c71" hwp:id="ref-71" hwp:rev-id="xref-ref-71-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.71" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-71"><string-name name-style="western" hwp:sortable="Liao Y."><surname>Liao</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smyth G. K."><surname>Smyth</surname>, <given-names>G. K.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Shi W."><surname>Shi</surname>, <given-names>W.</given-names></string-name> <article-title hwp:id="article-title-71">featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>. <source hwp:id="source-71">Bioinformatics (Oxford, England)</source> <volume>30</volume>, <fpage>923</fpage>—<lpage>930</lpage> (<year>2014</year>).</citation></ref><ref id="c72" hwp:id="ref-72" hwp:rev-id="xref-ref-72-1 xref-ref-72-2 xref-ref-72-3"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.72" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-72"><string-name name-style="western" hwp:sortable="Lopes Fischer N."><surname>Lopes Fischer</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Naseer N."><surname>Naseer</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shin S."><surname>Shin</surname>, <given-names>S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Brodsky I. E."><surname>Brodsky</surname>, <given-names>I. E.</given-names></string-name> <article-title hwp:id="article-title-72">Effector-triggered immunity and pathogen sensing in metazoans</article-title>. <source hwp:id="source-72">Nature Microbiology</source> <volume>5</volume>, <fpage>14</fpage>–<lpage>26</lpage> (<year>2020</year>).</citation></ref><ref id="c73" hwp:id="ref-73" hwp:rev-id="xref-ref-73-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.73" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-73"><string-name name-style="western" hwp:sortable="Love M. I."><surname>Love</surname>, <given-names>M. I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huber W."><surname>Huber</surname>, <given-names>W.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Anders S."><surname>Anders</surname>, <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-73">Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source hwp:id="source-73">Genome Biology</source> <volume>15</volume>, <fpage>550</fpage> (<year>2014</year>).</citation></ref><ref id="c74" hwp:id="ref-74" hwp:rev-id="xref-ref-74-1 xref-ref-74-2 xref-ref-74-3"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.74" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-74"><string-name name-style="western" hwp:sortable="Lun A. T."><surname>Lun</surname>, <given-names>A. T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Smyth G."><surname>Smyth</surname>, <given-names>G.</given-names></string-name> <article-title hwp:id="article-title-74">K. csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows</article-title>. <source hwp:id="source-74">Nucleic Acids Research</source> <volume>44</volume>, <fpage>e45</fpage>–<lpage>e45</lpage> (<year>2015</year>).</citation></ref><ref id="c75" hwp:id="ref-75" hwp:rev-id="xref-ref-75-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.75" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-75"><string-name name-style="western" hwp:sortable="Lupfer C."><surname>Lupfer</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Malik A."><surname>Malik</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Kanneganti T.-D."><surname>Kanneganti</surname>, <given-names>T.-D.</given-names></string-name> <article-title hwp:id="article-title-75">Inflammasome control of viral infection</article-title>. <source hwp:id="source-75">Current Opinion in Virology</source> <volume>12</volume>. Antiviral strategies • Virus structure and expression, <fpage>38</fpage> –<lpage>46</lpage> (<year>2015</year>).</citation></ref><ref id="c76" hwp:id="ref-76" hwp:rev-id="xref-ref-76-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.76" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-76"><string-name name-style="western" hwp:sortable="Malsin E. S."><surname>Malsin</surname>, <given-names>E. S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kim S."><surname>Kim</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lam A. P."><surname>Lam</surname>, <given-names>A. P.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Gottardi C. J."><surname>Gottardi</surname>, <given-names>C. J.</given-names></string-name> <article-title hwp:id="article-title-76">Macrophages as a Source and Recipient of Wnt Signals</article-title>. <source hwp:id="source-76">Frontiers in Immunology</source> <volume>10</volume>, <fpage>1813</fpage> (<year>2019</year>).</citation></ref><ref id="c77" hwp:id="ref-77" hwp:rev-id="xref-ref-77-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.77" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-77"><string-name name-style="western" hwp:sortable="Marketon M. M."><surname>Marketon</surname>, <given-names>M. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="DePaolo R. W."><surname>DePaolo</surname>, <given-names>R. W.</given-names></string-name>, <string-name name-style="western" hwp:sortable="DeBord K. L."><surname>DeBord</surname>, <given-names>K. L.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jabri B."><surname>Jabri</surname>, <given-names>B.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Schneewind O."><surname>Schneewind</surname>, <given-names>O.</given-names></string-name> <article-title hwp:id="article-title-77">Plague Bacteria Target Immune Cells During Infection</article-title>. <source hwp:id="source-77">Science</source> <volume>309</volume>, <fpage>1739</fpage>–<lpage>1741</lpage> (<year>2005</year>).</citation></ref><ref id="c78" hwp:id="ref-78" hwp:rev-id="xref-ref-78-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.78" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-78"><string-name name-style="western" hwp:sortable="McPhee J. B."><surname>McPhee</surname>, <given-names>J. B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mena P."><surname>Mena</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang Y."><surname>Zhang</surname>, <given-names>Y.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Bliska J. B."><surname>Bliska</surname>, <given-names>J. B.</given-names></string-name> <article-title hwp:id="article-title-78">Interleukin-10 Induction Is an Important Virulence Function of the Yersinia pseudotuberculosis Type III Effector YopM</article-title>. <source hwp:id="source-78">Infection and Immunity</source> <volume>80</volume> (ed <string-name name-style="western" hwp:sortable="Bäumler A. J."><surname>Bäumler</surname>, <given-names>A. J.</given-names></string-name>) <fpage>2519</fpage>–<lpage>2527</lpage> (<year>2012</year>).</citation></ref><ref id="c79" hwp:id="ref-79" hwp:rev-id="xref-ref-79-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.79" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-79"><string-name name-style="western" hwp:sortable="Mogensen T. H."><surname>Mogensen</surname>, <given-names>T. H.</given-names></string-name> <article-title hwp:id="article-title-79">Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses</article-title>. <source hwp:id="source-79">Clinical Microbiology Reviews</source> <volume>22</volume>, <fpage>240</fpage>–<lpage>273</lpage> (<year>2009</year>).</citation></ref><ref id="c80" hwp:id="ref-80" hwp:rev-id="xref-ref-80-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.80" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-80"><string-name name-style="western" hwp:sortable="Mott H. R."><surname>Mott</surname>, <given-names>H. R.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Owen D."><surname>Owen</surname>, <given-names>D.</given-names></string-name> <article-title hwp:id="article-title-80">Structures of Ras superfamily effector complexes: What have we learnt in two decades?</article-title> <source hwp:id="source-80">Critical Reviews in Biochemistry and Molecular Biology</source> <volume>50</volume>, <fpage>85</fpage>–<lpage>133</lpage> (<year>2015</year>).</citation></ref><ref id="c81" hwp:id="ref-81" hwp:rev-id="xref-ref-81-1 xref-ref-81-2 xref-ref-81-3 xref-ref-81-4"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.81" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-81"><string-name name-style="western" hwp:sortable="Mukherjee S."><surname>Mukherjee</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-81">Yersinia YopJ Acetylates and Inhibits Kinase Activation by Blocking Phosphorylation</article-title>. <source hwp:id="source-81">Science</source> <volume>312</volume>, <fpage>1211</fpage>–<lpage>1214</lpage> (<year>2006</year>).</citation></ref><ref id="c82" hwp:id="ref-82" hwp:rev-id="xref-ref-82-1 xref-ref-82-2 xref-ref-82-3 xref-ref-82-4 xref-ref-82-5 xref-ref-82-6 xref-ref-82-7 xref-ref-82-8"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.82" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-82"><string-name name-style="western" hwp:sortable="Müller P. M."><surname>Müller</surname>, <given-names>P. M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-82">Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions</article-title>. <source hwp:id="source-82">Nature Cell Biology</source> <volume>22</volume>, <fpage>498</fpage>–<lpage>511</lpage> (<year>2020</year>).</citation></ref><ref id="c83" hwp:id="ref-83" hwp:rev-id="xref-ref-83-1 xref-ref-83-2 xref-ref-83-3"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.83" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-83"><string-name name-style="western" hwp:sortable="Novakovic B."><surname>Novakovic</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-83">β-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance</article-title>. <source hwp:id="source-83">Cell</source> <volume>167</volume>, <fpage>1354</fpage>–<lpage>1368</lpage>.e14 (<year>2016</year>).</citation></ref><ref id="c84" hwp:id="ref-84" hwp:rev-id="xref-ref-84-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.84" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-84"><string-name name-style="western" hwp:sortable="Nuss A. M."><surname>Nuss</surname>, <given-names>A. M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-84">Tissue dual RNA-seq allows fast discovery of infection-specific functions and riboregulators shaping host–pathogen transcriptomes</article-title>. <source hwp:id="source-84">Proceedings of the National Academy of Sciences</source> <volume>114</volume>, <fpage>E791</fpage>–<lpage>E800</lpage> (<year>2017</year>).</citation></ref><ref id="c85" hwp:id="ref-85" hwp:rev-id="xref-ref-85-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.85" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-85"><string-name name-style="western" hwp:sortable="O’Reilly D."><surname>O’Reilly</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Quinn C. M."><surname>Quinn</surname>, <given-names>C. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="El-Shanawany T."><surname>El-Shanawany</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gordon S."><surname>Gordon</surname>, <given-names>S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Greaves D. R."><surname>Greaves</surname>, <given-names>D. R.</given-names></string-name> <article-title hwp:id="article-title-85">Multiple Ets Factors and Interferon Regulatory Factor-4 Modulate CD68 Expression in a Cell Type-specific Manner</article-title>. <source hwp:id="source-85">Journal of Biological Chemistry</source> <volume>278</volume>, <fpage>21909</fpage>–<lpage>21919</lpage> (<year>2003</year>).</citation></ref><ref id="c86" hwp:id="ref-86"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.86" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-86"><string-name name-style="western" hwp:sortable="Ostuni R."><surname>Ostuni</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-86">Latent Enhancers Activated by Stimulation in Differentiated Cells</article-title>. <source hwp:id="source-86">Cell</source> <volume>152</volume>, <fpage>157</fpage>–<lpage>171</lpage> (<year>2013</year>).</citation></ref><ref id="c87" hwp:id="ref-87" hwp:rev-id="xref-ref-87-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.87" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-87"><string-name name-style="western" hwp:sortable="Pacis A."><surname>Pacis</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-87">Gene activation precedes DNA demethylation in response to infection in human dendritic cells</article-title>. <source hwp:id="source-87">Proceedings of the National Academy of Sciences</source> <volume>116</volume>, <fpage>6938</fpage>–<lpage>6943</lpage> (<year>2019</year>).</citation></ref><ref id="c88" hwp:id="ref-88" hwp:rev-id="xref-ref-88-1 xref-ref-88-2 xref-ref-88-3 xref-ref-88-4 xref-ref-88-5 xref-ref-88-6 xref-ref-88-7"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.88" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-88"><string-name name-style="western" hwp:sortable="Park S. H."><surname>Park</surname>, <given-names>S. H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-88">Type I IFNs and TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation</article-title>. <source hwp:id="source-88">Nature immunology</source> <volume>18</volume>, <fpage>1104</fpage>–<lpage>1116</lpage> (<year>2017</year>).</citation></ref><ref id="c89" hwp:id="ref-89" hwp:rev-id="xref-ref-89-1 xref-ref-89-2 xref-ref-89-3 xref-ref-89-4 xref-ref-89-5"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.89" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-89"><string-name name-style="western" hwp:sortable="Paul F."><surname>Paul</surname>, <given-names>F.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-89">Quantitative GTPase Affinity Purification Identifies Rho Family Protein Interaction Partners</article-title>. <source hwp:id="source-89">Molecular &amp; Cellular Proteomics</source> <volume>16</volume>, <fpage>73</fpage>–<lpage>85</lpage> (<year>2017</year>).</citation></ref><ref id="c90" hwp:id="ref-90" hwp:rev-id="xref-ref-90-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.90" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-90"><string-name name-style="western" hwp:sortable="Phanstiel D. H."><surname>Phanstiel</surname>, <given-names>D. H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-90">Static and Dynamic DNA Loops form AP-1-Bound Activation Hubs during Macrophage Development</article-title>. <source hwp:id="source-90">Molecular Cell</source> <volume>67</volume>, <fpage>1037</fpage>–<lpage>1048</lpage>.e6 (<year>2017</year>).</citation></ref><ref id="c91" hwp:id="ref-91" hwp:rev-id="xref-ref-91-1"><citation publication-type="book" citation-type="book" ref:id="2021.09.07.459276v2.91" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-91"><string-name name-style="western" hwp:sortable="Philip N. H."><surname>Philip</surname>, <given-names>N. H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zwack E. E."><surname>Zwack</surname>, <given-names>E. E.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Brodsky I. E."><surname>Brodsky</surname>, <given-names>I. E.</given-names></string-name> in <source hwp:id="source-91">Inflammasome Signaling and Bacterial Infections</source>. <fpage>69</fpage>–<lpage>90</lpage> (<publisher-name>Springer International Publishing</publisher-name>, <publisher-loc>Cham</publisher-loc>, <year>2016</year>).</citation></ref><ref id="c92" hwp:id="ref-92" hwp:rev-id="xref-ref-92-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.92" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-92"><string-name name-style="western" hwp:sortable="Pujol C."><surname>Pujol</surname>, <given-names>C.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Bliska J. B."><surname>Bliska</surname>, <given-names>J. B.</given-names></string-name> <article-title hwp:id="article-title-91">The Ability To Replicate in Macrophages Is Conserved between Yersinia pestis and Yersinia pseudotuberculosis</article-title>. <source hwp:id="source-92">Infection and Immunity</source> <volume>71</volume>, <fpage>5892</fpage>–<lpage>5899</lpage> (<year>2003</year>).</citation></ref><ref id="c93" hwp:id="ref-93" hwp:rev-id="xref-ref-93-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.93" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-93"><string-name name-style="western" hwp:sortable="Pujol C."><surname>Pujol</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-92">Yersinia pestis Can Reside in Autophagosomes and Avoid Xenophagy in Murine Macrophages by Preventing Vacuole Acidification</article-title>. <source hwp:id="source-93">Infection and Immunity</source> <volume>77</volume>, <fpage>2251</fpage>– <lpage>2261</lpage> (<year>2009</year>).</citation></ref><ref id="c94" hwp:id="ref-94" hwp:rev-id="xref-ref-94-1 xref-ref-94-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.94" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-94"><string-name name-style="western" hwp:sortable="Quinlan A. R."><surname>Quinlan</surname>, <given-names>A. R.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Hall I. M."><surname>Hall</surname>, <given-names>I. M.</given-names></string-name> <article-title hwp:id="article-title-93">BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source hwp:id="source-94">Bioinformatics</source> <volume>26</volume>, <fpage>841</fpage>–<lpage>842</lpage> (<year>2010</year>).</citation></ref><ref id="c95" hwp:id="ref-95" hwp:rev-id="xref-ref-95-1 xref-ref-95-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.95" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-95"><string-name name-style="western" hwp:sortable="Rada-Iglesias A."><surname>Rada-Iglesias</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-94">A unique chromatin signature uncovers early developmental enhancers in humans</article-title>. <source hwp:id="source-95">Nature</source> <volume>470</volume>, <fpage>279</fpage>–<lpage>283</lpage> (<year>2011</year>).</citation></ref><ref id="c96" hwp:id="ref-96" hwp:rev-id="xref-ref-96-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.96" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-96"><string-name name-style="western" hwp:sortable="Reinés M."><surname>Reinés</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-95">Deciphering the Acylation Pattern of Yersinia enterocolitica Lipid A</article-title>. <source hwp:id="source-96">PLOS Pathogens</source> <volume>8</volume>, <fpage>1</fpage>–<lpage>21</lpage> (<year>2012</year>).</citation></ref><ref id="c97" hwp:id="ref-97" hwp:rev-id="xref-ref-97-1 xref-ref-97-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.97" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-97"><string-name name-style="western" hwp:sortable="Ritchie M. E."><surname>Ritchie</surname>, <given-names>M. E.</given-names></string-name> <etal>et al</etal><article-title hwp:id="article-title-96">. limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source hwp:id="source-97">Nucleic Acids Research</source> <volume>43</volume>, <fpage>e47</fpage>–<lpage>e47</lpage> (<year>2015</year>).</citation></ref><ref id="c98" hwp:id="ref-98" hwp:rev-id="xref-ref-98-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.98" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-98"><string-name name-style="western" hwp:sortable="Roach J. C."><surname>Roach</surname>, <given-names>J. C.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-97">Transcription factor expression in lipopolysaccharide-activated peripheral-blood-derived mononuclear cells</article-title>. <source hwp:id="source-98">Proceedings of the National Academy of Sciences</source> <volume>104</volume>, <fpage>16245</fpage>–<lpage>16250</lpage> (<year>2007</year>).</citation></ref><ref id="c99" hwp:id="ref-99" hwp:rev-id="xref-ref-99-1 xref-ref-99-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.99" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-99"><string-name name-style="western" hwp:sortable="Rolando M."><surname>Rolando</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-98">Legionella pneumophila Effector RomA Uniquely Modifies Host Chromatin to Repress Gene Expression and Promote Intracellular Bacterial Replication</article-title>. <source hwp:id="source-99">Cell Host &amp; Microbe</source> <volume>13</volume>, <fpage>395</fpage> –<lpage>405</lpage> (<year>2013</year>).</citation></ref><ref id="c100" hwp:id="ref-100" hwp:rev-id="xref-ref-100-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.100" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-100"><string-name name-style="western" hwp:sortable="Ruckdeschel K"><surname>Ruckdeschel</surname>, <given-names>K</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-99">Interaction of Yersinia enterocolitica with macrophages leads to macrophage cell death through apoptosis</article-title>. <source hwp:id="source-100">Infection and Immunity</source> <volume>65</volume>, <fpage>4813</fpage>–<lpage>4821</lpage> (<year>1997</year>).</citation></ref><ref id="c101" hwp:id="ref-101" hwp:rev-id="xref-ref-101-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.101" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-101"><string-name name-style="western" hwp:sortable="Ruckdeschel K."><surname>Ruckdeschel</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-100">Yersinia Outer Protein P of Yersinia enterocolitica Simultaneously Blocks the Nuclear Factor-κB Pathway and Exploits Lipopolysaccharide Signaling to Trigger Apoptosis in Macrophages</article-title>. <source hwp:id="source-101">The Journal of Immunology</source> <volume>166</volume>, <fpage>1823</fpage>–<lpage>1831</lpage> (<year>2001</year>).</citation></ref><ref id="c102" hwp:id="ref-102" hwp:rev-id="xref-ref-102-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.102" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-102"><string-name name-style="western" hwp:sortable="Ryan D. G."><surname>Ryan</surname>, <given-names>D. G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="O’Neill L. A."><surname>O’Neill</surname>, <given-names>L. A.</given-names></string-name> <article-title hwp:id="article-title-101">Krebs Cycle Reborn in Macrophage Immunometabolism</article-title>. <source hwp:id="source-102">Annual Review of Immunology</source> <volume>38</volume>, <fpage>289</fpage>–<lpage>313</lpage> (<year>2020</year>).</citation></ref><ref id="c103" hwp:id="ref-103" hwp:rev-id="xref-ref-103-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.103" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-103"><string-name name-style="western" hwp:sortable="Ryu J. R."><surname>Ryu</surname>, <given-names>J. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Echarri A."><surname>Echarri</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li R."><surname>Li</surname>, <given-names>R.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Pendergast A. M."><surname>Pendergast</surname>, <given-names>A. M.</given-names></string-name> <article-title hwp:id="article-title-102">Regulation of Cell-Cell Adhesion by Abi/Diaphanous Complexes</article-title>. <source hwp:id="source-103">Molecular and Cellular Biology</source> <volume>29</volume>, <fpage>1735</fpage>–<lpage>1748</lpage> (<year>2009</year>).</citation></ref><ref id="c104" hwp:id="ref-104" hwp:rev-id="xref-ref-104-1 xref-ref-104-2 xref-ref-104-3"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.104" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-104"><string-name name-style="western" hwp:sortable="Saeed S."><surname>Saeed</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-103">Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity</article-title>. <source hwp:id="source-104">Science</source> <volume>345</volume> (<year>2014</year>).</citation></ref><ref id="c105" hwp:id="ref-105" hwp:rev-id="xref-ref-105-1 xref-ref-105-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.105" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-105"><string-name name-style="western" hwp:sortable="Sarhan J."><surname>Sarhan</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-104">Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection</article-title>. <source hwp:id="source-105">Proceedings of the National Academy of Sciences</source> <volume>115</volume>, <fpage>E10888</fpage>–<lpage>E10897</lpage> (<year>2018</year>).</citation></ref><ref id="c106" hwp:id="ref-106" hwp:rev-id="xref-ref-106-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.106" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-106"><string-name name-style="western" hwp:sortable="Sauvonnet N."><surname>Sauvonnet</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pradet-Balade B."><surname>Pradet-Balade</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Garcia-Sanz J. A."><surname>Garcia-Sanz</surname>, <given-names>J. A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Cornelis G. R."><surname>Cornelis</surname>, <given-names>G. R.</given-names></string-name> <article-title hwp:id="article-title-105">Regulation of mRNA Expression in Macrophages afterYersinia enterocolitica Infection: ROLE OF DIFFERENT Yop EFFECTORS</article-title>. <source hwp:id="source-106">Journal of Biological Chemistry</source> <volume>277</volume>, <fpage>25133</fpage>–<lpage>25142</lpage> (<year>2002</year>).</citation></ref><ref id="c107" hwp:id="ref-107" hwp:rev-id="xref-ref-107-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.107" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-107"><string-name name-style="western" hwp:sortable="Sauvonnet N."><surname>Sauvonnet</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lambermont I."><surname>Lambermont</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bruggen P. v. d."><surname>Bruggen</surname>, <given-names>P. v. d.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Cornelis G. R."><surname>Cornelis</surname>, <given-names>G. R.</given-names></string-name> <article-title hwp:id="article-title-106">YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T-cell proliferation through inactivation of the phosphatidylinositoI 3-kinase pathway</article-title>. <source hwp:id="source-107">Molecular Microbiology</source> <volume>45</volume>, <fpage>805</fpage>–<lpage>815</lpage> (<year>2002</year>)b</citation></ref><ref id="c108" hwp:id="ref-108" hwp:rev-id="xref-ref-108-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.108" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-108"><string-name name-style="western" hwp:sortable="Sawicka A."><surname>Sawicka</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Seiser C."><surname>Seiser</surname>, <given-names>C.</given-names></string-name> <article-title hwp:id="article-title-107">Sensing core histone phosphorylation — A matter of perfect timing</article-title>. <source hwp:id="source-108">Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms</source> <volume>1839</volume>. Molecular mechanisms of histone modification function, <fpage>711</fpage>–<lpage>718</lpage> (<year>2014</year>).</citation></ref><ref id="c109" hwp:id="ref-109" hwp:rev-id="xref-ref-109-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.109" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-109"><string-name name-style="western" hwp:sortable="Schmid Y."><surname>Schmid</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-108">Yersinia enterocolitica Adhesin A Induces Production of Interleukin-8 in Epithelial Cells</article-title>. <source hwp:id="source-109">Infection and Immunity</source> <volume>72</volume>, <fpage>6780</fpage>–<lpage>6789</lpage> (<year>2004</year>).</citation></ref><ref id="c110" hwp:id="ref-110" hwp:rev-id="xref-ref-110-1 xref-ref-110-2 xref-ref-110-3 xref-ref-110-4 xref-ref-110-5 xref-ref-110-6 xref-ref-110-7"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.110" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-110"><string-name name-style="western" hwp:sortable="Schubert K. A."><surname>Schubert</surname>, <given-names>K. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xu Y."><surname>Xu</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shao F."><surname>Shao</surname>, <given-names>F.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Auerbuch V."><surname>Auerbuch</surname>, <given-names>V.</given-names></string-name> <article-title hwp:id="article-title-109">The Yersinia Type III Secretion System as a Tool for Studying Cytosolic Innate Immune Surveillance</article-title>. <source hwp:id="source-110">Annual Review of Microbiology</source> <volume>74</volume>, <fpage>221</fpage>–<lpage>245</lpage> (<year>2020</year>).</citation></ref><ref id="c111" hwp:id="ref-111" hwp:rev-id="xref-ref-111-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.111" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-111"><string-name name-style="western" hwp:sortable="Schulte R."><surname>Schulte</surname>, <given-names>R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-110">Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers</article-title>. <source hwp:id="source-111">The FASEB Journal</source> <volume>14</volume>, <fpage>1471</fpage>–<lpage>1484</lpage> (<year>2000</year>).</citation></ref><ref id="c112" hwp:id="ref-112" hwp:rev-id="xref-ref-112-1 xref-ref-112-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.112" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-112"><string-name name-style="western" hwp:sortable="Senoo H."><surname>Senoo</surname>, <given-names>H.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-111">Phosphorylated Rho-GDP directly activates mTORC2 kinase towards AKT through dimerization with Ras-GTP to regulate cell migration</article-title>. <source hwp:id="source-112">Nature cell biology</source> <volume>21</volume>, <fpage>867</fpage>—<lpage>878</lpage> (<year>2019</year>).</citation></ref><ref id="c113" hwp:id="ref-113" hwp:rev-id="xref-ref-113-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.113" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-113"><string-name name-style="western" hwp:sortable="Shen L."><surname>Shen</surname>, <given-names>L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-112">diffReps: Detecting Differential Chromatin Modification Sites from ChIP-seq Data with Biological Replicates</article-title>. <source hwp:id="source-113">PLOS ONE</source> <volume>8</volume>, <fpage>1</fpage>–<lpage>13</lpage> (<year>2013</year>).</citation></ref><ref id="c114" hwp:id="ref-114" hwp:rev-id="xref-ref-114-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.114" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-114"><string-name name-style="western" hwp:sortable="Spinner J. L."><surname>Spinner</surname>, <given-names>J. L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-113">Yersinia pestis survival and replication within human neutrophil phagosomes and uptake of infected neutrophils by macrophages</article-title>. <source hwp:id="source-114">Journal of Leukocyte Biology</source> <volume>95</volume>, <fpage>389</fpage>–<lpage>398</lpage> (<year>2014</year>).</citation></ref><ref id="c115" hwp:id="ref-115" hwp:rev-id="xref-ref-115-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.115" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-115"><string-name name-style="western" hwp:sortable="Stahnke S."><surname>Stahnke</surname>, <given-names>S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-114">Loss of Hem1 disrupts macrophage function and impacts migration, phagocytosis, and integrin-mediated adhesion</article-title>. <source hwp:id="source-115">Current Biology</source> <volume>31</volume>, <fpage>2051</fpage>–<lpage>2064</lpage>.e8 (<year>2021</year>).</citation></ref><ref id="c116" hwp:id="ref-116" hwp:rev-id="xref-ref-116-1 xref-ref-116-2 xref-ref-116-3 xref-ref-116-4"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.116" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-116"><string-name name-style="western" hwp:sortable="Stiegler A. L."><surname>Stiegler</surname>, <given-names>A. L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Boggon T. J."><surname>Boggon</surname>, <given-names>T. J.</given-names></string-name> <article-title hwp:id="article-title-115">The pseudoGTPase group of pseudoenzymes</article-title>. <source hwp:id="source-116">The FEBS Journal</source> <volume>287</volume>, <fpage>4232</fpage>–<lpage>4245</lpage> (<year>2020</year>).</citation></ref><ref id="c117" hwp:id="ref-117" hwp:rev-id="xref-ref-117-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.117" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-117"><string-name name-style="western" hwp:sortable="St. John A. L."><surname>St. John</surname>, <given-names>A. L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-116">S1P-Dependent Trafficking of Intracellular <italic toggle="yes">Yersinia pestis</italic> through Lymph Nodes Establishes Buboes and Systemic Infection</article-title>. <source hwp:id="source-117">Immunity</source> <volume>41</volume>, <fpage>440</fpage>–<lpage>450</lpage> (<year>2014</year>).</citation></ref><ref id="c118" hwp:id="ref-118" hwp:rev-id="xref-ref-118-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.118" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-118"><string-name name-style="western" hwp:sortable="Subrahmanyam Y. V. B. K."><surname>Subrahmanyam</surname>, <given-names>Y. V. B. K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-117">RNA expression patterns change dramatically in human neutrophils exposed to bacteria</article-title>. <source hwp:id="source-118">Blood</source> <volume>97</volume>, <fpage>2457</fpage>–<lpage>2468</lpage> (<year>2001</year>).</citation></ref><ref id="c119" hwp:id="ref-119" hwp:rev-id="xref-ref-119-1 xref-ref-119-2 xref-ref-119-3 xref-ref-119-4"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.119" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-119"><string-name name-style="western" hwp:sortable="Tajadura-Ortega V."><surname>Tajadura-Ortega</surname>, <given-names>V.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-118">An RNAi screen of Rho signalling networks identifies RhoH as a regulator of Rac1 in prostate cancer cell migration</article-title>. <source hwp:id="source-119">BMC Biology</source> <volume>16</volume> (<year>2018</year>).</citation></ref><ref id="c120" hwp:id="ref-120" hwp:rev-id="xref-ref-120-1 xref-ref-120-2 xref-ref-120-3"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.120" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-120"><string-name name-style="western" hwp:sortable="Takeuchi O."><surname>Takeuchi</surname>, <given-names>O.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Akira S."><surname>Akira</surname>, <given-names>S.</given-names></string-name> <article-title hwp:id="article-title-119">Pattern Recognition Receptors and Inflammation</article-title>. <source hwp:id="source-120">Cell</source> <volume>140</volume>, <fpage>805</fpage> –<lpage>820</lpage> (<year>2010</year>).</citation></ref><ref id="c121" hwp:id="ref-121" hwp:rev-id="xref-ref-121-1 xref-ref-121-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.121" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-121"><string-name name-style="western" hwp:sortable="Tcherkezian J."><surname>Tcherkezian</surname>, <given-names>J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Lamarche-Vane N."><surname>Lamarche-Vane</surname>, <given-names>N.</given-names></string-name> <article-title hwp:id="article-title-120">Current knowledge of the large RhoGAP family of proteins</article-title>. <source hwp:id="source-121">Biology of the Cell</source> <volume>99</volume>, <fpage>67</fpage>–<lpage>86</lpage> (<year>2007</year>).</citation></ref><ref id="c122" hwp:id="ref-122" hwp:rev-id="xref-ref-122-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.122" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-122"><string-name name-style="western" hwp:sortable="Thorvaldsdóttir H."><surname>Thorvaldsdóttir</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Robinson J. T."><surname>Robinson</surname>, <given-names>J. T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Mesirov J. P."><surname>Mesirov</surname>, <given-names>J. P.</given-names></string-name> <article-title hwp:id="article-title-121">Integrative Genomics Viewer (IGV): highperformance genomics data visualization and exploration</article-title>. <source hwp:id="source-122">Briefings in Bioinformatics</source> <volume>14</volume>, <fpage>178</fpage>– <lpage>192</lpage> (<year>2012</year>).</citation></ref><ref id="c123" hwp:id="ref-123" hwp:rev-id="xref-ref-123-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.123" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-123"><string-name name-style="western" hwp:sortable="Trülzsch K."><surname>Trülzsch</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sporleder T."><surname>Sporleder</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Igwe E. I."><surname>Igwe</surname>, <given-names>E. I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rüssmann H."><surname>Rüssmann</surname>, <given-names>H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Heesemann J."><surname>Heesemann</surname>, <given-names>J.</given-names></string-name> <article-title hwp:id="article-title-122">Contribution of the Major Secreted Yops of Yersinia enterocolitica O:8 to Pathogenicity in the Mouse Infection Model</article-title>. <source hwp:id="source-123">Infection and Immunity</source> <volume>72</volume>, <fpage>5227</fpage>–<lpage>5234</lpage> (<year>2004</year>).</citation></ref><ref id="c124" hwp:id="ref-124" hwp:rev-id="xref-ref-124-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.124" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-124"><string-name name-style="western" hwp:sortable="Verger A."><surname>Verger</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Duterque-Coquillaud M."><surname>Duterque-Coquillaud</surname>, <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-123">When Ets transcription factors meet their partners</article-title>. <source hwp:id="source-124">BioEssays</source> <volume>24</volume>, <fpage>362</fpage>–<lpage>370</lpage> (<year>2002</year>).</citation></ref><ref id="c125" hwp:id="ref-125" hwp:rev-id="xref-ref-125-1 xref-ref-125-2 xref-ref-125-3"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.125" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-125"><string-name name-style="western" hwp:sortable="Viboud G. I."><surname>Viboud</surname>, <given-names>G. I.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Bliska J. B."><surname>Bliska</surname>, <given-names>J. B.</given-names></string-name> <article-title hwp:id="article-title-124">YERSINIA OUTER PROTEINS: Role in Modulation of Host Cell Signaling Responses and Pathogenesis</article-title>. <source hwp:id="source-125">Annual Review of Microbiology</source> <volume>59</volume>, <fpage>69</fpage>–<lpage>89</lpage> (<year>2005</year>).</citation></ref><ref id="c126" hwp:id="ref-126" hwp:rev-id="xref-ref-126-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.126" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-126"><string-name name-style="western" hwp:sortable="Vincent S"><surname>Vincent</surname>, <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jeanteur P"><surname>Jeanteur</surname>, <given-names>P</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Fort P."><surname>Fort</surname>, <given-names>P.</given-names></string-name> <article-title hwp:id="article-title-125">Growth-regulated expression of rhoG, a new member of the ras homolog gene family</article-title>. <source hwp:id="source-126">Molecular and Cellular Biology</source> <volume>12</volume>, <fpage>3138</fpage>–<lpage>3148</lpage> (<year>1992</year>).</citation></ref><ref id="c127" hwp:id="ref-127" hwp:rev-id="xref-ref-127-1 xref-ref-127-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.127" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-127"><string-name name-style="western" hwp:sortable="Wang Z."><surname>Wang</surname>, <given-names>Z.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-126">Combinatorial patterns of histone acetylations and methylations in the human genome</article-title>. <source hwp:id="source-127">Nature Genetics</source> <volume>40</volume>, <fpage>897</fpage>–<lpage>903</lpage> (<year>2008</year>).</citation></ref><ref id="c128" hwp:id="ref-128" hwp:rev-id="xref-ref-128-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.128" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-128"><string-name name-style="western" hwp:sortable="Wennerberg K."><surname>Wennerberg</surname>, <given-names>K.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Der C. J."><surname>Der</surname>, <given-names>C. J.</given-names></string-name> <article-title hwp:id="article-title-127">Rho-family GTPases: it’s not only Rac and Rho (and I like it)</article-title>. <source hwp:id="source-128">Journal of Cell Science</source> <volume>117</volume>, <fpage>1301</fpage>–<lpage>1312</lpage> (<year>2004</year>).</citation></ref><ref id="c129" hwp:id="ref-129" hwp:rev-id="xref-ref-129-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.129" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-129"><string-name name-style="western" hwp:sortable="Yamazaki D."><surname>Yamazaki</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Oikawa T."><surname>Oikawa</surname>, <given-names>T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Takenawa T."><surname>Takenawa</surname>, <given-names>T.</given-names></string-name> <article-title hwp:id="article-title-128">Rac-WAVE-mediated actin reorganization is required for organization and maintenance of cell-cell adhesion</article-title>. <source hwp:id="source-129">Journal of Cell Science</source> <volume>120</volume>, <fpage>86</fpage>–<lpage>100</lpage> (<year>2007</year>).</citation></ref><ref id="c130" hwp:id="ref-130" hwp:rev-id="xref-ref-130-1 xref-ref-130-2"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.130" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-130"><string-name name-style="western" hwp:sortable="Ye J."><surname>Ye</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-129">Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction</article-title>. <source hwp:id="source-130">BMC Bioinformatics</source> <volume>13</volume>, <fpage>134</fpage> (<year>2012</year>).</citation></ref><ref id="c131" hwp:id="ref-131" hwp:rev-id="xref-ref-131-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.131" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-131"><string-name name-style="western" hwp:sortable="Yun M."><surname>Yun</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Workman J. L."><surname>Workman</surname>, <given-names>J. L.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Li B."><surname>Li</surname>, <given-names>B.</given-names></string-name> <article-title hwp:id="article-title-130">Readers of histone modifications</article-title>. <source hwp:id="source-131">Cell research</source> <volume>21</volume>, <fpage>564</fpage>–<lpage>578</lpage> (<year>2011</year>).</citation></ref><ref id="c132" hwp:id="ref-132" hwp:rev-id="xref-ref-132-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.132" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-132"><string-name name-style="western" hwp:sortable="Zang C."><surname>Zang</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-131">A clustering approach for identification of enriched domains from histone modification ChIP-Seq data</article-title>. <source hwp:id="source-132">Bioinformatics</source> <volume>25</volume>, <fpage>1952</fpage>–<lpage>1958</lpage> (<year>2009</year>).</citation></ref><ref id="c133" hwp:id="ref-133" hwp:rev-id="xref-ref-133-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.133" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-133"><string-name name-style="western" hwp:sortable="Zhang Y."><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ting A. T."><surname>Ting</surname>, <given-names>A. T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marcu K. B."><surname>Marcu</surname>, <given-names>K. B.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Bliska J. B."><surname>Bliska</surname>, <given-names>J. B.</given-names></string-name> <article-title hwp:id="article-title-132">Inhibition of MAPK and NF-κB Pathways Is Necessary for Rapid Apoptosis in Macrophages Infected with Yersinia</article-title>. <source hwp:id="source-133">The Journal of Immunology</source> <volume>174</volume>, <fpage>7939</fpage>–<lpage>7949</lpage> (<year>2005</year>).</citation></ref><ref id="c134" hwp:id="ref-134" hwp:rev-id="xref-ref-134-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.134" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-134"><string-name name-style="western" hwp:sortable="Zhang X"><surname>Zhang</surname>, <given-names>X</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Mosser D."><surname>Mosser</surname>, <given-names>D.</given-names></string-name> <article-title hwp:id="article-title-133">Macrophage activation by endogenous danger signals</article-title>. <source hwp:id="source-134">The Journal of Pathology</source> <volume>214</volume>, <fpage>161</fpage>–<lpage>178</lpage> (<year>2008</year>).</citation></ref><ref id="c135" hwp:id="ref-135" hwp:rev-id="xref-ref-135-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.135" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-135"><string-name name-style="western" hwp:sortable="Zhang Y."><surname>Zhang</surname>, <given-names>Y.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-134">Model-based Analysis of ChIP-Seq (MACS)</article-title>. <source hwp:id="source-135">Genome Biology</source> <volume>9</volume>, <fpage>R137</fpage> (<year>2008</year>).</citation></ref><ref id="c136" hwp:id="ref-136" hwp:rev-id="xref-ref-136-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.136" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-136"><string-name name-style="western" hwp:sortable="Zhou P."><surname>Zhou</surname>, <given-names>P.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-135">Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose</article-title>. <source hwp:id="source-136">Nature</source> <volume>561</volume>, <fpage>122</fpage>–<lpage>126</lpage> (<year>2018</year>).</citation></ref><ref id="c137" hwp:id="ref-137" hwp:rev-id="xref-ref-137-1"><citation publication-type="journal" citation-type="journal" ref:id="2021.09.07.459276v2.137" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-137"><string-name name-style="western" hwp:sortable="Zipfel P. A."><surname>Zipfel</surname>, <given-names>P. A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-136">Role for the Abi/Wave Protein Complex in T Cell Receptor-Mediated Proliferation and Cytoskeletal Remodeling</article-title>. <source hwp:id="source-137">Current Biology</source> <volume>16</volume>, <fpage>35</fpage>–<lpage>46</lpage> (<year>2006</year>).</citation></ref></ref-list><sec id="s5" hwp:id="sec-44"><title hwp:id="title-54">Supporting information</title><sec id="s5a" hwp:id="sec-45"><title hwp:id="title-55">Figures</title><fig id="figs1" position="float" orientation="portrait" fig-type="figure" hwp:id="F7" hwp:rev-id="xref-fig-7-1 xref-fig-7-2 xref-fig-7-3 xref-fig-7-4 xref-fig-7-5 xref-fig-7-6 xref-fig-7-7 xref-fig-7-8 xref-fig-7-9"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIGS1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F7</object-id><object-id pub-id-type="publisher-id">figs1</object-id><label>Fig S1.</label><caption hwp:id="caption-7"><title hwp:id="title-56">Analysis of infection conditions.</title><p hwp:id="p-132"><bold>A,</bold> Left: Immunofluorescence staining of primary human macrophages mock infected or infected with WA314-YopE-ALFA for 6 h with MOI 10, 25, 50 or 100. Cells were stained with anti-ALFA nanobody-635 (red) to visualize YopE, Alexa568 phalloidin (green) to visualize actin and DAPI (blue) to visualize nucleus. Right: Quantification of YopE-ALFA positive cells. Bars show mean and error bars represent standard deviation when analyzing two different coverslips.</p><p hwp:id="p-133"><bold>B,</bold> Line plot showing time course H3K4me3 (IL1B, SOCS3, IDO1 genes) and H3K27ac (IL6, SOCS3 genes) ChIP-qPCR analysis of WAC infected primary human macrophages with MOI of 100. Lines represent means and error bars represent standard deviation from two independent macrophage donors/ biological replicates.</p><p hwp:id="p-134"><bold>C,</bold> Bar plot showing membrane permeability due to cell death in primary human macrophages mock infected, infected with WA314 (MOI of 100) or treated with positive (pos.) control (1 % TRITON-X-100) for 6 h. Increased membrane permeability is expressed as higher SYTOX Green intensity, where the dye binds to DNA and emits fluorescence when plasma membrane integrity is compromised. Bars represent means of two biological replicates/ macrophage donors (dots with different shapes).</p><p hwp:id="p-135"><bold>D,</bold> Western blot analysis of primary human macrophages showing caspase-3 cleavage in mock or WA314 (MOI 100) infected cells or treated with positive control Staurosporine (5 μM) for 6 h. * indicates full length caspase-3 (35 kDa) and cleavage fragments (17 and 19 kDa). GAPDH was used as a loading control. Data are representative of four biological replicates/ different macrophage donors.</p><p hwp:id="p-136"><bold>E,</bold> Bar plot showing colony forming unit (CFU) analysis of <italic toggle="yes">Y. enterocolitica</italic> WA314 growth during infection of primary human macrophages for 0 h, 1.5 h or 6 h at 37 °C. Bars represent means of two different biological replicates (dots with different shapes).</p><p hwp:id="p-137"><bold>F,</bold> Flow cytometry analysis of monocyte-derived primary human macrophages after 6 days of differentiation. Live cells (L/D negative) were selected (blue areas; first top panel) and doublets excluded (second top panel). CD14 positive macrophages were selected (third top panel) and analyzed for expression of macrophage markers CD163, CD38, CD86, HLA-DR,CD206 and CD16 (bottom panels).</p></caption><graphic xlink:href="459276v2_figs1" position="float" orientation="portrait" hwp:id="graphic-7"/></fig><fig id="figs2" position="float" orientation="portrait" fig-type="figure" hwp:id="F8" hwp:rev-id="xref-fig-8-1 xref-fig-8-2 xref-fig-8-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIGS2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F8</object-id><object-id pub-id-type="publisher-id">figs2</object-id><label>Fig S2.</label><caption hwp:id="caption-8"><title hwp:id="title-57">Confirmation of ChIP-seq and RNA-seq results by qPCR.</title><p hwp:id="p-138"><bold>A,</bold> Bar plot showing H3K27me3 (left) and H4K4me3 (right) ChIP-qPCR from primary human macrophages mock infected or infected with WAC or WA314 for 6 h with MOI of 100. HOXC12 and NXPH4 are positive controls for H3K27me3 and ADH5 and TUBA1C are positive controls for H3K4me3. Data are representative of at least two experiments with different biological replicates/ macrophage donors.</p><p hwp:id="p-139"><bold>B,</bold> Peak tracks showing tag density of H3K4me3 (red) or H3K27ac (blue) ChIP-seq from primary human macrophages infected for 6 h with indicated strains (MOI of 100) (left). qPCR target refers to the primer binding site used for fragment amplification in ChIP-qPCR analysis shown as a dot plot (right). The ChIP-qPCR signal was expressed as relative (rel.) enrichment (enr.) vs mock. Lines represent means from at least two different biological replicates/ macrophage donors (dots with different shapes).</p><p hwp:id="p-140"><bold>C,</bold> Dot plots showing gene expression analysis of PPARGC1B, ABI1, TNF and IL1B genes with RT-qPCR from primary human macrophages infected for 6 h with indicated strains (MOI 100). The RT-qPCR signal was expressed as fold vs mock. Lines represent means from at least two different biological replicates/ macrophage donors (dots with different shapes).</p></caption><graphic xlink:href="459276v2_figs2" position="float" orientation="portrait" hwp:id="graphic-8"/></fig><fig id="figs3" position="float" orientation="portrait" fig-type="figure" hwp:id="F9" hwp:rev-id="xref-fig-9-1 xref-fig-9-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIGS3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F9</object-id><object-id pub-id-type="publisher-id">figs3</object-id><label>Fig S3.</label><caption hwp:id="caption-9"><title hwp:id="title-58">Analysis of association between histone marks and gene expression.</title><p hwp:id="p-141"><bold>A-D,</bold> Bar plots showing fraction (%) of genes associated with H3K4me3 at promoter <bold>(A)</bold>, H3K27ac at promoter <bold>(B)</bold>, H3K4me3 and H3K27ac at promoter <bold>(C)</bold> and H3K27ac at enhancer</p><p hwp:id="p-142"><bold>(D)</bold> changes for comparisons between mock, WAC and WA314 showing significant (≥ 2-fold change, adjusted P-value ≤ 0.05) associated change in gene expression (overlap RNA).</p></caption><graphic xlink:href="459276v2_figs3" position="float" orientation="portrait" hwp:id="graphic-9"/></fig><fig id="figs4" position="float" orientation="portrait" fig-type="figure" hwp:id="F10" hwp:rev-id="xref-fig-10-1 xref-fig-10-2 xref-fig-10-3 xref-fig-10-4 xref-fig-10-5 xref-fig-10-6 xref-fig-10-7 xref-fig-10-8"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIGS4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F10</object-id><object-id pub-id-type="publisher-id">figs4</object-id><label>Fig S4.</label><caption hwp:id="caption-10"><title hwp:id="title-59">Pathway and transcription factor motif enrichment analysis of genes with associated histone modification and gene expression changes during <italic toggle="yes">Y. enterocolitica</italic> infection.</title><p hwp:id="p-143"><bold>A,</bold> Heatmap of row-scaled (row Z-score) RNA-seq rlog gene counts for genes with RNA-seq and ChIP-seq promoter or enhancer overlaps belonging to “Inflammatory response” pathway as in <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-32" hwp:rel-id="F3">Figure 3H</xref>.</p><p hwp:id="p-144"><bold>B,</bold> GO terms associated with latent enhancer genes from <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-20" hwp:rel-id="F2">Figure 2F</xref>.</p><p hwp:id="p-145"><bold>C-D,</bold> Heatmaps of row-scaled (row Z-score) RNA-seq rlog gene counts for selected genes with RNA-seq and ChIP-seq promoter or enhancer overlaps belonging to phosphatases and kinases from MAPK signalling in Suppression profile <bold>(C)</bold> and Rab GTPase pathway in Prevention and Suppression profiles <bold>(D)</bold> from S16 Table.</p><p hwp:id="p-146"><bold>E,</bold> Heatmap showing transcription factor motif enrichment in promoter and enhancer regions of genes with RNA-seq and ChIP-seq overlaps from <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-33" hwp:rel-id="F3">Figure 3G</xref>. Color indicates level of log10 transformed P-value positively correlating with significance of enrichment.</p></caption><graphic xlink:href="459276v2_figs4" position="float" orientation="portrait" hwp:id="graphic-10"/></fig><fig id="figs5" position="float" orientation="portrait" fig-type="figure" hwp:id="F11" hwp:rev-id="xref-fig-11-1 xref-fig-11-2 xref-fig-11-3 xref-fig-11-4 xref-fig-11-5 xref-fig-11-6 xref-fig-11-7 xref-fig-11-8"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIGS5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F11</object-id><object-id pub-id-type="publisher-id">figs5</object-id><label>Fig S5.</label><caption hwp:id="caption-11"><title hwp:id="title-60">Epigenetic and transcriptional regulation of Rho GTPase pathway genes in <italic toggle="yes">Y. enterocolitica</italic> infected macrophages.</title><p hwp:id="p-147"><bold>A,</bold> Bar plot showing fraction and number (in bars) of indicated Rho GTPase pathway genes with changes in expression only (RNA only), any associated histone modification only (ChIP only), overlaps between RNA-seq and ChIP-seq (RNA &amp; ChIP) and no overlap with neither ChIP-seq nor RNA-seq (no overlap).</p><p hwp:id="p-148"><bold>B,</bold> Bar plot showing number of Rho GTPase pathway genes with dynamic histone modifications at promoters, enhancers or both (overlap).</p><p hwp:id="p-149"><bold>C,</bold> Table showing number of Rho GTPase pathway genes with histone modification changes at enhancers and number of associated enhancers. “% total enhancer associated genes” indicates what fraction of all Rho GTPase pathway genes with changes at enhancers show a certain number of changed enhancers.</p><p hwp:id="p-150"><bold>D, E,</bold> Heatmaps of DEGs with associated histone modification changes at promoters or enhancers encoding Rho GTPase effectors <bold>(D)</bold> and GEFs <bold>(E)</bold>. Associated profiles are color coded on the left. The specificity of GEFs for Rho GTPases is color coded on the right <bold>(E)</bold>. Gene rlog counts were row-scaled (row Z-score).</p><p hwp:id="p-151"><bold>F,</bold> Table showing specificity of Rho GTPase effectors associated with RNA-seq and ChIP-seq overlaps in <bold>(A)</bold> and <xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-15" hwp:rel-id="F4">Figure 4C</xref>.</p></caption><graphic xlink:href="459276v2_figs5" position="float" orientation="portrait" hwp:id="graphic-11"/></fig><fig id="figs6" position="float" orientation="portrait" fig-type="figure" hwp:id="F12" hwp:rev-id="xref-fig-12-1 xref-fig-12-2 xref-fig-12-3 xref-fig-12-4 xref-fig-12-5 xref-fig-12-6 xref-fig-12-7 xref-fig-12-8 xref-fig-12-9 xref-fig-12-10 xref-fig-12-11"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;2021.09.07.459276v2/FIGS6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F12</object-id><object-id pub-id-type="publisher-id">figs6</object-id><label>Fig S6.</label><caption hwp:id="caption-12"><title hwp:id="title-61">Analysis of YopM and YopP effect on epigenetic and gene expression changes in macrophages upon <italic toggle="yes">Y. enterocolitica</italic> infection.</title><p hwp:id="p-152"><bold>A,</bold> Principal component analysis of H3K4me3 tag counts in classes P1a-b of macrophages infected with the indicated strains for all biological replicates used in the analysis.</p><p hwp:id="p-153"><bold>B,</bold> Percentage YopP effect (median value) for H3K4me3 (P1a-b classes) and H3K27ac (P2a-d, E1-4 classes) when compared to WA314 vs mock (Up and Down profiles) or WA314 vs WAC (Suppression and Prevention profiles).</p><p hwp:id="p-154"><bold>C,</bold> Percentage YopP effect (median value) for DEGs associated with respective histone modification changes at promoters or enhancers. “Median”: median value when taking % YopP effect from all classes together.</p><p hwp:id="p-155"><bold>D,</bold> Scatter plot of % YopP effect for RNA-seq DEGs and ChIP-seq differential regions for genes with associated gene expression and histone modification change from Rho GTPase and Inflammatory response pathways from <xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-16" hwp:rel-id="F5">Figures 5C, D</xref>. Purple dots associated with ABI1 gene are indicated.</p><p hwp:id="p-156"><bold>E,</bold> Top: Dot plots showing ChIP-qPCR of H3K27ac at enhancer within ABI1 gene and H3K4me3 at ABI1 promoter from primary human macrophages infected for 6 h with indicated strains (MOI of 100). Lines represent means from three different biological replicates/ macrophage donors (dots with different shapes). Bottom: Peak tracks showing tag density of H3K27ac at enhancer (blue) and H3K4me3 at promoter (red) ChIP-seq and primer binding site used for fragment amplification in ChIP-qPCR analysis (qPCR target) shown in dot plots. The ChIP-qPCR signal was expressed as relative (rel.) enrichment (enr.) vs mock. inh: MAPK inhibitors.</p><p hwp:id="p-157"><bold>F,</bold> Dot plots showing RT-qPCR gene expression analysis of ABI1 from primary human macrophages infected for 6 h with indicated strains (MOI of 100). The RT-qPCR signal was expressed as fold vs mock. Lines represent means from three different biological replicates/ macrophage donors (dots with different shapes). inh: MAPK inhibitors.</p><p hwp:id="p-158"><bold>G,</bold> Immunofluorescence staining of primary human macrophages infected with WA314ΔYopP+C646 (p300 inhibitor) and WA314ΔYopP with MOI of 100 for 6 h. Cells were stained with antibody for H3K27ac. Images are representative of two independent experiments.</p></caption><graphic xlink:href="459276v2_figs6" position="float" orientation="portrait" hwp:id="graphic-12"/></fig></sec><sec id="s5b" hwp:id="sec-46"><title hwp:id="title-62">Tables</title><p hwp:id="p-159"><bold>S1 Table. Yersinia enterocolitica strains used in the study.</bold></p><p hwp:id="p-160"><bold>S2 Table. Analysis of promoter regions in P1 and P2 modules.</bold></p><p hwp:id="p-161"><bold>S3 Table. Analysis of enhancer regions in E1-4 classes.</bold></p><p hwp:id="p-162"><bold>S4 Table. Analysis of latent enhancers.</bold></p><p hwp:id="p-163"><bold>S5 Table. RNA-seq background from DESeq2 analysis.</bold></p><p hwp:id="p-164"><bold>S6 Table. Clustering of RNA-seq DEGs in a heatmap.</bold></p><p hwp:id="p-165"><bold>Table S7. Metabolic pathways in Prevention profile.</bold></p><p hwp:id="p-166"><bold>S8 Table. Enriched pathways associated with Rho GTPase pathway genes.</bold></p><p hwp:id="p-167"><bold>S9 Table. Analysis of Rho GTPase pathway genes in promoter and enhancer classes.</bold></p><p hwp:id="p-168"><bold>S10 Table. RNA-seq heatmap of DEGs from Rho GTPase pathway.</bold></p><p hwp:id="p-169"><bold>S11 Table. Rho GTPase specificity of GAPs and GEFs with RNA-seq and ChIP-seq overlaps in different profiles.</bold></p><p hwp:id="p-170"><bold>S12 Table. Rho GTPase specificity and reported function in epigenetics for effectors with RNA-seq and ChIP-seq overlaps.</bold></p><p hwp:id="p-171"><bold>S13 Table. Analysis of YopP effect on Rho GTPase pathway genes.</bold></p><p hwp:id="p-172"><bold>S14 Table. Analysis of YopP effect on inflammatory response pathway genes.</bold></p><p hwp:id="p-173"><bold>S15 Table. Primer sequences used for ChIP-qPCR and RT-qPCR analysis.</bold></p><p hwp:id="p-174"><bold>S16 Table. Enriched pathways associated with trafficking, MAPK signaling, Akt signaling and cell death.</bold></p><p hwp:id="p-175"><bold>S17 Table. Summary of all replicates used for ChIP-seq and RNA-seq experiments.</bold></p><p hwp:id="p-176"><bold>S18 Table. All filtered differentially enriched regions for histone marks based on diffReps analysis.</bold></p></sec></sec></back></article>
